US20050075713A1 - Minimally invasive valve replacement system - Google Patents

Minimally invasive valve replacement system Download PDF

Info

Publication number
US20050075713A1
US20050075713A1 US10/680,728 US68072803A US2005075713A1 US 20050075713 A1 US20050075713 A1 US 20050075713A1 US 68072803 A US68072803 A US 68072803A US 2005075713 A1 US2005075713 A1 US 2005075713A1
Authority
US
United States
Prior art keywords
valve
anchoring structure
inflow
sinus
outflow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/680,728
Inventor
Brian Biancucci
Tuoc Nguyen
Keith Myers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46599162&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20050075713(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to US10/680,728 priority Critical patent/US20050075713A1/en
Priority to US10/680,716 priority patent/US20050075718A1/en
Priority to US10/680,069 priority patent/US20050075729A1/en
Priority to US10/680,732 priority patent/US20050075720A1/en
Priority to US10/680,562 priority patent/US20050075724A1/en
Priority to US10/680,068 priority patent/US7044966B2/en
Priority to US10/680,567 priority patent/US20050096738A1/en
Priority to US10/680,075 priority patent/US20050075728A1/en
Priority to US10/680,717 priority patent/US20050075719A1/en
Application filed by Individual filed Critical Individual
Priority to US10/680,719 priority patent/US20050075712A1/en
Priority to US10/680,071 priority patent/US7101396B2/en
Priority to US10/680,560 priority patent/US20050075717A1/en
Priority to US10/680,070 priority patent/US20050075730A1/en
Priority to US10/680,733 priority patent/US20050075584A1/en
Priority to EP14163073.1A priority patent/EP2789314B1/en
Priority to EP20198702.1A priority patent/EP3821852A3/en
Priority to PCT/US2004/033026 priority patent/WO2005046528A1/en
Priority to EP04794398.0A priority patent/EP1684671B1/en
Priority to CA2545874A priority patent/CA2545874C/en
Publication of US20050075713A1 publication Critical patent/US20050075713A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2/013Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • A61F2/243Deployment by mechanical expansion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • A61F2/2439Expansion controlled by filaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2496Devices for determining the dimensions of the prosthetic valve to be implanted, e.g. templates, sizers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A61F2210/0019Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A61F2210/0023Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply
    • A61F2210/0028Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply cooled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • A61F2220/0016Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/005Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0066Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements stapled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0075Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0059Additional features; Implant or prostheses properties not otherwise provided for temporary

Definitions

  • the present invention relates to devices and systems for the replacement of physiological valves.
  • valves The transport of vital fluids in the human body is largely regulated by valves.
  • Physiological valves are designed to prevent the backflow of bodily fluids, such as blood, lymph, urine, bile, etc., thereby keeping the body's fluid dynamics unidirectional for proper homeostasis.
  • bodily fluids such as blood, lymph, urine, bile, etc.
  • venous valves maintain the upward flow of blood, particularly from the lower extremities, back toward the heart
  • lymphatic valves prevent the backflow of lymph within the lymph vessels, particularly those of the limbs.
  • valves Because of their common function, valves share certain anatomical features despite variations in relative size.
  • the cardiac valves are among the largest valves in the body with diameters that may exceed 30 mm, while valves of the smaller veins may have diameters no larger than a fraction of a millimeter. Regardless of their size, however, many physiological valves are situated in specialized anatomical structures known as sinuses.
  • Valve sinuses can be described as dilations or bulges in the vessel wall that houses the valve.
  • the geometry of the sinus has a function in the operation and fluid dynamics of the valve. One function is to guide fluid flow so as to create eddy currents that prevent the valve leaflets from adhering to the wall of the vessel at the peak of flow velocity, such as during systole.
  • Another function of the sinus geometry is to generate currents that facilitate the precise closing of the leaflets at the beginning of backflow pressure.
  • the sinus geometry is also important in reducing the stress exerted by differential fluid flow pressure on the valve leaflets or
  • the eddy currents occurring within the sinuses of Valsalva in the natural aortic root have been shown to be important in creating smooth, gradual and gentle closure of the aortic valve at the end of systole. Blood is permitted to travel along the curved contour of the sinus and onto the valve leaflets to effect their closure, thereby reducing the pressure that would otherwise be exerted by direct fluid flow onto the valve leaflets.
  • the sinuses of Valsalva also contain the coronary ostia, which are outflow openings of the arteries that feed the heart muscle. When valve sinuses contain such outflow openings, they serve the additional purpose of providing blood flow to such vessels throughout the cardiac cycle.
  • valves When valves exhibit abnormal anatomy and function as a result of valve disease or injury, the unidirectional flow of the physiological fluid they are designed to regulate is disrupted, resulting in increased hydrostatic pressure.
  • venous valvular dysfunction leads to blood flowing back and pooling in the lower legs, resulting in pain, swelling and edema, changes in skin color, and skin ulcerations that can be extremely difficult to treat. Lymphatic valve insufficiency can result in lymphedema with tissue fibrosis and gross distention of the affected body part.
  • Cardiac valvular disease may lead to pulmonary hypertension and edema, atrial fibrillation, and right heart failure in the case of mitral and tricuspid valve stenosis; or pulmonary congestion, left ventricular contractile impairment and congestive heart failure in the case of mitral regurgitation and aortic stenosis.
  • all valvular diseases result in either stenosis, in which the valve does not open properly, impeding fluid flow across it and causing a rise in fluid pressure, or insufficiency/regurgitation, in which the valve does not close properly and the fluid leaks back across the valve, creating backflow.
  • Some valves are afflicted with both stenosis and insufficiency, in which case the valve neither opens fully nor closes completely.
  • valve replacement surgery is becoming a widely used medical procedure, described and illustrated in numerous books and articles.
  • the diseased or abnormal valve is typically cut out and replaced with either a mechanical or tissue valve.
  • a conventional heart valve replacement surgery involves accessing the heart in a patient's thoracic cavity through a longitudinal incision in the chest. For example, a median sternotomy requires cutting through the sternum and forcing the two opposite halves of the rib cage to be spread apart, allowing access to the thoracic cavity and the heart within. The patient is then placed on cardiopulmonary bypass, which involves stopping the heart to permit access to the internal chambers.
  • Such open heart surgery is particularly invasive and involves a lengthy and difficult recovery period. Reducing or eliminating the time a patient spends in surgery is thus a goal of foremost clinical priority.
  • valve assemblies that allow implantation with minimal or no sutures would be greatly advantageous.
  • devices have been developed for the endovascular implantation of replacement valves, including collapsing, delivering, and then expanding the valve, such devices do not configure the valve in a manner that takes advantage of the natural compartments formed by the valve sinuses for optimal fluid dynamics and valve performance.
  • such valve constructs are configured such that the tissue leaflets of the support valve come into contact with the support structure, either during the collapsed or expanded state, or both.
  • Such contact is capable of contributing undesired stress on the valve leaflet.
  • support structures are not configured to properly support a tissue valve having a scalloped inflow annulus such as that disclosed in the U.S. patent application Ser. No. 09/772,526 which is incorporated by reference herein in its entirety.
  • a valve replacement system comprising a collapsible and expandable valve assembly that is capable of being secured into position with minimal or no suturing; facilitating an anatomically optimal position of the valve; maintaining an open pathway for other vessel openings of vessels that may be located in the valvular sinuses; and minimizing or reducing stress to the tissue valve leaflets.
  • the valves of the present invention may comprise a plurality of joined leaflets with a corresponding number of commissural tabs. Generally, however, the desired valve will contain two to four leaflets and commissural tabs. Examples of other suitable valves are disclosed in U.S. patent application Ser. Nos. 09/772,526, 09/853,463, 09/924,970, 10/121,208, 10/122,035, 10/153,286, 10/153,290, the disclosures of all of which are incorporated by reference in their entirety herein.
  • the present invention provides systems and devices for the replacement of physiological valves.
  • the replacement valve assemblies are adapted to fit substantially within the valve sinuses. Because the devices and procedures provided by the present invention eliminate or reduce the need for suturing, time spent in surgery is significantly decreased, and the risks associated with surgery are minimized. Further, the devices of the present invention are suitable for delivery by cannula or catheter.
  • a valve anchoring structure is provided that is dimensioned to be placed substantially within the valve sinus.
  • the valve anchoring structure extends substantially across the length of the valve sinus region.
  • a valve assembly comprising a valve and anchoring structure, in which the valve comprises a body having a proximal end and a distal end, an inlet at the proximal end, and an outlet at the distal end.
  • the inlet comprises an inflow annulus, preferably with either a scalloped or straight edge.
  • the outlet comprises a plurality of tabs that are supported by the anchoring means at the distal end. In preferred embodiments of the invention, the plurality of tabs are spaced evenly around the circumference of the valve.
  • a valve assembly is provided in which there is minimal or no contact between the valve and anchoring structure.
  • a valve assembly in which the valve is capable of achieving full opening and full closure without contacting the anchoring structure.
  • a valve assembly in which the vertical components of the anchoring structure are limited to the commissural posts between sinus cavities, thereby minimizing contact between mechanical components and fluid, as well as providing flow to vessels located in the valve sinus.
  • a valve is provided that firmly attaches to the valve sinus, obviating the need for suturing to secure the valve placement.
  • a valve assembly in which the anchoring structure may be collapsed to at least fifty percent of its maximum diameter.
  • an expansion and contraction device is provided to facilitate implantation of the valve and anchoring structure.
  • the present invention provides adhesive means for securing the valve assembly in a valve sinus.
  • a valve sizing apparatus for the noninvasive determination of native valve size.
  • the present invention also provides cutting means to remove the native diseased valve.
  • One aspect of the cutting means comprises a plurality ofjaw elements, each jaw element having a sharp end enabling the jaw element to cut through at least a portion of the native valve.
  • Another aspect of the cutting means comprises a plurality of electrode elements, wherein radiofrequency energy is delivered to each electrode element enabling the electrode element to cut through at least a portion of the native valve.
  • a further aspect of the cutting means comprises a plurality of ultrasound transducer elements, wherein ultrasound energy is delivered to each transducer element enabling the transducer element to cut through at least a portion of the native valve.
  • the present invention provides a temporary two-way valve and distal protection filter assembly.
  • FIG. 1 shows an exemplary valve during operation.
  • FIG. 1A shows the valve in the open position during peak flow.
  • FIG. 1B shows the valve in closed position to prevent backflow of the fluid across the valve.
  • FIG. 2 shows a preferred embodiment of the valve of the present invention. This valve features commissural tabs and a scalloped inflow annulus.
  • FIGS. 3A , B and C are representations of a typical valve sinus. These figures illustrate the anatomy of the sinus cavities, commissural posts, leaflets and inflow/outflow annuli.
  • FIG. 4 is a schematic representation of the geometry and relative dimensions of the valve sinus region.
  • FIG. 5 shows a valve anchoring structure, in accordance with a preferred embodiment of the present invention, that is lodged inside a vessel.
  • FIGS. 6A and B are schematics of a valve assembly comprising a valve and an anchoring structure in which the anchoring structure features an additional cloth ring along the valve inflow edge that serves as a gasket.
  • FIG. 6C shows a valve anchoring structure according to one preferred embodiment of the present invention featuring a two-ring inflow rim.
  • FIG. 7 is a diagrammatic representation of a flat pattern of a preferred embodiment of an anchoring structure in the expanded state.
  • FIG. 8 is a diagrammatic representation of a flat pattern of a preferred embodiment of an anchoring structure in the compressed state.
  • FIG. 9 shows a flat valve leaflet of a preferred valve to which the anchoring structure dimensions can be fitted.
  • FIG. 10 illustrates the relative dimensions of a preferred embodiment of an anchoring structure of the present invention.
  • FIG. 11 shows a flared anchoring structure dimensioned to lodge inside the sinus cavities.
  • FIG. 12 shows a different view of the flared anchoring structure.
  • FIG. 13 shows a preferred embodiment of an anchoring structure lacking an outflow ring, and having support posts dimensioned to lodge in the sinus commissural posts, providing cantilevered support for the valve outflow end.
  • FIG. 14 shows a preferred embodiment of an anchoring structure with flared in- and outflow ends and support posts for lodging in the commissural posts with attachment windows capable of deflecting inward at back flow pressure.
  • FIG. 15A shows a top view of a preferred embodiment of a valve assembly comprising a valve and an anchoring structure made of elliptical segments joined together.
  • FIG. 15B shows a lateral view of the preferred anchoring structure without valve.
  • FIG. 16A shows the valve assembly comprising a valve and elliptical segment anchoring structure in expanded form.
  • FIG. 16B shows the same in compressed form
  • FIG. 17 shows the lodging of an elliptical anchoring structure inside the valve sinus cavities.
  • FIG. 18A shows how the elliptical segments of the anchoring structure may be joined by a double crimp.
  • FIG. 18B shows how the valve is positioned inside the anchoring structure.
  • FIG. 19A shows a double crimp uniquely designed to flexibly join the elliptical segments.
  • FIG. 19B shows a modified double crimp.
  • FIG. 20A shows how the elliptical segments may be assembled into the double crimp.
  • FIG. 20B shows the final assembly.
  • FIGS. 21 A-G show different views of an elliptical segment anchoring structure further comprising cloth covering including a gasket cloth cuff at the inflow rim.
  • FIGS. 22A and B show different views of an elliptical segment anchoring structure made from a single piece of tubing.
  • FIGS. 23A through D show an elliptical segment anchoring structure in which the upper segments have been removed and the ends of the junctions are formed into prongs.
  • FIG. 24 shows a preferred valve assembly of the present invention with an anchoring structure comprising a ring incorporated into the valve inflow rim.
  • FIG. 25A shows an anchoring structure comprising two undulating rings with inverse wave patterns.
  • FIG. 25B shows an anchoring structure comprising two such rings connected by vertical elements.
  • FIG. 26 shows a valve assembly comprising an anchoring structure in which the inflow ring and outflow ring are structurally unconnected.
  • FIG. 27A -C show a tubular anchoring structure.
  • FIGS. 28 A-D show an anchoring structure comprising an inflow ring and an outflow ring connected by vertical posts that slide across one another upon compression.
  • FIGS. 29A and B show an anchoring structure comprising an inflow and outflow ring connected by vertical posts that join to form a single vertical element upon compression.
  • FIGS. 30A and B shows an anchoring structure comprising a three-member spring aided frame.
  • FIGS. 31A and B show a preferred embodiment of an expansion and contraction device.
  • FIGS. 32A and B more particularly shows the angled wires of the device.
  • FIG. 33 shows the positioning of an anchoring structure on the expansion and contraction device.
  • FIG. 34 shows another preferred embodiment of an expansion and contraction device featuring a wire-spindle mechanism.
  • FIG. 35 shows a different perspective of the wire-spindle expansion and contraction device.
  • FIGS. 36A and B show another preferred embodiment of an expansion and contraction device for self-expanding valve assemblies.
  • FIG. 37A shows a further preferred embodiment of an expansion and contraction device featuring a rotating plate mechanism.
  • FIGS. 37B and C more particularly shows the spiral-shaped rotating plate.
  • FIGS. 38A and B show the expansion and contraction device expanding an anchoring frame.
  • FIG. 39 shows another preferred embodiment of an expansion and contraction device featuring a groove-pin mechanism.
  • FIG. 40 shows one preferred embodiment of a valve having an outer circumferential reservoir containing a sealable fixation means for securely fixing the valve prosthesis at a desired location within a vessel or body cavity.
  • FIGS. 41A and B show another embodiment of a valve having an outer circumferential reservoir, wherein the sealabe fixation means comprises a two component biological adhesive.
  • FIG. 42 illustrates a reservoir with thin spots adapted to rupture when the reservoir is under pressure, thereby releasing the contents of the reservoir.
  • FIG. 43 is a cross-sectional view of the reservoir showing the thin spots.
  • FIG. 44 is a cross-sectional view of a valve reservoir having two concentric component compartments.
  • FIGS. 45A and B depict a minimally-invasive valve replacement sizer.
  • FIG. 46 is a cross-sectional view of a minimally-invasive valve replacement sizer comprising a guidewire, an intravascular ultrasound (IVUS) catheter having a transducer, and a balloon catheter, all positioned within the central lumen of the catheter.
  • IVUS intravascular ultrasound
  • FIG. 47 shows a balloon catheter comprising a balloon that circumferentially surrounds a portion of the catheter at its distal portion.
  • FIG. 48 shows a cross-sectional view of an inflated balloon with curves forming leaflets to enable fluid to pass.
  • FIG. 49 shows one preferred embodiment of a minimally-invasive valve replacement sizer, wherein the balloon is inflated with saline.
  • FIG. 50 shows a preferred embodiment of a minimally-invasive valve replacement sizer system, wherein the transducer emits an ultrasonic signal in a perpendicular direction to an intravascular ultrasound catheter (IVUS), which is reflected off the outer wall of the balloon and then received by the transducer and wherein the radius and diameter of the body cavity is determined by the auxiliary processor.
  • IVUS intravascular ultrasound catheter
  • FIG. 51 shows an anchoring structure of the present invention having ultrasound cutting means.
  • FIG. 52 shows an anchoring structure of the present invention having radiofrequency cutting means.
  • FIG. 53 shows an anchoring structure having sharp edge cutting means.
  • FIG. 54 is a partial view of the valve assembly with cutting means on a partially inflated balloon catheter.
  • FIGS. 55 A-C show a temporary two-way valve for distal protection.
  • a valve ( 1 ) comprises a distal or outflow end ( 2 ), leaflets ( 3 ) and a proximal or inflow end ( 4 ).
  • a typical valve functions similar to a collapsible tube in that it opens widely during systole or in response to muscular contraction, to enable unobstructed forward flow across the valvular orifice ( FIG. 1A ).
  • FIG. 1B At the end of systole or contraction, as illustrated in FIG. 1B , as forward flow decelerates, the walls of the tube are forced centrally between the sites of attachment to the vessel wall and the valve closes completely.
  • a preferred valve ( 5 ) for use with the systems and devices of the present invention is illustrated in FIG. 2 and is comprised of a body having a proximal end or inflow ring ( 6 ) and a distal end or outflow ring ( 7 ).
  • the body is comprised of multiple leaflets of valve tissue joined by seams ( 8 ), wherein each seam is formed by a junction of two leaflets.
  • a commissural tab region ( 9 ) extends from each seam at the distal end of the valve body.
  • the proximal end ( 6 ) has an inflow ring with a peripheral edge that can be scalloped or straight.
  • the inflow ring ( 6 ) of the valve can further comprise a reinforcement structure ( 10 ) that can be stitched to it.
  • valve replacement systems and devices of the present invention are not limited, however, to the specific valve illustrated in FIG. 2 .
  • An important consideration in the design of valve replacement systems and devices that has received insufficient attention in previous approaches is the architecture of valve sinus.
  • Valve sinuses are dilations of the vessel wall that surround the natural valve leaflets.
  • each natural valve leaflet has a separate sinus bulge or cavity that allows for maximal opening of the leaflet at peak flow without permitting contact between the leaflet and the vessel wall.
  • a two-leaflet valve is surrounded by two sinus bulges, a three-leaflet valve by three, and a four-leaflet valve by four sinus cavities.
  • FIGS. 3A and B illustrate the reduced curvature of the commissural posts ( 11 ) compared with the curvature of the sinus cavities ( 12 ).
  • FIG. 3C shows a view from outside the vessel of a commissural post ( 11 ) between two sinus cavities ( 12 ), while FIG. 3A shows a cross sectional view from the top of a closed valve within a valve sinus.
  • the areas between the bulges define the commissural posts ( 11 ) and as can be clearly seen in FIG. 3B , the commissural posts serve as the sites of attachment for the valve leaflets to the vessel wall ( 13 ).
  • FIGS. 3B and C also show the narrowing diameter of the sinus region at both its inflow end ( 14 ) and outflow end ( 15 ) to form the inflow and outflow annuli of the sinus region.
  • the valve sinuses form a natural compartment to support the operation of the valve by preventing contact between the leaflets and the vessel wall, which, in turn, may lead to adherence of the leaflets and/or result in detrimental wear and tear of the leaflets.
  • the valve sinuses are also designed to share the stress conditions imposed on the valve leaflets during closure when fluid pressure on the closed leaflets is greatest.
  • the valve sinuses further create favorable fluid dynamics through currents that soften an otherwise abrupt closure of the leaflets under conditions of high backflow pressure.
  • the sinuses ensure constant flow to any vessels located within the sinus cavities.
  • the valve sinus region is characterized by certain relative dimensions which remain constant regardless of the actual size of the sinuses.
  • the diameter of the sinus is at its largest at the center of the cavities or bulges ( 16 ), while there is pronounced narrowing of the sinus region at both the inflow annulus ( 17 ) and outflow annulus ( 18 ).
  • the height of the sinus ( 19 ) i.e. the distance between the inflow and outflow annuli remains proportional to its overall dimensions. It is thus apparent that the sinus region forms an anatomical compartment with certain constant features that are uniquely adapted to house a valve.
  • the systems and devices of the present invention are designed to utilize these anatomical features of the native sinus region for optimal replacement valve function and position.
  • the replacement valve assembly comprises a collapsible and expandable anchoring structure adapted to support a valve distally along the commissural tab region and proximally along the inflow annulus.
  • FIG. 5 shows a preferred anchoring structure adapted to support a valve such as that illustrated in FIG. 2 .
  • the preferred anchoring structure has a generally tubular configuration within which the valve is secured.
  • the valve is secured at its proximal (inflow) annulus by attachment to the inflow rim ( 20 ) of the anchoring structure and at its distal end via the commissural tabs that are threaded through the axially extending slots ( 21 ), which are formed in the support posts ( 22 ) that extend longitudinally from the inflow rim ( 20 ) to the outflow rim ( 23 ) of the anchoring structure.
  • the distal ends ( 24 ) of the support posts contact the outflow rim ( 23 ) of the anchoring structure
  • the proximal ends ( 25 ) of the support posts contact the inflow rim ( 20 ) of the anchoring structure.
  • the outflow rim ( 23 ) of the anchoring structure is depicted as comprising a plurality of rings that extend between the support posts ( 22 ) generally at or above the axially extending slots ( 21 ) that reside therein.
  • the plurality of rings of the outflow rim ( 23 ) are configured in an undulating or zigzag pattern forming peaks ( 26 ) and valleys ( 27 ), wherein the individual rings remain substantially parallel to one another.
  • the plurality of rings of the outflow rim comprise a vertical connector element ( 28 ) positioned at the center of the valleys ( 27 ) formed by the undulating or zigzag pattern.
  • This vertical connector element ( 2 o) is designed to stabilize the anchoring structure and to prevent distortion of the valve during compression and expansion of the anchoring structure comprising the valve.
  • the vertical element ( 28 ) extends longitudinally in the axial direction of the cylindrical anchoring structure.
  • the outflow rim ( 23 ) of the anchoring structure comprises two rings.
  • the inflow rim ( 20 ) of the support structure comprises a single ring that extends between the support posts ( 22 ).
  • Both the inflow ( 20 ) and outflow ( 23 ) rims of the anchoring structure are formed with an undulating or zigzag configuration, although the inflow rim ( 20 ) may have a shorter wavelength (circumferential dimension from peak to peak) and a lesser wave height (axial dimension from peak to peak) than the outflow rim ( 23 ).
  • the wavelengths and wave heights of the inflow ( 20 ) and outflow ( 23 ) rims are selected to ensure uniform compression and expansion of the anchoring structure without distortion.
  • the wavelength of the inflow rim ( 20 ) is further selected to support the geometry of the scalloped inflow annulus of a preferred valve of the present invention. Notably, as shown in FIG.
  • the undulating or zigzag pattern that forms the inflow rim ( 20 ) of the anchoring structure is configured such that the proximal ends ( 25 ) of the vertical support posts ( 22 ) are connected to the peaks ( 29 ) of the inflow rim ( 20 ).
  • the undulating or zigzag pattern that forms the outflow rim ( 23 ) of the anchoring structure is configured such that the distal ends ( 24 ) of the support posts ( 22 ) are connected to the valleys ( 27 ) of the outflow rim ( 23 ).
  • Locating the distal ends ( 24 ) of the support posts at the valleys ( 27 ) of the outflow rim ( 23 ) will prevent the longitudinal extension of outflow rim ( 23 ) in the direction of the valve secured within the lumen of the anchoring structure upon compression of the valve assembly, thereby eliminating any contact between valve and anchoring structure.
  • Locating the proximal ends ( 25 ) of the support posts at the peaks ( 29 ) of the inflow rim ( 20 ) will prevent longitudinal extension of the inflow rim ( 20 ) in the direction of the valve tissue.
  • compression of the valve and anchoring structure does not lead to distortion of or injury to the valve.
  • FIG. 5 further shows that the support posts ( 22 ) are configured generally in the shape of paddle with the axial slot ( 21 ) extending internally within the blade ( 30 ) of the paddle.
  • the blade ( 30 ) of the paddle is oriented toward the outflow rim ( 23 ) of the anchoring structure and connects to the outflow rim ( 23 ) at a valley ( 27 ) of the undulating or zigzag pattern of the outflow rim ( 23 ).
  • An important function of the support posts ( 22 ) is the stabilization of the valve in general, and in particular the prevention of any longitudinal extension at points of valve attachment to preclude valve stretching or distortion upon compression of the device.
  • the blades ( 30 ) of the paddle-shaped support posts ( 22 ) are designed to accommodate the commissural tabs of the valve.
  • the support posts ( 22 ) further comprise triangular shaped elements ( 31 ) extending on each side of the proximal end ( 25 ) of the support post.
  • the triangular shaped elements ( 31 ) are designed to serve as attachments sites for the sewing cuff gasket and may be designed in different shapes without losing their function.
  • the number of support posts ( 22 ) in this preferred embodiment can range from two to four, depending on the number of commissural posts present in the valve sinus.
  • the anchoring structure comprises three support posts for a three-leaflet valve with a sinus that features three natural commissural posts.
  • the support posts ( 22 ) of the anchoring structure are configured to coincide with the natural commissural posts of the sinus.
  • FIGS. 6A and B show the preferred embodiment of FIG. 5 having a valve secured internally.
  • the valve ( 32 ) is secured at its proximal (inflow) annulus ( 33 ) by attachment to the inflow rim ( 20 ) of the anchoring structure and at its outflow or distal end ( 34 ) via the commissural tabs ( 35 ) that are threaded through the axially extending slots ( 21 ), which are formed in the support posts ( 22 ) that extend longitudinally from the inflow rim ( 20 ) to the outflow rim ( 23 ) of the anchoring structure.
  • the outflow rim ( 23 ) of the anchoring structure is configured to be longitudinally displaced from the distal outflow annulus ( 34 ) of the valve leaflets ( 36 ) that reside within the lumen of the tubular anchoring structure, thereby avoiding any contact between the valve leaflets ( 36 ) and the anchoring structure.
  • the inflow rim ( 20 ) of the anchoring structure can be secured to the proximal inflow annulus ( 33 ) of the valve via a suitable fabric that may be wrapped around the circumferential juncture at the inflow end ( 33 ) and stitched into position to form a sewing cuff ( 37 ).
  • the fabric may be made of any suitable material including but not limited to woven polyester, such as polyethylene terepthalate, polytetrafluoroethylene (PTFE), or other biocompatible material.
  • the valve ( 32 ) is secured inside the anchoring structure by sewing a fabric ring ( 37 ) around the inflow rim ( 20 ) of the anchoring structure so as to create a sealing surface around the outer perimeter of valve's inflow annulus ( 33 ).
  • the fabric ring ( 37 ) comprises two sewing cuff rings as shown in FIGS. 6A and B, with the second sewing cuff ring ( 38 ) having a larger diameter than the inflow annulus of the native valve sinus to ensure the firm lodging of the anchoring structure against the inflow annulus of the native valve sinus, thereby creating a tight, gasket-like seal.
  • valve ( 32 ) The positioning of the valve ( 32 ) internally to the preferred anchoring structure with only the fabric of the commissural mounting tabs ( 35 ) of the valve ( 32 ) contacting the support posts ( 22 ) at the distal outflow annulus of the valve ( 34 ), while the proximal inflow annulus ( 33 ) of the valve is separated from the inflow rim ( 20 ) of the anchoring structure by the sewing cloth ( 37 ), ensures that no part of the valve ( 32 ) is contacted by the anchoring structure during operation of the valve ( 32 ), thereby eliminating wear on the valve ( 32 ) that may be occasioned by contact with mechanical elements.
  • the outflow rim ( 23 ) of the anchoring structure is depicted as comprising a plurality of rings that extend between the support posts ( 22 ) generally at or above the axially extending slots ( 21 ) that reside at their distal ends ( 24 ).
  • the plurality of rings of the outflow rim ( 23 ) are configured in an undulating or zigzag pattern forming peaks ( 26 ) and valleys ( 27 ), wherein the individual rings remain substantially parallel to one another.
  • the plurality of rings of the outflow rim comprise a vertical connector element ( 28 ) positioned at the center of the valleys ( 27 ) formed by the undulating or zigzag pattern.
  • This vertical connector element ( 28 ) is designed to stabilize the anchoring structure and to prevent distortion of the valve during compression and expansion of the anchoring structure containing the valve within.
  • the vertical element ( 28 ) extends longitudinally in the axial direction of the cylindrical anchoring structure.
  • the outflow rim of the anchoring structure comprises two rings.
  • FIG. 6C shows another implementation of a preferred anchoring structure of the present invention.
  • the implementation shown in FIG. 6C features an inflow rim ( 20 ) comprising two rings that are substantially parallel to each other and are connected by a vertical connector element ( 39 ) positioned at the center of the peaks ( 29 ) formed by the undulating or zigzag pattern.
  • This vertical connector element ( 39 ) is designed to stabilize the anchoring structure and to prevent distortion of the valve during compression and expansion of the anchoring structure comprising the valve.
  • the vertical element ( 39 ) extends longitudinally in the axial direction of the cylindrical anchoring structure.
  • FIG. 6C also shows that the distal end ( 24 ) of the support post ( 22 ) may further comprise suture bores ( 41 ) to facilitate the placement of additional sutures for the securing the valve to the anchoring structure.
  • the wavelengths and wave heights of the inflow ( 20 ) and outflow rims ( 23 ) are selected to ensure uniform compression and expansion of the anchoring structure without distortion, a different wavelength and height may be chosen for the inflow ring ( 20 ) of an implementation of a preferred embodiment of an anchoring structure featuring an inflow rim ( 20 ) with two substantially parallel undulating rings as shown in FIG. 6C .
  • the inflow rim ( 20 ) depicted in FIG. 6C may have substantially the same wavelength and height as the outflow rim ( 23 ).
  • the support posts ( 22 ) may be modified to comprise a widened proximal end ( 25 ) with an axial slot ( 40 ) extending longitudinally from the inflow rim ( 20 ) toward the distal end ( 24 ) of the support posts ( 22 ) and centrally through the triangular shaped elements ( 31 ).
  • the widening of the proximal end ( 25 ) of the support posts ( 22 ) protects the triangular shaped elements ( 31 ) from distortion by the different collapsed profile of the inflow rim ( 20 ) with larger wavelength and height and ensures that no part of the valve ( 32 ) will be contacted by the anchoring structure during compression.
  • FIGS. 7 and 8 show the expansion ( FIG. 7 ) and compression ( FIG. 8 ) profile of a preferred anchoring structure of the present invention.
  • the anchoring structure is collapsible to at least 50% of its expanded diameter.
  • the undulating or zigzag pattern that forms the inflow rim ( 20 ) of the anchoring structure is configured such that the proximal ends ( 25 ) of the vertical support posts ( 22 ) are connected to the peaks ( 29 ) of the inflow rim ( 20 ).
  • the undulating or zigzag pattern that forms the outflow rim ( 23 ) of the anchoring structure is configured such that the support posts ( 22 ) are connected to the valleys ( 27 ) of the outflow rim ( 23 ). Locating the distal ends ( 24 ) of the support posts ( 22 ) at the valleys ( 27 ) of the outflow rim ( 23 ) will prevent the longitudinal extension of outflow rim ( 23 ) in the direction of the valve upon compression of the device, thereby eliminating any contact between valve and anchoring structure.
  • proximal ends ( 25 ) of the support posts ( 22 ) at the peaks ( 29 ) of the inflow rim ( 20 ) prevents structural interference between the proximal ends ( 25 ) of the support posts ( 22 ), in particular the triangular shaped elements ( 31 ) designed to support the scalloped inflow annulus of the replacement valve, and the undulating pattern of the inflow rim ( 20 ), as well as longitudinal extension of the inflow rim ( 20 ) in the direction of the valve tissue.
  • compression of the valve and anchoring structure does not lead to distortion of or injury to the valve.
  • FIG. 8 shows that the support posts ( 22 ) connect to the outflow rim ( 23 ) at a valley ( 27 ) of the undulating or zigzag pattern and that during compression, the support posts stabilize the anchoring structure by preventing any longitudinal extension at points of valve attachment, that is at the proximal ( 25 ) and distal ( 24 ) ends of the support posts.
  • the commissural mounting tabs of the valve are attached to the anchoring structure by extending through the axial slots ( 40 ) of the support posts to the exterior of the anchoring structure, while the inflow annulus of the valve is connected to the inflow rim ( 20 ) of the anchoring structure via a fabric ring.
  • the number of support posts ( 22 ) in this preferred embodiment can range from two to four, depending on the number of commissural posts present in the valve sinus.
  • the anchoring structure comprises three support posts ( 22 ) for a three-leaflet valve with a sinus that features three natural commissural posts.
  • the support posts ( 22 ) of the anchoring structure are configured to coincide with the natural commissural posts of the sinus.
  • an advantage of this arrangement is the additional option for the surgeon of suturing the valve assembly into place, wherein the anchoring structure provides the surgeon with additional guidance as to the proper anatomical positioning of the valve inside the native valve sinuses. Since the anchoring structure is dimensioned to fit precisely into the valve sinus cavities, the surgeon's positioning task is simplified to a visual determination of the location of the commissural posts of the native sinuses and their alignment with the support posts ( 22 ) of the anchoring structure of the valve. Thus, the present preferred embodiment takes advantage of the natural features of the valve sinus for the rapid orientation and attachment of the valve assembly. The ability of the anchoring structure to emulate the architecture of the valve sinus thus significantly reduces the surgeon's time spent on suturing the valve into position, should he so desire.
  • the geometry of the preferred embodiment of a valve anchoring structure further naturally positions it across the entire longitudinal extension of the native valve sinus, lodging the anchoring structure firmly against the vessel walls.
  • the inflow rim ( 20 ) of the anchoring structure naturally fits into the native valve sinus at a position near the inflow narrowing (annulus) of the native valve sinus against which it is designed to rest
  • the outflow rim ( 23 ) of the anchoring structure fits into the sinus at a position near the outflow narrowing (annulus) of the sinus against which it is designed to rest.
  • a further advantage of this preferred embodiment of the present invention is the ability of the anchoring structure to emulate the natural compartment formed by the sinus for anchoring the valve.
  • the anchoring structure is able to extend completely across the sinuses without placing mechanical elements into the path of fluid flow and without obstructing flow to any vessel openings that may be present in the valve sinuses.
  • the anchoring structure exerts radial force against the vessel wall so as to produce a compression fit. This may be accomplished by oversizing the anchoring structure such that it permanently seeks to expand to its original size.
  • both the inflow ( 20 ) and outflow ( 23 ) rims are designed to push radially against the sinus walls near the inflow and outflow annuli of the sinus.
  • the undulating or zigzag pattern formed by the inflow ( 20 ) and outflow ( 23 ) rings further serves to provide tire-like traction against the sinus wall for anchoring.
  • the combination of compression fit, traction and sewing cuff rings ( 37 and 38 ) of the anchoring structure provides a firm anchor for the replacement valve and an optimal configuration in the native valve sinus.
  • the anchoring structure comprises a material that is expandable from a compressed configuration illustrated in FIG. 8 into the configuration depicted in FIG. 7 .
  • the anchoring structure may be non-self expanding, i.e. capable of being expanded from a compressed state using mechanical means, such as a balloon inflated from within the radial center of the anchoring structure, or using the expansion and compression devices disclosed herein.
  • the anchoring structure comprises vertical tab support posts ( 22 ) which are designed to prevent inelastic deformation when the anchoring structure is collapsed prior to implantation.
  • FIG. 9 shows a representative flat valve leaflet ( 36 ) before it is sewn together with a desired number of additional leaflets ( 36 ) to form a three-dimensional replacement valve.
  • the flat pattern of the leaflet ( 36 ) can be used to dimension the anchoring structure shown in FIG.
  • commissural tabs ( 35 ) of the valve ( 36 ) will coincide with the axial slots ( 21 ) at the distal ends ( 24 ) of the support posts ( 22 ) and the proximal edges ( 42 ) at which the leaflets will be stitched or otherwise attached to each other to form the inflow annulus of the valve can be attached to the proximal ends ( 25 ) of the support posts ( 22 ) of the anchoring structure via the triangular shaped elements ( 31 ).
  • FIGS. 9 and 10 also show how an anchoring structure and valve may be scaled to fit different sizes of valve sinuses while retaining the proportional dimensions of the valve sinus. For example, if the width ( 43 ) of the leaflet ( 36 ) shown in FIG. 9 is chosen for a certain valve size, then the distance ( 44 ) between support posts ( 22 ) of the anchoring structure shown in FIG. 10 will be determined accordingly. Likewise, the height ( 45 ) of the leaflet ( 36 ) in FIG. 9 will determine the length ( 46 ) of the support posts ( 22 ) of the anchoring structure in FIG. 10 . In this manner, a person of skill in the art can dimension both the valve and anchoring structure to fit any size of valve sinus.
  • FIGS. 11 and 12 Another preferred embodiment of the present invention, illustrated in FIGS. 11 and 12 , comprises a valve supported by a flared anchoring structure.
  • the flared anchoring structure preferably comprises flared-out sections located at both the inflow ( 47 ) and outflow rims ( 48 ) to anchor it firmly against the narrowed inflow and outflow annuli of the valve sinuses.
  • the flared distal end ( 48 ) of the anchoring structure is adapted to support the tab regions of the valve while the flared proximal end ( 47 ) supports the valve inflow annulus ( 33 ).
  • the flared-out feature prevents contact between the valve tissue and the anchoring structure if the outflow rim ( 48 ) is positioned below the upper edges of the valve leaflets ( 36 ) in the open position, while also allowing the anchoring structure to secure itself in a sinus cavity of the vascular passageway.
  • the outflow rim ( 48 ) of the anchoring structure is comprised of diamond ( 49 ) and hexagon ( 50 ) shaped structures which facilitate collapsibility and dynamic compliance.
  • the commissural tabs ( 35 ) of the valve ( 32 ) can be stitched directly to the hexagon shaped elements ( 50 ) of the outflow ring, rather than being secured via slots.
  • the flared inflow rim ( 47 ) of the anchoring structure preferably comprises a single ring in the form of an undulating or zigzag pattern to which the valve's fabric ring ( 37 ) can be sewn.
  • the inflow ring ( 47 ) of the anchoring structure is connected to the outflow rim ( 48 ) through vertical elements ( 51 ) that are positioned to coincide with the commissural posts of the native sinus region.
  • the exemplary embodiment of FIGS. 11 and 12 comprises three vertical connecting elements ( 51 ) for a three-leaflet valve ( 32 ).
  • the number of vertical connecting elements ( 51 ) is meant to be adapted to the number of native commissural posts present in the particular sinus region.
  • the area between vertical connector elements ( 51 ) is thus left free of any structural elements for the accommodation of vessel openings that may be present in the particular valve sinus.
  • a valve is supported by an anchoring structure comprising a plurality of posts ( 52 ) with a single ring ( 53 ) at the inflow rim.
  • the ring ( 53 ) is configured in an undulating or zigzag pattern.
  • the plurality of posts ( 52 ) number three for a three-leaflet valve sinus region.
  • the three posts ( 52 ) extend in the distal direction from the single ring ( 53 ) located at the inflow end of the anchoring structure.
  • the proximal end ( 33 ) of the valve is attached to the ring ( 53 ) portion of the anchoring structure so that the ring ( 53 ) provides support to the inflow annulus ( 33 ) of the valve.
  • the inflow ring ( 53 ) comprises an undulating or zigzag pattern for tire-like traction against the vessel wall.
  • the anchoring structure portion surrounding the proximal end ( 33 ) of the valve is preferably flared in an outward direction to improve anchoring forces against the vascular wall.
  • the three posts ( 52 ) extend from the proximal end ( 33 ) to the distal end ( 34 ) of the valve and provide cantilevered support to the tab regions ( 35 ) of the valve at the distal end ( 34 ).
  • the three posts ( 52 ) are designed to be sufficiently flexible so that they may deflect inwardly in a controlled motion at back flow pressures to optimize the fatigue life of the anchoring structure.
  • the posts ( 52 ) comprise a distal end ( 54 ) for the attachment of the valve commissural tabs ( 35 ). Below the distal end ( 54 ), the posts ( 52 ) comprise a diamond-shaped element ( 55 ) for enhanced structural stability and valve support.
  • the design according to the present embodiment creates open space between the proximal ( 33 ) and distal ends of the valve ( 34 ). This also ensures that there is no direct contact between the valve and the anchoring structure and that vessel openings located within the particular sinus remain unencumbered.
  • the support posts ( 52 ) are configured to spatially coincide with the commissural posts of the valve sinuses for ease of positioning and anatomical optimization.
  • the anchoring structure embodiment illustrated in FIG. 14 comprises a valve supported by a multi-operational anchoring structure ( 56 ).
  • the multi-operational anchoring structure ( 56 ) comprises a proximal end ( 57 ), a distal end ( 58 ), posts ( 59 ) extending from the proximal end ( 57 ) to the distal end ( 58 ), and a tab attachment window ( 60 ) attached to each post ( 59 ) at the distal end ( 58 ).
  • the tab attachment windows ( 60 ) in the present embodiment have a triangular geometry that is designed to create an optimal interference fit between the anchoring structure and the commissural tabs.
  • the post ( 59 ) and tab attachment window ( 60 ) construction of the present embodiment allows inward deflection of the post at back flow pressure, thus providing cantilevered support to the valve and greater dynamic compliance with the sinus region.
  • Both the proximal ( 57 ) and distal ( 58 ) ends of the anchoring structure are flared out to better secure the valve in the valvular sinus region.
  • the proximal end or inflow rim ( 57 ) of the anchoring structure also preferably possesses barbs or hooks ( 61 ) at the proximal end ( 62 ) of the post ( 59 ) for better attachment to the vascular wall and/or the valve's inflow annulus.
  • the flared inflow rim ( 57 ) is depicted as featuring two undulating rings that are substantially parallel to one another, while the flared outflow rim features three undulating rings.
  • FIGS. 15-21 Yet another preferred embodiment of a valve anchoring device according to the present invention is illustrated in FIGS. 15-21 .
  • an elliptical segment ( 70 ) anchoring structure is used to support the valve ( 32 ) as shown in FIG. 15A .
  • the elliptical segment anchoring structure ( 70 ) comprises a plurality of elliptical segments ( 71 ) that are joined together, either integrally, mechanically, or by adhesive means.
  • Each elliptical segment ( 71 ) is flared outward at the proximal ( 72 ) and distal ends ( 73 ) of the anchoring structure and curved inward at the junctures ( 74 ) with the other segments ( 71 ) assuming the shape of a potato chip.
  • the elliptical segments ( 71 ) form a tubular structure that is flared outward at both the inflow ( 72 ) and outflow ( 73 ) ends.
  • the junctures ( 74 ) of the elliptical segments ( 71 ) are located at the center of a substantially straight area of the elliptical segments ( 71 ) that defines the longitudinal support post elements ( 75 ) of the elliptical segment anchoring structure ( 70 ) and also provides a gap location ( 75 ) near which the valve tabs ( 35 ) can be secured.
  • the tab regions ( 35 ) extending from the seams of the valve can be attached to the anchoring structure using any suitable means, including, sewing, stapling, wedging or adhesive means.
  • the tab regions ( 35 ) are preferably attached to the gaps ( 75 ) formed above the junctures ( 74 ) between the elliptical segments ( 71 ).
  • the inflow ( 72 ) and outflow ( 73 ) rims of the anchoring structure are formed by the corresponding regions of the elliptical segments ( 71 ) that reside below and above the junctures ( 74 ).
  • the inflow annulus of the valve can be secured at the inflow rim ( 72 ) via stitching to the inflow annulus fabric which also serves as a sealing gasket.
  • FIG. 16A shows how both the valve ( 32 ) and anchoring structure ( 70 ) of the present embodiment can be compressed radially to facilitate implantation.
  • the concave configurations of the elliptical segments ( 71 ) effectively form a radial spring that is capable of being radially collapsed under pressure for deployment and then expanded when positioned at the implant site.
  • One advantageous feature of the instant design is that the region of juncture ( 74 ) between the elliptical segments ( 71 ) does not become extended upon compression of the anchoring structure.
  • the valve ( 32 ) and anchoring structure ( 70 ) of the present embodiment can also be compression fit within a valve sinus cavity to exert radial force against the sinus walls.
  • the anchoring structure ( 70 ) is preferably dimensioned to be lodged substantially within a valve sinus, with the regions of juncture ( 74 ) between the elliptical segments ( 71 ) being configured to reside at the location of the native commissural posts.
  • the elliptical segment anchoring structure ( 70 ) is designed to expand at the proximal end ( 72 ) during peak flow and at the distal end ( 73 ) during peak backflow pressure, thereby maintaining pressure against the vascular wall.
  • the valve and anchoring structure ( 70 ) of the present embodiment will remain secure in the valve sinus without sutures.
  • a metal wire frame made from a metal that exhibits a high modulus of elasticity and that is biocompatible is preferred, such as Nitinol, as such materials exhibiting superior compressibility allow the anchoring structure to be self-expandable.
  • FIGS. 18A and B A further preferred embodiment of a valve anchoring structure according to the present invention is illustrated in FIGS. 18A and B.
  • an elliptical segment anchoring structure ( 70 ) is presented in which the elliptical segments ( 71 ) are joined together by a specialized double crimp ( 78 ).
  • FIG. 18B shows that the valve tabs ( 35 ) can be secured near the double crimp ( 78 ) that joins the elliptical segments ( 71 ).
  • the tab regions ( 35 ) are preferably attached to the gaps ( 75 ) between the elliptical segments ( 71 ).
  • the inflow annulus of the valve ( 33 ) can be secured at the inflow rim ( 72 ) via stitching to the inflow annulus fabric which also serves as a sealing gasket.
  • FIGS. 19A and B illustrate the double crimp ( 78 ) used to join the elliptical segments ( 71 ).
  • the double crimp ( 78 ) comprises two hollow tubes ( 79 ), one for each elliptical segment ( 71 ) to be inserted.
  • the hollow tubes ( 79 ) of the double crimp ( 78 ) are designed to allow for better motion of the individual elliptical segments ( 71 ) and to minimize material stresses during expansion and compression of the anchoring structure.
  • the double crimp ( 78 ) further comprises a central portion ( 80 ) joining the two hollow tubes ( 79 ).
  • This central portion ( 80 ) comprises one or more holes ( 81 ) to facilitate the attachment of the valve commissural tabs to the anchoring structure and to reduce the mass of the double crimp ( 78 ).
  • the double crimp ( 78 ) also serves as an attachment site for the valve and further acts as a stop against backflow pressure on the valve leaflets.
  • FIG. 20A shows the insertion of the elliptical segments ( 71 ) of the preferred anchoring structure embodiment ( 70 ) into the double crimp ( 78 ).
  • the present embodiment is dimensioned to be lodged substantially within the valve sinuses, with the joined regions ( 74 ) of the elliptical segments in FIG. 20B configured to align with the commissural posts of the sinus and the flared inflow ( 72 ) and outflow ends ( 73 ) of the anchoring structure configured to rest against the sinus cavities.
  • FIGS. 21A through G show how the elliptical segment anchoring structure ( 70 ) may additionally be covered with cloth ( 82 ), particularly at the inflow end ( 72 ) to provide traction and a gasket-like seal.
  • this preferred embodiment of the present invention is dimensioned to follow the sinus architecture and to lodge into the sinus cavities and against the inflow and outflow annuli of the sinuses for optimal securing and positioning of the replacement valve.
  • FIGS. 22A and B illustrate a further preferred embodiment the present invention.
  • This figure shows an elliptical segment anchoring structure ( 90 ) made from one piece of tubing.
  • the support posts ( 91 ) that form the slots ( 92 ) for the valve tabs include a series of small holes ( 93 ) on either side of the slot ( 92 ) to facilitate suture or mechanical attachment of the commissural tabs of the valve.
  • this anchoring structure ( 90 ) is dimensioned to fit substantially within the valve sinuses with the support posts ( 91 ) being configured to reside in the commissural posts between the individual sinus cavities.
  • the present embodiment also exerts axial force particularly at the flared inflow ( 94 ) and outflow rims ( 95 ) against the sinus walls to anchor the valve.
  • FIGS. 23A through D Yet another embodiment of a valve and anchoring structure according to the present invention is illustrated in FIGS. 23A through D.
  • a claw anchoring structure ( 100 ) is shown in FIG. 23A .
  • This embodiment corresponds to an elliptical segment embodiment wherein the upper portions of each elliptical segment have been removed.
  • the ends of the junctures ( 101 ) of the remaining elliptical segments are shaped into prongs or claws ( 102 ).
  • the claw anchoring structure ( 100 ) comprises a flexible spring frame having a plurality of barbs ( 102 ), located distally just beyond where the valve leaflet tab regions meet the anchoring structure.
  • the claw anchoring structure ( 100 ) preferably comprises at least one barb ( 102 ) for each valve leaflet tab included in the valve.
  • the barbs ( 102 ) are designed to anchor the valve ( 32 ) and anchoring structure ( 100 ) to the vascular wall.
  • an anchoring structure that lacks vertical support posts.
  • the representative anchoring structure configuration comprises an inflow ring ( 110 ) that is adapted to being secured to the inflow annulus of the valve ( 33 ) via stitching to the reinforced fabric sewing ring in a manner similar to the prior representative implementations.
  • the undulating or sinusoidal pattern of the ring ( 110 ) facilitates radial collapse and expansion and exerts radial force against the vessel wall.
  • the anchoring structure does not support the outflow annulus ( 34 ) of the valve. Rather, the valve's commissural tabs ( 35 ) are attached to the sinus walls via mechanical means, such as sutures, staples, or wire.
  • FIG. 25A Another representative embodiment of an anchoring structure is shown in FIG. 25A .
  • the present embodiment comprises a dual-ring anchoring structure ( 120 ).
  • the dual ring ( 120 ) of the present embodiment may, as in the previous embodiment, be secured to the inflow annulus of the valve via stitching to the reinforced fabric sewing ring.
  • the undulating or sinusoidal pattern of the individual rings ( 121 ) is configured such that the peaks ( 122 ) of one ring ( 121 ) coincide with the valleys ( 123 ) of the other ring and vice versa, thereby forming a sine-cosine pattern. This pattern facilitates radial collapse and expansion and exerts radial force against the vessel wall.
  • the dual ring anchoring structure ( 120 ) does not support the outflow annulus of the valve. Rather, the valve's commissural tabs are attached to the native sinus walls via mechanical means, such as sutures, staples, or wire, or additionally by the adhesive means disclosed herein.
  • FIG. 25B shows another dual ring embodiment of the present invention.
  • This anchoring structure is comprised of an upper (distal) dual ring ( 130 ) and a lower (proximal) dual ring ( 131 ).
  • the lower dual ring ( 131 ) is connected to the proximal end of the valve at the inflow annulus while the upper dual ring ( 130 ) is connected to the distal end of the valve at the outflow annulus.
  • the valve may be connected to the rings ( 130 , 131 ) via sutures, clips or any other suitable means for attachment.
  • the valve and the attached proximal ( 131 ) and distal ( 130 ) rings can be collapsed and inserted via a catheter.
  • each dual ring ( 130 , 131 ) comprises a wire frame with a circular cross-section and a sinusoidal pattern.
  • the sinusoidal pattern may be of a sine-cosine shape with a varied frequency and amplitude.
  • One or more longitudinal rods ( 132 ) may be used to connect the two dual rings ( 130 , 131 ) and maintain longitudinal separation and radial orientation. The rods ( 132 ) may be removable so that once the valve is implanted in the vascular passageway they can be removed.
  • an upper single ring ( 140 ) with an undulating or zigzag pattern provides support to the tab regions ( 35 ) of the valve ( 32 ) at the distal end ( 34 ) of the valve whereas a lower single ring ( 141 ) configured in an undulating or sinusoidal pattern provides support to the inflow annulus ( 33 ) at the proximal end of the valve ( 32 ).
  • the inflow ring ( 141 ) is stitched to the sewing fabric wrapped around the circumference of the inflow annulus of the valve, as described previously.
  • the outflow ring ( 140 ) of the anchoring structure generally resides above the leaflets ( 36 ) to avoid leaflet contact.
  • the inflow or outflow rings may comprise attachment barbs ( 142 ).
  • the structural dissociation between the rings ( 140 , 141 ) provides improved dynamic compliance while retaining the benefits of a two ring design.
  • FIGS. 27A through C Yet another embodiment of a valve and anchoring structure according to the present invention is illustrated in FIGS. 27A through C.
  • the valve ( 32 ) is supported by a tubular anchoring structure ( 150 ).
  • the tubular anchoring structure ( 150 ) is preferably made of metal or plastic.
  • the tubular anchoring structure ( 150 ) is also preferably designed to be expandable.
  • the anchoring structure may be designed to be self-expandable, balloon-expandable, or mechanically-expandable.
  • the tab regions ( 35 ) of the valve ( 32 ) are preferably attached to the distal end ( 151 ) of the tubular anchoring structure ( 150 ) using staples, sutures, wire fasteners, or any other suitable means.
  • the inflow rim ( 152 ) of the tubular anchoring structure may comprise a plurality of suture bores ( 153 ) to facilitate attachment of the valve ( 32 ).
  • the tubular anchoring structure ( 150 ) also comprises vertical support posts ( 154 ) with axial slots ( 155 ) for the insertion of the valve tabs ( 35 ).
  • the vertical support posts ( 154 ) extend to the distal end ( 151 ) of the tubular anchoring structure ( 150 ).
  • the means of attachment is used to also attach the tab regions ( 35 ) of the valve ( 32 ) to the vascular wall thereby securing the valve ( 32 ) and tubular anchoring structure ( 150 ) in the valve sinuses.
  • Such fastening means can also be optionally used at the inflow annulus to provide additional anchoring.
  • FIG. 28 Another embodiment of a valve and anchoring structure according to the present invention is illustrated in FIG. 28 .
  • a dual-ring anchoring structure ( 160 ) is shown, as seen in FIGS. 28C and D, with an inflow ring ( 161 ) and an outflow ring ( 162 ) connected by a vertical element ( 163 ) comprised of two posts ( 164 ).
  • the anchoring structure ( 160 ) is designed to be circumferentially collapsible as can be seen in FIGS. 28A and B. As shown in FIGS. 28C and D, the anchoring structure ( 160 ) is collapsed by sliding the two posts ( 164 ) that are adjacent to each other in the expanded state ( FIG.
  • the anchoring structure ( 160 ) prior to implantation the anchoring structure ( 160 ) is collapsed and, once the valve is properly positioned in the valve sinuses, the anchoring structure freely self-expands to its original dimensions.
  • the self-expanding behavior of the present embodiment is due to Nitinol's relatively high modulus of elasticity, which imparts superior spring-like properties to the anchoring structure.
  • the anchoring structure is constructed of a non-self expanding material, it may be mechanically collapsed and expanded using the devices disclosed herein.
  • FIGS. 29A and B Another embodiment of a valve and anchoring structure according to the present invention is illustrated in FIGS. 29A and B.
  • a dual-ring anchoring structure ( 170 ) is shown, with an inflow ring ( 171 ) and an outflow ring ( 172 ) connected by a vertical element ( 173 ) comprised of two posts ( 174 ).
  • the inflow rim may further comprise tissue mounting posts ( 175 ).
  • the anchoring structure ( 170 ) is designed to be circumferentially collapsible.
  • FIG. 29A shows how the posts ( 174 ) are separated in the expanded state
  • FIG. 29B shows how the posts ( 174 ) form a single vertical element ( 173 ) in the collapsed state.
  • the anchoring structure prior to implantation the anchoring structure is collapsed and upon the positioning of the valve assembly in the valve sinuses, the anchoring structure ( 170 ) freely self-expands to its original dimensions.
  • the self-expanding behavior of the present embodiment is a function of Nitinol's high modulus of elasticity.
  • the anchoring structure is constructed of a non-self expanding material, it may be mechanically collapsed and expanded using the devices disclosed herein.
  • FIGS. 30A and B A further embodiment of a valve and anchoring structure according to the present invention is illustrated in FIGS. 30A and B.
  • the present embodiment comprises a spring-aided anchoring structure ( 180 ).
  • the spring aided anchoring structure ( 180 ) preferably comprises three members ( 181 ) that are radially collapsible for implantation into the valve sinuses.
  • the members ( 181 ) comprise peaks ( 182 ) that serve as valve attachment points and valleys ( 183 ) that serve to lodge the anchoring structure at the valve sinus inflow annulus.
  • the anchoring structure ( 180 ) is expanded to its original dimensions by coil springs ( 184 ) that provide an outward radial force on each member.
  • the spring aided anchoring structure ( 180 ) comprises at least one anchoring section ( 185 ) for selectively securing the anchoring structure ( 180 ) in the valve sinus at the inflow annulus.
  • the present embodiment illustrates three members ( 181 ) and three coil springs ( 184 ), it should be appreciated that two or more members ( 181 ) with a corresponding number of coil springs ( 184 ) may be used.
  • the anchoring structures of the present invention may be constructed from superelastic memory metal alloys, such as Nitinol, described in U.S. Pat. No. 6,451,025, incorporated herein by reference.
  • Nitinol belongs to a family of intermetallic materials which contain a nearly equal mixture of nickel and titanium. Other elements can be added to adjust or modify the material properties.
  • Nitinol exhibits both shape memory and superelastic properties.
  • the shape memory effect of Nitinol allows for the restoration of the original shape of a plastically deformed structure by heating it. This is a result of the crystalline phase change known as thermoelastic martensitic transformation.
  • Nitinol is martensitic, i.e. easily deformable.
  • the valve assembly Prior to implantation, the valve assembly is chilled in sterile ice water. Upon cooling, the Nitinol anchoring structure enters its martensite phase. Once in this phase, the structure is malleable and can maintain a plastically deformed crushed configuration. When the crushed anchoring structure comprising the valve is delivered into the valve sinus, the increase in temperature results in a phase change from martensite to austenite. Through the phase change, the anchoring structure returns to its memorized shape, and thus expands back to its original size.
  • the anchoring structures can also be designed to use the superelasticity properties of Nitinol. With the superelastic design, the chilling procedure would not be necessary. The anchoring structure would be crushed at room temperature. The phase change to martensite would be accomplished by means of the stress generated during the crushing process. The anchoring structure would be held in the crushed configuration using force. Force is removed once the anchoring structure is delivered to the valve sinus, resulting in a phase transformation of the Nitinol from martensite to austenite. Through the phase change, the anchoring structure returns to its memorized shape and stresses and strains generated during the crushing process are removed.
  • the anchoring structures of the present invention may be composed of a non-self expanding suitable material, such as biocompatible metals, including titanium, and plastics. Whether the valve assembly is designed to be self-expandable or non-self expandable, it may be compressed (and expanded, if non-self expandable) for implantation using the expansion and contraction devices disclosed herein.
  • FIGS. 31-33 A preferred embodiment of an expansion and contraction device for implanting the valve assemblies of the present invention is illustrated in FIGS. 31-33 .
  • the device of the present embodiment comprises a group of bendable hollow tubes or wires ( 200 ), a grip handle ( 201 ), and a circular element ( 202 ) that holds the wires ( 200 ) together at their proximal ends ( 203 ).
  • Each wire ( 200 ) comprises a proximal end ( 203 ), a distal end ( 204 ) and a hollow shaft ( 205 ) running from the proximal end ( 203 ) to the distal end ( 204 ).
  • the wires ( 200 ) are attached to the grip handle ( 201 ) at their proximal ends ( 203 ) via the circular element ( 202 ) such that the wires form a circular pattern.
  • the expansion and contraction device further comprises a cylinder ( 206 ) having a proximal end ( 207 ) and a distal end ( 208 ).
  • the cylinder ( 206 ) has holes ( 209 ) drilled along its distal perimeter ( 208 ).
  • the holes ( 209 ) in the cylinder ( 206 ) are preferably drilled at an outward angle so that by forcing the wires ( 200 ) through the angled holes ( 209 ), the distal ends ( 204 ) of the wires ( 200 ) are driven radially outward.
  • the angle of the cylinder holes ( 209 ) controls the relationship between the longitudinal movement of the wires ( 200 ) and their radial dilation.
  • a representative anchoring structure ( 210 ) of the present invention is attached to the distal ends ( 204 ) of the hollow wires ( 200 ).
  • the cylinder ( 206 ) having a proximal end ( 207 ) and a distal end ( 208 ) has holes ( 209 ) drilled along its distal perimeter ( 208 ).
  • the holes ( 209 ) in the cylinder ( 206 ) are drilled at an outward angle so that by forcing the wires ( 200 ) through the angled holes ( 209 ), the distal ends ( 204 ) of the wires ( 200 ) are driven radially outward.
  • a long suture is routed from the proximal end to the distal end of the wire down its hollow shaft, looped around a segment of the anchoring structure at the distal end of the wire and then routed back to the proximal end of the wire, where it is secured.
  • the anchoring structure ( 210 ) contracts and expands radially in response to the longitudinal motion of the wires ( 200 ). Pulling the grip handle ( 201 ) proximally contracts the anchoring structure ( 210 ) into a collapsed state for implantation whereas pushing the grip handle ( 201 ) distally expands the anchoring structure ( 210 ).
  • the anchoring structure ( 210 ) is positioned in a desirable location in the vessel and expanded to the desired dimensions, the sutures are severed and removed from the proximal end ( 203 ) of the wires ( 200 ) in order to disconnect the anchoring structure ( 210 ) from the device. The device of the present embodiment is removed, thereby leaving the valve assembly securely situated in the valve sinus.
  • the device of the present embodiment comprises a tube ( 220 ), multiple wall panels ( 221 ), springs ( 222 ) corresponding to the multiple wall panels ( 221 ), a spindle ( 223 ) and a plurality of connecting wires ( 224 ).
  • the tube ( 220 ) comprises a hollow shaft ( 225 ) having a radial center ( 226 ), a proximal end ( 227 ), a distal end ( 228 ) as shown in FIG.
  • the perimeter of the exterior wall ( 230 ) is surrounded by adjacent wall panels ( 221 ), only buffered by the springs ( 222 ) corresponding to the wall panels ( 221 ).
  • the spindle ( 223 ) is attached to the interior wall ( 229 ) of the tube ( 220 ), preferably facing the tube's ( 220 ) radial center ( 226 ).
  • a connecting wire ( 224 ) is attached to each wall panel ( 221 ) and routed through the spring ( 222 ) and the corresponding hole ( 231 ) in the tube wall ( 229 , 230 ) to meet the other connecting wires ( 224 ), preferably at the radial center ( 226 ) of the tube ( 220 ).
  • the tension in the wires ( 224 ) is relieved to force the wall panels ( 221 ) outward, thereby expanding the anchoring structure and valve.
  • the length of the uncompressed spring ( 222 ) determines the diameter to which the anchoring structure can be expanded.
  • the anchoring structure can optionally be secured to the wall panels ( 221 ), by staples, sutures, wire fasteners, or any other suitable means, so that the valve assembly may be selectively expanded and collapsed by preferably varying the tension on the connecting wires.
  • the anchoring structure ( 240 ) is composed of a shape memory metal or the like having a relatively high modulus of elasticity, and possessing an outward spring-like force when in a compressed state. Therefore, spring loaded wall panels are not necessary in the present embodiment. Instead, the wires ( 241 ) pass through sutures ( 242 ) that are threaded through holes ( 243 ) in the tube ( 244 ) wall and wrap around portions of the anchoring structure. Thus, the wires ( 241 ) keep the anchoring structure ( 240 ) compressed by pulling the sutures ( 242 ) around the anchoring structure ( 240 ) against the tube ( 244 ).
  • the tube structure can be omitted with only the wires ( 241 ) and sutures ( 242 ) keeping the anchoring structure ( 240 ) in a compressed state. This would ensure that the valve within the anchoring structure is not contacted by any mechanical elements, such as a tube ( 244 ).
  • the tube could be made from a cloth- or tissue-like material.
  • each wall panel ( 250 ) is connected to a pin ( 251 ) which runs through the corresponding hole ( 252 ) in the tube ( 253 ) wall.
  • the pin ( 251 ) protruding radially inward from the tube's interior, is preferably spring-loaded ( 254 ) toward the radial center of the tube ( 253 ).
  • the wall panels ( 250 ) rest against the exterior wall of the tube ( 253 ) and the collapsed anchoring structure rests against the wall panels ( 250 ).
  • the present embodiment comprises a longitudinal shaft ( 255 ) running through the radial center of the tube.
  • the shaft is comprised of a proximal end ( 256 ) and a distal end ( 257 ).
  • the distal end ( 257 ) is connected to a central plate ( 258 ) having spiral shaped edges ( 259 ) as shown in FIGS. 37B and C.
  • the central plate ( 258 ) is located in the tube ( 253 ), parallel to the tube's cross-section and is aligned with the spring-loaded ( 254 ) pins ( 251 ).
  • the plate's spiral-shaped edges ( 259 ) preferably cause the distance from the plate's perimeter to the tube's radial center to vary along the plate's ( 258 ) perimeter.
  • FIGS. 38A and B show how rotation of the shaft ( 255 ) pushes the wall panels ( 250 ) radially out, thereby expanding the anchoring structure ( 260 ).
  • the anchoring structure ( 260 ) is sutured to the wall panels ( 250 ) to allow expansion and contraction of the anchoring structure by alternating rotation of the shaft.
  • the sutures are preferably removable from the shaft's ( 255 ) proximal end to free the valve assembly from the device following implantation in the valve sinus.
  • an expansion and contraction device similar to the previous embodiment is presented.
  • the present preferred embodiment utilizes a circular disk ( 270 ) with pre-cut spiral-shaped grooves ( 271 ) corresponding to the spring-loaded pins ( 272 ).
  • the grooves ( 271 ) provide a track of varying depth for the pins ( 272 ) such that the pins ( 272 ) are forced radially outward upon rotation of the disk ( 270 ), thereby expanding the anchoring structure.
  • the present invention provides the use of biocompatible adhesives.
  • a number of adhesives may be used to seal the valve assembly to the surrounding tissue in the valve sinus. The following are examples of available adhesives and methods of use:
  • U.S. Pat. No. 5,549,904 discloses a formulated biological adhesive composition
  • a formulated biological adhesive composition comprising tissue transglutaminase and a pharmaceutically acceptable carrier, the tissue transglutaminase in an effective amount to promote adhesion upon treatment of tissue in the presence of a divalent metal ion, such as calcium or strontium.
  • a divalent metal ion such as calcium or strontium.
  • the two components are mixed to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
  • U.S. Pat. No. 5,407,671 discloses a one-component tissue adhesive containing, in aqueous solution, fibrinogen, F XIII, a thrombin inhibitor, prothrombin factors, calcium ions and, where appropriate, a plasmin inhibitor.
  • This adhesive can be reconstituted from a freeze-dried form with water. It can contain all active substances in pasteurized form and is then free of the risk of transmission of hepatitis and HTLV III.
  • the one-component tissue adhesive is reconstituted from a freeze-dried form with water to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
  • the fibrin monomer or noncrosslinked fibrin is converted to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
  • U.S. Pat. No. 5,744,545 discloses a method for effecting the nonsurgical attachment of a first surface to a second surface, comprising the steps of: (a) providing collagen and a multifunctionally activated synthetic hydrophilic polymer; (b) mixing the collagen and synthetic polymer to initiate crosslinking between the collagen and the synthetic polymer; (c) applying the mixture of collagen and synthetic polymer to a first surface before substantial crosslinking has occurred between the collagen and the synthetic polymer; and (d) contacting the first surface with the second surface to effect adhesion between the two surfaces.
  • Each surface can be a native tissue or implant surface.
  • collagen and a multifunctionally activated synthetic hydrophilic polymer are mixed to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
  • U.S. Pat. No. 6,113,9408 discloses soluble microparticles comprising fibrinogen or thrombin, in free-flowing form. These microparticles can be mixed to give a dry powder, to be used as a fibrin sealant that is activated only at a tissue site upon dissolving the soluble microparticles. In operation, soluble microparticles comprising fibrinogen or thrombin are contacted with water to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
  • thermally activatable adhesive is an adhesive which exhibits an increase in “tack” or adhesion after being warmed to a temperature at or above the activation temperature of the adhesive.
  • the activation temperature of the thermally activatable adhesive is between about 28° C. and 60° C. More preferably, the activation temperature is between about 30° C. and 40° C.
  • One exemplary thermally activatable adhesive is described as Example 1 in U.S. Pat. No. 5,648,167, which is incorporated by reference herein.
  • FIG. 40 shows a preferred embodiment, wherein an outer circumferential reservoir ( 401 ) is located at an outermost radius of a valve anchoring structure ( 400 ) when the anchoring structure ( 400 ) is in an expanded state, wherein the reservoir is filled with a sealable fixation means for securely fixing the valve assembly ( 400 ) at a desired location within a body cavity.
  • FIG. 40 further illustrates one embodiment of the reservoir ( 401 ) comprising a sealable fixation means, wherein the sealable fixation means may comprise a one-component biological adhesive.
  • the sealable fixation means may be activated by exposing the biological adhesive to blood or heat.
  • FIG. 41 illustrates another preferred embodiment wherein the sealable fixation means may comprise a two-component biological adhesive.
  • the sealable fixation means may be activated by mixing the two components.
  • the second reservoir ( 403 ) would contain the water for the activation of the microparticles.
  • the reservoirs may be arranged concentrically as shown in FIG. 41B or adjacent to each other as shown in FIG. 41A .
  • FIG. 42 illustrates an exemplary reservoir ( 401 ) which may be attached to the valve anchoring structure by its inner wall ( 404 ) by sutures, glue, staples or some other appropriate method.
  • FIG. 42 further illustrates a thin spot ( 405 ) on the outer wall ( 406 ) of the reservoir ( 401 ).
  • the thin spots ( 405 ) are areas on the reservoir ( 401 ) that are adapted to rupture when placed under certain levels of pressure. The pressure is exerted on the thin spots ( 405 ) as the reservoir ( 401 ) is expanded along with the valve anchoring structure.
  • the thin spots ( 405 ) are unable to withstand the pressure and therefore rupture releasing the contents of the reservoir ( 401 ) or reservoirs.
  • the reservoir ( 401 ) is made of an elastic material that expands along with the expansion of the valve anchoring structure.
  • FIG. 43 illustrates a cross sectional view of the reservoir ( 401 ).
  • the reservoir ( 401 ) may contain a lumen ( 407 ) which extends along at least a portion of the circumference of the reservoir.
  • the reservoir ( 401 ) has one or more thin spots ( 405 ) along its outermost circumference, wherein the thin spots ( 405 ) are sized and configured to rupture when the reservoir ( 401 ) is expanded to an appropriate diameter. When the anchoring structure comprising the valve is fully expanded, the pressure exerted upon the expanded thin spots ( 405 ) causes them to rupture.
  • the reservoir ( 401 ) is made of a biodegradable material adapted for erosion or rupture to release the content of the reservoir ( 401 ) and activate the sealable fixation means in a desired timeframe after implantation.
  • a circumferentially outermost portion is pressure sensitive to rupture, wherein the contents of the reservoir ( 401 ) are released when the reservoir ( 401 ) is compressed against the sinus cavities during expansion and implantation of the valve assembly.
  • FIG. 44 shows a cross-sectional view of another preferred embodiment, illustrating thin spots ( 405 ) on a reservoir having two concentric component compartments, an inner compartment ( 408 ) and an outer compartment ( 409 ).
  • Component A in an inner compartment ( 408 ) and component B in an outer compartment ( 409 ) are to be mixed to form adhesive for sealing the valve assembly against the valve sinuses.
  • the inner compartment ( 408 ) has a plurality of thin spots ( 405 ) along its outermost circumference, wherein the thin spots ( 405 ) are sized and configured to rupture when the reservoir ( 401 ) is expanded to an appropriate diameter.
  • the outer compartment ( 409 ) also has a plurality of thin spots ( 405 ) along its innermost circumference.
  • the thin spots ( 405 ) of the inner compartment ( 408 ) and the thin spots ( 405 ) of the outer compartment ( 409 ) may be located adjacent to each other.
  • the space between the adjacent pair of thin spots ( 405 ) on the inner ( 408 ) and outer ( 409 ) compartment may comprise a piercing element that is activated to rupture the thin spot or the pair of adjacent spots when the reservoir is expanded to an appropriate diameter or a predetermined diameter.
  • Other embodiments of reservoir configuration for example, two parallel compartments circumferentially or longitudinally, and suitable activation mechanism for the sealable fixation means are also within the scope of the present invention.
  • the present invention further comprises methods and devices for the sizing of native valves that require replacement.
  • Intravascular ultrasound uses high-frequency sound waves that are sent with a device called a transducer.
  • the transducer is attached to the end of a catheter, which is threaded through a vein, artery, or other vessel lumen.
  • the sound waves bounce off of the walls of the vessel and return to the transducer as echoes.
  • the echoes can be converted into distances by computer.
  • a preferred minimally invasive valve replacement sizer is shown in FIGS. 45A and B.
  • the distal end or portion refers to the area closer to the body while the proximal end or portion refers to the area closer to the user of the valve replacement sizer.
  • the device comprises a guidewire ( 500 ), an intravascular ultrasound (IVUS) catheter ( 501 ) having a transducer ( 502 ), and a balloon dilatation catheter ( 503 ) all positioned within the central lumen of a catheter.
  • the transducer ( 502 ) is positioned in the IVUS sizing window ( 504 ) of the balloon catheter.
  • the guide wire ( 500 ) advances and guides the catheter ( 501 ) to the appropriate location for valve sizing.
  • FIG. 45A shows the catheter in deflated form, whereas in FIG. 45B the balloon dilatation catheter ( 503 ) has inflated the balloon ( 505 ).
  • the catheter ( 510 ) contains multiple lumens ( 511 ) in order to house a guidewire ( 512 ), an IVUS catheter ( 513 ), and a balloon dilatation catheter ( 514 ).
  • FIG. 46 illustrates a cross sectional view.
  • One of the separate lumens ( 511 ) contains the guidewire ( 512 ), another contains the IVUS catheter ( 513 ), and another contains the balloon dilatation catheter ( 514 ).
  • the balloon dilatation catheter ( 514 ) has a balloon ( 515 ) attached circumferentially surrounding the balloon dilatation catheter ( 514 ) as well as a portion of the catheter ( 510 ).
  • FIG. 47 shows a balloon dilatation catheter ( 516 ) comprising a balloon ( 517 ) that circumferentially surrounds a portion of the catheter ( 518 ) proximal to its distal portion ( 519 ). More specifically, the balloon ( 517 ) comprises an outer wall ( 520 ) that circumferentially surrounds a portion of the catheter ( 518 ) near its distal portion ( 519 ). The balloon ( 517 ) also has a distal end ( 521 ) and a proximal end ( 522 ). In a preferred embodiment, within the area encompassed by the balloon, a transducer ( 523 ) is located on the IVUS catheter ( 524 ).
  • a sizing window ( 525 ) is placed on the IVUS catheter ( 524 ) to enable signals to be transmitted and received by the transducer ( 523 ) without interference.
  • the sizing window ( 525 ) is simply an empty space.
  • the sizing window ( 525 ) could be made from any substance which does not interfere with the signals emitted and received by the transducer ( 523 ).
  • the balloon ( 517 ) is round but other shapes are possible and contemplated for use with the valve sizing apparatus.
  • FIG. 48 shows a cross section of an inflated balloon ( 530 ) with curves forming leaflets ( 531 ) to enable fluid ( 532 ) to pass through the vessel while the balloon ( 530 ) is in its inflated state and the outer edges ( 533 ) of the leaflets ( 531 ) are in contact with the vessel wall ( 534 ) to measure the diameter.
  • the balloon may further be made from compliant or non-compliant material.
  • FIG. 49 shows a preferred embodiment wherein the balloon ( 540 ) is inflated with saline ( 541 ).
  • the saline is pumped into the balloon ( 540 ) through the balloon dilatation catheter.
  • the balloon ( 540 ) may be inflated with a gas or any other suitable substance.
  • the balloon ( 540 ) is inflated to a chosen pressure by the person using the valve replacement sizer. When the balloon ( 540 ) has been inflated, the outermost portion of the outer wall ( 542 ) will be in contact with the vessel wall ( 543 ) or other lumen at the location where the replacement valve is to be placed.
  • the farthest radial points of the balloon's outer wall ( 542 ) will be equidistant to the center of the catheter ( 544 ). This distance is labeled as R.
  • the transducer ( 545 ) may or may not be at the centermost point of the inflated balloon ( 540 ). Any deviation from the centermost point by the transducer ( 545 ) may be accounted for when calculating the diameter of the vessel lumen. However, the signal emitted by the transducer ( 545 ) preferably intersects the balloon ( 540 ) at its greatest radius.
  • FIG. 50 shows a preferred embodiment, wherein a transducer ( 550 ) emits an ultrasonic signal ( 556 ) in a perpendicular direction to the IVUS catheter ( 551 ). The signal is then reflected off the outer wall ( 552 ) of the balloon ( 540 ) and received by the transducer ( 550 ). The transducer ( 550 ) then transmits the data to the auxiliary processor ( 553 ) to determine the radius and diameter of the vessel lumen. Alternatively, an infrared light may be emitted and received by the transducer ( 550 ) to determine the radius and diameter of the vessel lumen.
  • the diameter is calculated by knowing the speed of the signal and the time it takes for the signal to be reflected off the balloon wall ( 552 ) back to the transducer ( 550 ). The known speed is multiplied by the time to determine the radius of the balloon ( 540 ). The radius may be adjusted if the transducer ( 550 ) was not located at the centermost point of the catheter.
  • the present invention further provides devices and methods to remove the native diseased valves prior to implantation of the replacement valve assembly.
  • the valve removing means is provided by the replacement valve assembly.
  • the valve removing means is provided by a valve sizing device of the present invention.
  • the present invention further provides valve assemblies comprising native valve removing capabilities.
  • a valve anchoring structure having cutting means located at the annulus base for cutting a native valve is provided. Accordingly, when passing the valve assembly comprising the valve and anchoring structure through the vessel with the anchoring structure in a collapsed state, the cutting means can be advanced against the native valve with the anchoring structure in a partially expanded state. In this manner, the anchoring structure comprising the cutting means cuts at least a portion of the native valve by deploying the cutting means, before the valve assembly is secured to the desired valve location with the anchoring structure in the expanded state.
  • the native valve removing means on the anchoring structure is selected from a group consisting of: a plurality of sharp edge elements, each sharp edge element having a sharp end enabling the element to cut through at least a portion of the native valve; a plurality of electrode elements, wherein radiofrequency energy is delivered to each electrode element enabling the electrode element to cut through at least a portion of the native valve, and a plurality of ultrasound transducer elements, wherein ultrasound energy is delivered to each transducer element enabling the transducer element to cut through at least a portion of the native valve.
  • valve anchoring structure is made from a radially collapsible and re-expandable cylindrical support means for folding and expanding together with the collapsible replacement valve for implantation in the body by means of catheterization or other minimally invasive procedure.
  • catheter balloon systems are well known to those of skill in the art, for example, U.S. Pat. No. 6,605,056 issued on Aug. 23, 2003.
  • the anchoring structure ( 600 ) comprises at least one ultrasound transducer ( 601 ) at the distal end portion of the lower ring ( 602 ), wherein each ultrasound transducer is sized and configured with ultrasound energy as cutting means for cutting a native valve.
  • Ultrasound energy is delivered through conductor means ( 603 ) to each transducer element ( 601 ) enabling the transducer element ( 601 ) to cut through at least a portion of the native valve.
  • the conductor ( 603 ) passes through a delivery means and is connected to an external ultrasound energy generator.
  • the ablative ultrasound delivery means and methods are well known to one skilled in the art, for example, U.S. Pat. No. 6,241,692 issued on Jun. 5, 2001.
  • FIG. 52 shows another preferred embodiment of a native valve removal system comprising a valve assembly having radiofrequency cutting means.
  • the anchoring structure comprises at least one radiofrequency electrode ( 610 ) at the distal end portion of the lower ring ( 602 ), wherein each radiofrequency electrode ( 610 ) is sized and configured with radiofrequency energy as cutting means for cutting a native valve.
  • Radiofrequency energy is delivered through conductor means ( 611 ) to each electrode element ( 610 ) enabling the electrode element to cut through at least a portion of the native valve.
  • the conductor ( 611 ) passes through delivery means and is connected to an external radiofrequency energy generator.
  • the ablative radiofrequency delivery means and methods are well known to one skilled in the art, for example, U.S. Pat. No. 6,033,402 issued on Mar. 7, 2000.
  • FIG. 53 shows another embodiment of an anchoring structure having sharp edge cutting means ( 620 ).
  • the anchoring structure comprises a set of sharp edge cutting elements ( 621 ) at the distal end portion of the cutting means ( 620 ) of the lower ring ( 602 ) of the anchoring structure, wherein each cutting element ( 621 ) has a cutting tip ( 622 ), and wherein each cutting element ( 621 ) of the cutting means is sized and configured, optionally with radiofrequency energy, as cutting means for cutting a native valve.
  • sharp edge cutting means on the delivery apparatus is rotatable, enabling the cutting element ( 621 ) to cut through at least a portion of the native valve.
  • Sharp edge cutting means with optionally ablative radiofrequency delivery means and methods, are well known to one skilled in the art, for example, U.S. Pat. No. 5,980,515 issued on Nov. 9, 1999.
  • FIG. 54 shows a partially inflated balloon catheter.
  • a balloon catheter ( 630 ) is introduced in the vessel.
  • the balloon means ( 632 ) of the balloon catheter ( 630 ) is led out of the protection cap ( 633 ) at the catheter tip ( 634 ) and is partly inflated through a fluid channel ( 635 ), which is led to the surface of the patient.
  • the balloon ( 632 ) is partially expanded and the sharp end ( 636 ) of the cutting means of the valve anchoring structure ( 637 ) is advanced to cut and remove at least a portion of the native valve.
  • the valve anchoring structure ( 637 ) comprises an ultrasound or radiofrequency cutting means ( 638 ).
  • the support structure is expanded at about 30 to 95% of full expansion for cutting the native valve. More preferably, the support structure is expanded at about 50 to 90% of the full expansion.
  • the balloon catheter ( 630 ) comprises a central channel ( 639 ) with respect to a central axial line ( 640 ) to receive a guide wire ( 641 ) which is used in a way known for viewing the introduction of the catheter through fluoroscopy.
  • Some aspects of the present invention provide a method of endovascularly implanting a valve through a vessel, comprising the steps of providing a collapsibly expandable valve assembly that comprises an anchoring structure according to the present invention with an annulus base and a collapsible valve connected to the anchoring structure, the collapsible valve being configured to permit blood flow in a direction and prevent blood flow in an opposite direction, the anchoring structure having cutting means located at the annulus base for cutting a native valve, passing the valve assembly through the vessel with the anchoring structure in a collapsed state, advancing the cutting means against the native valve with the anchoring structure in a partially expanded state, cutting at least a portion of the native valve by deploying the cutting means, and securing the valve assembly to the desired valve location with the anchoring structure in the expanded shape.
  • a method of implanting a valve assembly is given below: a valve assembly made of an anchoring structure of the present invention and a collapsible valve, as described above, is placed on a deflated balloon means and is compressed thereon, either manually or by use of the expansion/compression devices of the instant invention; the balloon means and the valve assembly are drawn into an insertion cover; a guide wire is inserted into a vessel through the central opening of the balloon catheter under continuous fluoroscopy; the insertion cover conveys the guide wire to a point in the channel in the immediate vicinity of the desired position of the valve assembly; the balloon means is pushed out of the protection cap and the valve assembly is positioned in the desired position if necessary by use of further imaging means to ensure accurate positioning; the balloon means is inflated partially; the valve assembly is advanced with its cutting means cutting at least a portion of the native valve; the balloon means is further inflated to position the valve at a desired site, preferably against the truncated valvular annulus; the balloon means is
  • the present invention also provides for devices and methods to prevent the release of debris during removal of the native diseased valves from traveling to distant sites where such debris may cause undesirable physiological effects.
  • the present invention provides for specialized filters that capture material and debris generated during valve replacement procedures.
  • the distal protection devices of the present invention are also effective in trapping material that may be released during other percutaneous interventional procedures, such as balloon angioplasty or stenting procedures by providing a temporary valve and filter in the same device.
  • the present invention provides for a temporary valve ( 700 ), which may be deployed at a desired location in a collapsed state and then expanded and secured to the walls of the passageway.
  • the temporary valve ( 700 ) comprises two concentric one-way valves, an outer valve ( 701 ) and an inner valve ( 702 ) disposed within the outer valve ( 701 ), that open in opposite directions as shown in FIG. 55B .
  • the outer valve ( 701 ) opens in response to positive fluid flow pressure, thereby regulating blood flow in substantially one direction.
  • the inner valve ( 702 ) opens in the opposite direction of the outer valve ( 701 ) to facilitate the insertion of catheter based equipment ( 703 ) as shown in FIG.
  • the inner valve ( 702 ) be configured or constructed to open with relatively more pressure than that required to open the outer valve.
  • the outer ( 701 ) and inner valves ( 702 ) of the temporary valve ( 700 ) may be coupled together by radial support members.
  • the radial support members couple the inner surface of the outer valve to the outer surface of the inner valve.
  • the length of the radial support means depends upon the dimension of the blood vessel or body cavity within which the temporary valve is to be deployed.
  • the temporary valve may be constructed from material that is capable of self-expanding the temporary valve, once it is deployed from the collapsed state at the desired location. Once expanded, catheter based equipment required for the particular surgical procedure may be passed through and movably operated in relation to the temporary valve.
  • the temporary valve may be combined with a filter that extends distally from the temporary valve to capture debris material.
  • the temporary valve-filter device is preferably configured such that the open proximal end is secured to the temporary valve and the closed distal end comprises an opening or a third valve to facilitate the passage of the catheter equipment through the distal end of the bag and out of the temporary valve. Additional valves may also be positioned in the filter to coincide with one or more branching arteries.
  • the temporary valve-filter device may include one or more traps within the filter bag to trap debris material within the bag to reduce the likelihood of debris material leaving the filter when the catheter equipment is being passed through the filter bag.
  • the filter traps may be comprised of one or more valves disposed within the filter bag that are configured to open with retrograde pressure.
  • the traps may be comprised of flaps that extend inwardly from the perimeter of the bag to create a cupping effect that traps particulate matter and directs it outwardly toward the perimeter of the filter bag.
  • the filter traps may be constructed of material that is capable of facilitating and filtering antegrade fluid flow, while retaining the debris material within the filter bag.
  • the valve-filter assembly previously described may also incorporate multiple valves. In this arrangement, debris may be better and better entrapped, and thus reduces the chance of debris coming out of the valve-filter assembly.
  • the present invention is particularly useful while performing an interventional procedure in vital arteries, such as the carotid arteries and the aorta, in which critical downstream blood vessels can become blocked with debris material.
  • the valve-filter assembly may also include a cannulation system at the downstream end of the filter to remove particles and debris.
  • the valve-filter assembly may also include a grinder for cutting up or reducing the size of the debris. This debris, in turn, may be removed by a cannulation system or be allowed to remain in the filter.
  • valve-filter assembly is well-suited for use in minimally invasive surgery where the valve-filter may be placed in the aorta between the aortic valve and the innominate branch or the braciocephalic branch.
  • the valve-filter may be put in place before the start of surgery and function as a valve.
  • the valve-filter may further collect debris and particles during removal and clean up of the old valve.
  • the valve-filter may also stay in place while the new valve is put in place and until the end of the procedure to function as protection and as a valve.
  • a vascular filter system is well known to one skilled in the art, for example, U.S. Pat. No. 6,485,501 issued on Nov. 26, 2002.
  • the invention may be part of a catheter.
  • the invention may also be assembled onto a separate catheter.
  • the valve-filter may also be part of a non-catheter device, placed directly into a blood vessel or other lumen.
  • the valve-filter may be introduced into the body by the ways described in the following non-inclusive list: femoral artery, femoral vein, carotid artery, jugular vein, mouth, nose, urethra, vagina, brachial artery, subclavian vein, open sternotomies, partial sternotomies, and other places in the arterial and venous system.
  • the filter mesh of the valve-filter may be of any size and shape required to trap all of the material while still providing sufficient surface area for providing satisfactory flows during the use of the filter.
  • the filter may be a sheet or bag of different mesh sizes.
  • the mesh size is optimized taking the following factors into consideration: flow conditions, application site, size of filter bag, rate of clotting, etc.
  • Radiopaque markers and/or sonoreflective markers may be located on the catheter and/or the valve-filter assembly.
  • An embodiment of the valve-filter catheter is described having an aortic transillumination system for locating and monitoring the position and deployment state of the catheter and the valve-filter assembly without fluoroscopy.
  • visualization techniques including transcranial Doppler ultrasonography, transesophageal echocardiograpy, transthoracic echocardiography, epicardiac echocardiography, and transcutaneous or intravascular ultrasoneography in conjunction with the procedure may be used to ensure effective filtration.
  • the material of the filter screen in each embodiment of the filter catheter may be made of or coated with an adherent material or substance to capture or hold embolic debris which comes into contact with the filter screen within the valve-filter assembly.
  • adherent materials include, but are not limited to, known biocompatible adhesives and bioadhesive materials or substances, which are hemocompatible and non-thrombogenic. Such material are known to those having ordinary skill in the art and are described in, among other references, U.S. Pat. Nos. 4,768,523, 5,055,046, 5,066,709, 5,197,973, 5,225,196, 5,374,431, 5,578,310, 5,645,062, 5,648,167, 5,651,982, and 5,665,477.
  • only the upstream side of the elements of the filter screen are coated with the adherent material to capture the embolic material which comes in contact with the upstream side of the filter screen after entering the filter assembly.
  • Other bioactive substances for example, heparin or thrombolytic agents, may be impregnated into or coated on the surface of the filter screen material or incorporated into an adhesive coating.
  • blood is filtered during cardiac surgery, in particular during percutaneous valve surgery, to protect a patient from embolization.
  • the valve-filter is positioned in the aorta between the aortic valve and the inominate branch, where it filters blood before it reaches the carotid arteries, brachiocephalic trunk, and left subclavian artery.
  • the valve contains the embolic material and foreign matter dislodged during the surgery and also provides a temporary valve for use during valve surgery.
  • Such a method may be utilized both on and off pump.
  • Such a method may also be utilized for aortic, mitral, and pulmonary valve surgery and repair.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Prostheses (AREA)
  • Endoscopes (AREA)

Abstract

Methods and systems for minimally invasive replacement of a valve. The system includes a collapsible valve and anchoring structure, devices and methods for expanding the valve anchoring structure, adhesive means to seal the valve to the surrounding tissue, a catheter-based valve sizing and delivery system, native valve removal means, and a temporary valve and filter assembly to facilitate removal of debris material. The valve assembly comprises a valve and anchoring structure for the valve, dimensioned to fit substantially within the valve sinus.

Description

    FIELD OF THE INVENTION
  • The present invention relates to devices and systems for the replacement of physiological valves.
  • BACKGROUND OF THE INVENTION
  • The transport of vital fluids in the human body is largely regulated by valves. Physiological valves are designed to prevent the backflow of bodily fluids, such as blood, lymph, urine, bile, etc., thereby keeping the body's fluid dynamics unidirectional for proper homeostasis. For example, venous valves maintain the upward flow of blood, particularly from the lower extremities, back toward the heart, while lymphatic valves prevent the backflow of lymph within the lymph vessels, particularly those of the limbs.
  • Because of their common function, valves share certain anatomical features despite variations in relative size. The cardiac valves are among the largest valves in the body with diameters that may exceed 30 mm, while valves of the smaller veins may have diameters no larger than a fraction of a millimeter. Regardless of their size, however, many physiological valves are situated in specialized anatomical structures known as sinuses. Valve sinuses can be described as dilations or bulges in the vessel wall that houses the valve. The geometry of the sinus has a function in the operation and fluid dynamics of the valve. One function is to guide fluid flow so as to create eddy currents that prevent the valve leaflets from adhering to the wall of the vessel at the peak of flow velocity, such as during systole. Another function of the sinus geometry is to generate currents that facilitate the precise closing of the leaflets at the beginning of backflow pressure. The sinus geometry is also important in reducing the stress exerted by differential fluid flow pressure on the valve leaflets or cusps as they open and close.
  • Thus, for example, the eddy currents occurring within the sinuses of Valsalva in the natural aortic root have been shown to be important in creating smooth, gradual and gentle closure of the aortic valve at the end of systole. Blood is permitted to travel along the curved contour of the sinus and onto the valve leaflets to effect their closure, thereby reducing the pressure that would otherwise be exerted by direct fluid flow onto the valve leaflets. The sinuses of Valsalva also contain the coronary ostia, which are outflow openings of the arteries that feed the heart muscle. When valve sinuses contain such outflow openings, they serve the additional purpose of providing blood flow to such vessels throughout the cardiac cycle.
  • When valves exhibit abnormal anatomy and function as a result of valve disease or injury, the unidirectional flow of the physiological fluid they are designed to regulate is disrupted, resulting in increased hydrostatic pressure. For example, venous valvular dysfunction leads to blood flowing back and pooling in the lower legs, resulting in pain, swelling and edema, changes in skin color, and skin ulcerations that can be extremely difficult to treat. Lymphatic valve insufficiency can result in lymphedema with tissue fibrosis and gross distention of the affected body part. Cardiac valvular disease may lead to pulmonary hypertension and edema, atrial fibrillation, and right heart failure in the case of mitral and tricuspid valve stenosis; or pulmonary congestion, left ventricular contractile impairment and congestive heart failure in the case of mitral regurgitation and aortic stenosis. Regardless of their etiology, all valvular diseases result in either stenosis, in which the valve does not open properly, impeding fluid flow across it and causing a rise in fluid pressure, or insufficiency/regurgitation, in which the valve does not close properly and the fluid leaks back across the valve, creating backflow. Some valves are afflicted with both stenosis and insufficiency, in which case the valve neither opens fully nor closes completely.
  • Because of the potential severity of the clinical consequences of valve disease, valve replacement surgery is becoming a widely used medical procedure, described and illustrated in numerous books and articles. When replacement of a valve is necessary, the diseased or abnormal valve is typically cut out and replaced with either a mechanical or tissue valve. A conventional heart valve replacement surgery involves accessing the heart in a patient's thoracic cavity through a longitudinal incision in the chest. For example, a median sternotomy requires cutting through the sternum and forcing the two opposite halves of the rib cage to be spread apart, allowing access to the thoracic cavity and the heart within. The patient is then placed on cardiopulmonary bypass, which involves stopping the heart to permit access to the internal chambers. Such open heart surgery is particularly invasive and involves a lengthy and difficult recovery period. Reducing or eliminating the time a patient spends in surgery is thus a goal of foremost clinical priority.
  • One strategy for reducing the time spent in surgery is to eliminate or reduce the need for suturing a replacement valve into position. Toward this end, valve assemblies that allow implantation with minimal or no sutures would be greatly advantageous. Furthermore, while devices have been developed for the endovascular implantation of replacement valves, including collapsing, delivering, and then expanding the valve, such devices do not configure the valve in a manner that takes advantage of the natural compartments formed by the valve sinuses for optimal fluid dynamics and valve performance. In addition, to the extent that such devices employ a support structure in conjunction with a tissue valve, such valve constructs are configured such that the tissue leaflets of the support valve come into contact with the support structure, either during the collapsed or expanded state, or both. Such contact is capable of contributing undesired stress on the valve leaflet. Moreover, such support structures are not configured to properly support a tissue valve having a scalloped inflow annulus such as that disclosed in the U.S. patent application Ser. No. 09/772,526 which is incorporated by reference herein in its entirety.
  • Accordingly, there is a need for a valve replacement system comprising a collapsible and expandable valve assembly that is capable of being secured into position with minimal or no suturing; facilitating an anatomically optimal position of the valve; maintaining an open pathway for other vessel openings of vessels that may be located in the valvular sinuses; and minimizing or reducing stress to the tissue valve leaflets. The valves of the present invention may comprise a plurality of joined leaflets with a corresponding number of commissural tabs. Generally, however, the desired valve will contain two to four leaflets and commissural tabs. Examples of other suitable valves are disclosed in U.S. patent application Ser. Nos. 09/772,526, 09/853,463, 09/924,970, 10/121,208, 10/122,035, 10/153,286, 10/153,290, the disclosures of all of which are incorporated by reference in their entirety herein.
  • SUMMARY OF THE INVENTION
  • The present invention provides systems and devices for the replacement of physiological valves. In one embodiment of the present invention, the replacement valve assemblies are adapted to fit substantially within the valve sinuses. Because the devices and procedures provided by the present invention eliminate or reduce the need for suturing, time spent in surgery is significantly decreased, and the risks associated with surgery are minimized. Further, the devices of the present invention are suitable for delivery by cannula or catheter.
  • In one preferred embodiment of the present invention a valve anchoring structure is provided that is dimensioned to be placed substantially within the valve sinus. In this embodiment, the valve anchoring structure extends substantially across the length of the valve sinus region.
  • In another preferred embodiment of the present invention a valve assembly is provided, comprising a valve and anchoring structure, in which the valve comprises a body having a proximal end and a distal end, an inlet at the proximal end, and an outlet at the distal end. The inlet comprises an inflow annulus, preferably with either a scalloped or straight edge. The outlet comprises a plurality of tabs that are supported by the anchoring means at the distal end. In preferred embodiments of the invention, the plurality of tabs are spaced evenly around the circumference of the valve.
  • In yet another embodiment of the present invention, a valve assembly is provided in which there is minimal or no contact between the valve and anchoring structure.
  • In still another embodiment of the present invention, a valve assembly is provided in which the valve is capable of achieving full opening and full closure without contacting the anchoring structure.
  • In yet another embodiment of the present invention, a valve assembly is provided in which the vertical components of the anchoring structure are limited to the commissural posts between sinus cavities, thereby minimizing contact between mechanical components and fluid, as well as providing flow to vessels located in the valve sinus.
  • In still another embodiment of the present invention, a valve is provided that firmly attaches to the valve sinus, obviating the need for suturing to secure the valve placement.
  • In a further embodiment of the present invention, a valve assembly is provided in which the anchoring structure may be collapsed to at least fifty percent of its maximum diameter.
  • In still a further embodiment of the present invention, an expansion and contraction device is provided to facilitate implantation of the valve and anchoring structure.
  • In another embodiment, the present invention provides adhesive means for securing the valve assembly in a valve sinus.
  • In yet another embodiment of the present invention, a valve sizing apparatus is provided for the noninvasive determination of native valve size.
  • The present invention also provides cutting means to remove the native diseased valve. One aspect of the cutting means comprises a plurality ofjaw elements, each jaw element having a sharp end enabling the jaw element to cut through at least a portion of the native valve. Another aspect of the cutting means comprises a plurality of electrode elements, wherein radiofrequency energy is delivered to each electrode element enabling the electrode element to cut through at least a portion of the native valve. A further aspect of the cutting means comprises a plurality of ultrasound transducer elements, wherein ultrasound energy is delivered to each transducer element enabling the transducer element to cut through at least a portion of the native valve.
  • In yet another embodiment, the present invention provides a temporary two-way valve and distal protection filter assembly.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows an exemplary valve during operation. FIG. 1A shows the valve in the open position during peak flow. FIG. 1B shows the valve in closed position to prevent backflow of the fluid across the valve.
  • FIG. 2 shows a preferred embodiment of the valve of the present invention. This valve features commissural tabs and a scalloped inflow annulus.
  • FIGS. 3A, B and C are representations of a typical valve sinus. These figures illustrate the anatomy of the sinus cavities, commissural posts, leaflets and inflow/outflow annuli.
  • FIG. 4 is a schematic representation of the geometry and relative dimensions of the valve sinus region.
  • FIG. 5 shows a valve anchoring structure, in accordance with a preferred embodiment of the present invention, that is lodged inside a vessel.
  • FIGS. 6A and B are schematics of a valve assembly comprising a valve and an anchoring structure in which the anchoring structure features an additional cloth ring along the valve inflow edge that serves as a gasket. FIG. 6C shows a valve anchoring structure according to one preferred embodiment of the present invention featuring a two-ring inflow rim.
  • FIG. 7 is a diagrammatic representation of a flat pattern of a preferred embodiment of an anchoring structure in the expanded state.
  • FIG. 8 is a diagrammatic representation of a flat pattern of a preferred embodiment of an anchoring structure in the compressed state.
  • FIG. 9 shows a flat valve leaflet of a preferred valve to which the anchoring structure dimensions can be fitted.
  • FIG. 10 illustrates the relative dimensions of a preferred embodiment of an anchoring structure of the present invention.
  • FIG. 11 shows a flared anchoring structure dimensioned to lodge inside the sinus cavities.
  • FIG. 12 shows a different view of the flared anchoring structure.
  • FIG. 13 shows a preferred embodiment of an anchoring structure lacking an outflow ring, and having support posts dimensioned to lodge in the sinus commissural posts, providing cantilevered support for the valve outflow end.
  • FIG. 14 shows a preferred embodiment of an anchoring structure with flared in- and outflow ends and support posts for lodging in the commissural posts with attachment windows capable of deflecting inward at back flow pressure.
  • FIG. 15A shows a top view of a preferred embodiment of a valve assembly comprising a valve and an anchoring structure made of elliptical segments joined together.
  • FIG. 15B shows a lateral view of the preferred anchoring structure without valve.
  • FIG. 16A shows the valve assembly comprising a valve and elliptical segment anchoring structure in expanded form. FIG. 16B shows the same in compressed form
  • FIG. 17 shows the lodging of an elliptical anchoring structure inside the valve sinus cavities.
  • FIG. 18A shows how the elliptical segments of the anchoring structure may be joined by a double crimp. FIG. 18B shows how the valve is positioned inside the anchoring structure.
  • FIG. 19A shows a double crimp uniquely designed to flexibly join the elliptical segments. FIG. 19B shows a modified double crimp.
  • FIG. 20A shows how the elliptical segments may be assembled into the double crimp. FIG. 20B shows the final assembly.
  • FIGS. 21A-G show different views of an elliptical segment anchoring structure further comprising cloth covering including a gasket cloth cuff at the inflow rim.
  • FIGS. 22A and B show different views of an elliptical segment anchoring structure made from a single piece of tubing.
  • FIGS. 23A through D show an elliptical segment anchoring structure in which the upper segments have been removed and the ends of the junctions are formed into prongs.
  • FIG. 24 shows a preferred valve assembly of the present invention with an anchoring structure comprising a ring incorporated into the valve inflow rim.
  • FIG. 25A shows an anchoring structure comprising two undulating rings with inverse wave patterns. FIG. 25B shows an anchoring structure comprising two such rings connected by vertical elements.
  • FIG. 26 shows a valve assembly comprising an anchoring structure in which the inflow ring and outflow ring are structurally unconnected.
  • FIG. 27A-C show a tubular anchoring structure.
  • FIGS. 28A-D show an anchoring structure comprising an inflow ring and an outflow ring connected by vertical posts that slide across one another upon compression.
  • FIGS. 29A and B show an anchoring structure comprising an inflow and outflow ring connected by vertical posts that join to form a single vertical element upon compression.
  • FIGS. 30A and B shows an anchoring structure comprising a three-member spring aided frame.
  • FIGS. 31A and B show a preferred embodiment of an expansion and contraction device.
  • FIGS. 32A and B more particularly shows the angled wires of the device.
  • FIG. 33 shows the positioning of an anchoring structure on the expansion and contraction device.
  • FIG. 34 shows another preferred embodiment of an expansion and contraction device featuring a wire-spindle mechanism.
  • FIG. 35 shows a different perspective of the wire-spindle expansion and contraction device.
  • FIGS. 36A and B show another preferred embodiment of an expansion and contraction device for self-expanding valve assemblies.
  • FIG. 37A shows a further preferred embodiment of an expansion and contraction device featuring a rotating plate mechanism. FIGS. 37B and C more particularly shows the spiral-shaped rotating plate.
  • FIGS. 38A and B show the expansion and contraction device expanding an anchoring frame.
  • FIG. 39 shows another preferred embodiment of an expansion and contraction device featuring a groove-pin mechanism.
  • FIG. 40 shows one preferred embodiment of a valve having an outer circumferential reservoir containing a sealable fixation means for securely fixing the valve prosthesis at a desired location within a vessel or body cavity.
  • FIGS. 41A and B show another embodiment of a valve having an outer circumferential reservoir, wherein the sealabe fixation means comprises a two component biological adhesive.
  • FIG. 42 illustrates a reservoir with thin spots adapted to rupture when the reservoir is under pressure, thereby releasing the contents of the reservoir.
  • FIG. 43 is a cross-sectional view of the reservoir showing the thin spots.
  • FIG. 44 is a cross-sectional view of a valve reservoir having two concentric component compartments.
  • FIGS. 45A and B depict a minimally-invasive valve replacement sizer.
  • FIG. 46 is a cross-sectional view of a minimally-invasive valve replacement sizer comprising a guidewire, an intravascular ultrasound (IVUS) catheter having a transducer, and a balloon catheter, all positioned within the central lumen of the catheter.
  • FIG. 47 shows a balloon catheter comprising a balloon that circumferentially surrounds a portion of the catheter at its distal portion.
  • FIG. 48 shows a cross-sectional view of an inflated balloon with curves forming leaflets to enable fluid to pass.
  • FIG. 49 shows one preferred embodiment of a minimally-invasive valve replacement sizer, wherein the balloon is inflated with saline.
  • FIG. 50 shows a preferred embodiment of a minimally-invasive valve replacement sizer system, wherein the transducer emits an ultrasonic signal in a perpendicular direction to an intravascular ultrasound catheter (IVUS), which is reflected off the outer wall of the balloon and then received by the transducer and wherein the radius and diameter of the body cavity is determined by the auxiliary processor.
  • FIG. 51 shows an anchoring structure of the present invention having ultrasound cutting means.
  • FIG. 52 shows an anchoring structure of the present invention having radiofrequency cutting means.
  • FIG. 53 shows an anchoring structure having sharp edge cutting means.
  • FIG. 54 is a partial view of the valve assembly with cutting means on a partially inflated balloon catheter.
  • FIGS. 55A-C show a temporary two-way valve for distal protection.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • The present invention relates to valve replacement systems and devices. As illustrated in FIG. 1, a valve (1) comprises a distal or outflow end (2), leaflets (3) and a proximal or inflow end (4). A typical valve functions similar to a collapsible tube in that it opens widely during systole or in response to muscular contraction, to enable unobstructed forward flow across the valvular orifice (FIG. 1A). In contrast, at the end of systole or contraction, as illustrated in FIG. 1B, as forward flow decelerates, the walls of the tube are forced centrally between the sites of attachment to the vessel wall and the valve closes completely.
  • Replacement Valves
  • A preferred valve (5) for use with the systems and devices of the present invention is illustrated in FIG. 2 and is comprised of a body having a proximal end or inflow ring (6) and a distal end or outflow ring (7). The body is comprised of multiple leaflets of valve tissue joined by seams (8), wherein each seam is formed by a junction of two leaflets. A commissural tab region (9) extends from each seam at the distal end of the valve body. The proximal end (6) has an inflow ring with a peripheral edge that can be scalloped or straight. The inflow ring (6) of the valve can further comprise a reinforcement structure (10) that can be stitched to it. In preferred embodiments of the invention, the inflow edge of the valve is scalloped. The valve replacement systems and devices of the present invention are not limited, however, to the specific valve illustrated in FIG. 2. An important consideration in the design of valve replacement systems and devices that has received insufficient attention in previous approaches is the architecture of valve sinus. Valve sinuses are dilations of the vessel wall that surround the natural valve leaflets. Typically, each natural valve leaflet has a separate sinus bulge or cavity that allows for maximal opening of the leaflet at peak flow without permitting contact between the leaflet and the vessel wall. Thus, for example, a two-leaflet valve is surrounded by two sinus bulges, a three-leaflet valve by three, and a four-leaflet valve by four sinus cavities. The individual sinus bulges or cavities are separated by vertical fibrous structures known as commissural posts. These commissural posts define longitudinal structures with lesser outward curvature than the sinus cavities, as can be seen in FIG. 3. FIGS. 3A and B illustrate the reduced curvature of the commissural posts (11) compared with the curvature of the sinus cavities (12). FIG. 3C shows a view from outside the vessel of a commissural post (11) between two sinus cavities (12), while FIG. 3A shows a cross sectional view from the top of a closed valve within a valve sinus. The areas between the bulges define the commissural posts (11) and as can be clearly seen in FIG. 3B, the commissural posts serve as the sites of attachment for the valve leaflets to the vessel wall (13).
  • FIGS. 3B and C also show the narrowing diameter of the sinus region at both its inflow end (14) and outflow end (15) to form the inflow and outflow annuli of the sinus region. Thus, the valve sinuses form a natural compartment to support the operation of the valve by preventing contact between the leaflets and the vessel wall, which, in turn, may lead to adherence of the leaflets and/or result in detrimental wear and tear of the leaflets. The valve sinuses are also designed to share the stress conditions imposed on the valve leaflets during closure when fluid pressure on the closed leaflets is greatest. The valve sinuses further create favorable fluid dynamics through currents that soften an otherwise abrupt closure of the leaflets under conditions of high backflow pressure. Lastly, the sinuses ensure constant flow to any vessels located within the sinus cavities.
  • As shown in FIG. 4, the valve sinus region is characterized by certain relative dimensions which remain constant regardless of the actual size of the sinuses. Generally, the diameter of the sinus is at its largest at the center of the cavities or bulges (16), while there is pronounced narrowing of the sinus region at both the inflow annulus (17) and outflow annulus (18). Furthermore, the height of the sinus (19), i.e. the distance between the inflow and outflow annuli remains proportional to its overall dimensions. It is thus apparent that the sinus region forms an anatomical compartment with certain constant features that are uniquely adapted to house a valve. The systems and devices of the present invention are designed to utilize these anatomical features of the native sinus region for optimal replacement valve function and position.
  • Accordingly, in one preferred embodiment of the present invention, the replacement valve assembly comprises a collapsible and expandable anchoring structure adapted to support a valve distally along the commissural tab region and proximally along the inflow annulus. FIG. 5 shows a preferred anchoring structure adapted to support a valve such as that illustrated in FIG. 2. As seen in FIG. 5, the preferred anchoring structure has a generally tubular configuration within which the valve is secured. The valve is secured at its proximal (inflow) annulus by attachment to the inflow rim (20) of the anchoring structure and at its distal end via the commissural tabs that are threaded through the axially extending slots (21), which are formed in the support posts (22) that extend longitudinally from the inflow rim (20) to the outflow rim (23) of the anchoring structure. Thus, the distal ends (24) of the support posts contact the outflow rim (23) of the anchoring structure, whereas the proximal ends (25) of the support posts contact the inflow rim (20) of the anchoring structure.
  • In FIG. 5 the outflow rim (23) of the anchoring structure is depicted as comprising a plurality of rings that extend between the support posts (22) generally at or above the axially extending slots (21) that reside therein. The plurality of rings of the outflow rim (23) are configured in an undulating or zigzag pattern forming peaks (26) and valleys (27), wherein the individual rings remain substantially parallel to one another. The plurality of rings of the outflow rim comprise a vertical connector element (28) positioned at the center of the valleys (27) formed by the undulating or zigzag pattern. This vertical connector element (2o) is designed to stabilize the anchoring structure and to prevent distortion of the valve during compression and expansion of the anchoring structure comprising the valve. The vertical element (28) extends longitudinally in the axial direction of the cylindrical anchoring structure. In a preferred embodiment, the outflow rim (23) of the anchoring structure comprises two rings. In a preferred implementation of this embodiment shown in FIG. 5, the inflow rim (20) of the support structure comprises a single ring that extends between the support posts (22).
  • Both the inflow (20) and outflow (23) rims of the anchoring structure are formed with an undulating or zigzag configuration, although the inflow rim (20) may have a shorter wavelength (circumferential dimension from peak to peak) and a lesser wave height (axial dimension from peak to peak) than the outflow rim (23). The wavelengths and wave heights of the inflow (20) and outflow (23) rims are selected to ensure uniform compression and expansion of the anchoring structure without distortion. The wavelength of the inflow rim (20) is further selected to support the geometry of the scalloped inflow annulus of a preferred valve of the present invention. Notably, as shown in FIG. 5, the undulating or zigzag pattern that forms the inflow rim (20) of the anchoring structure is configured such that the proximal ends (25) of the vertical support posts (22) are connected to the peaks (29) of the inflow rim (20). Similarly, the undulating or zigzag pattern that forms the outflow rim (23) of the anchoring structure is configured such that the distal ends (24) of the support posts (22) are connected to the valleys (27) of the outflow rim (23). Locating the distal ends (24) of the support posts at the valleys (27) of the outflow rim (23) will prevent the longitudinal extension of outflow rim (23) in the direction of the valve secured within the lumen of the anchoring structure upon compression of the valve assembly, thereby eliminating any contact between valve and anchoring structure. Likewise, locating the proximal ends (25) of the support posts at the peaks (29) of the inflow rim (20) will prevent longitudinal extension of the inflow rim (20) in the direction of the valve tissue. Thus, compression of the valve and anchoring structure does not lead to distortion of or injury to the valve.
  • FIG. 5 further shows that the support posts (22) are configured generally in the shape of paddle with the axial slot (21) extending internally within the blade (30) of the paddle. The blade (30) of the paddle is oriented toward the outflow rim (23) of the anchoring structure and connects to the outflow rim (23) at a valley (27) of the undulating or zigzag pattern of the outflow rim (23). An important function of the support posts (22) is the stabilization of the valve in general, and in particular the prevention of any longitudinal extension at points of valve attachment to preclude valve stretching or distortion upon compression of the device. The blades (30) of the paddle-shaped support posts (22) are designed to accommodate the commissural tabs of the valve. The support posts (22) further comprise triangular shaped elements (31) extending on each side of the proximal end (25) of the support post. The triangular shaped elements (31) are designed to serve as attachments sites for the sewing cuff gasket and may be designed in different shapes without losing their function.
  • The number of support posts (22) in this preferred embodiment can range from two to four, depending on the number of commissural posts present in the valve sinus. Thus, in a preferred embodiment, the anchoring structure comprises three support posts for a three-leaflet valve with a sinus that features three natural commissural posts. The support posts (22) of the anchoring structure are configured to coincide with the natural commissural posts of the sinus.
  • FIGS. 6A and B show the preferred embodiment of FIG. 5 having a valve secured internally. The valve (32) is secured at its proximal (inflow) annulus (33) by attachment to the inflow rim (20) of the anchoring structure and at its outflow or distal end (34) via the commissural tabs (35) that are threaded through the axially extending slots (21), which are formed in the support posts (22) that extend longitudinally from the inflow rim (20) to the outflow rim (23) of the anchoring structure. Notably, as can be seen in FIGS. 6A and B, in this preferred embodiment the outflow rim (23) of the anchoring structure is configured to be longitudinally displaced from the distal outflow annulus (34) of the valve leaflets (36) that reside within the lumen of the tubular anchoring structure, thereby avoiding any contact between the valve leaflets (36) and the anchoring structure.
  • As shown in FIGS. 6A and B, the inflow rim (20) of the anchoring structure can be secured to the proximal inflow annulus (33) of the valve via a suitable fabric that may be wrapped around the circumferential juncture at the inflow end (33) and stitched into position to form a sewing cuff (37). The fabric may be made of any suitable material including but not limited to woven polyester, such as polyethylene terepthalate, polytetrafluoroethylene (PTFE), or other biocompatible material. Thus, the valve (32) is secured inside the anchoring structure by sewing a fabric ring (37) around the inflow rim (20) of the anchoring structure so as to create a sealing surface around the outer perimeter of valve's inflow annulus (33). In a preferred embodiment, the fabric ring (37) comprises two sewing cuff rings as shown in FIGS. 6A and B, with the second sewing cuff ring (38) having a larger diameter than the inflow annulus of the native valve sinus to ensure the firm lodging of the anchoring structure against the inflow annulus of the native valve sinus, thereby creating a tight, gasket-like seal.
  • The positioning of the valve (32) internally to the preferred anchoring structure with only the fabric of the commissural mounting tabs (35) of the valve (32) contacting the support posts (22) at the distal outflow annulus of the valve (34), while the proximal inflow annulus (33) of the valve is separated from the inflow rim (20) of the anchoring structure by the sewing cloth (37), ensures that no part of the valve (32) is contacted by the anchoring structure during operation of the valve (32), thereby eliminating wear on the valve (32) that may be occasioned by contact with mechanical elements.
  • In FIGS. 6A, B and C the outflow rim (23) of the anchoring structure is depicted as comprising a plurality of rings that extend between the support posts (22) generally at or above the axially extending slots (21) that reside at their distal ends (24). The plurality of rings of the outflow rim (23) are configured in an undulating or zigzag pattern forming peaks (26) and valleys (27), wherein the individual rings remain substantially parallel to one another. The plurality of rings of the outflow rim comprise a vertical connector element (28) positioned at the center of the valleys (27) formed by the undulating or zigzag pattern. This vertical connector element (28) is designed to stabilize the anchoring structure and to prevent distortion of the valve during compression and expansion of the anchoring structure containing the valve within. The vertical element (28) extends longitudinally in the axial direction of the cylindrical anchoring structure. In a preferred embodiment, the outflow rim of the anchoring structure comprises two rings.
  • FIG. 6C shows another implementation of a preferred anchoring structure of the present invention. In contrast to the implementation shown in FIG. 5, wherein the inflow rim (20) of the anchoring structure comprises a single ring that extends between the support posts (22), the implementation shown in FIG. 6C features an inflow rim (20) comprising two rings that are substantially parallel to each other and are connected by a vertical connector element (39) positioned at the center of the peaks (29) formed by the undulating or zigzag pattern. This vertical connector element (39) is designed to stabilize the anchoring structure and to prevent distortion of the valve during compression and expansion of the anchoring structure comprising the valve. The vertical element (39) extends longitudinally in the axial direction of the cylindrical anchoring structure. FIG. 6C also shows that the distal end (24) of the support post (22) may further comprise suture bores (41) to facilitate the placement of additional sutures for the securing the valve to the anchoring structure.
  • Because the wavelengths and wave heights of the inflow (20) and outflow rims (23) are selected to ensure uniform compression and expansion of the anchoring structure without distortion, a different wavelength and height may be chosen for the inflow ring (20) of an implementation of a preferred embodiment of an anchoring structure featuring an inflow rim (20) with two substantially parallel undulating rings as shown in FIG. 6C. Thus, the inflow rim (20) depicted in FIG. 6C may have substantially the same wavelength and height as the outflow rim (23). Similarly, the support posts (22) may be modified to comprise a widened proximal end (25) with an axial slot (40) extending longitudinally from the inflow rim (20) toward the distal end (24) of the support posts (22) and centrally through the triangular shaped elements (31). The widening of the proximal end (25) of the support posts (22) protects the triangular shaped elements (31) from distortion by the different collapsed profile of the inflow rim (20) with larger wavelength and height and ensures that no part of the valve (32) will be contacted by the anchoring structure during compression.
  • FIGS. 7 and 8 show the expansion (FIG. 7) and compression (FIG. 8) profile of a preferred anchoring structure of the present invention. In a preferred embodiment of the present invention, the anchoring structure is collapsible to at least 50% of its expanded diameter. As shown in FIGS. 7 and 8, the undulating or zigzag pattern that forms the inflow rim (20) of the anchoring structure is configured such that the proximal ends (25) of the vertical support posts (22) are connected to the peaks (29) of the inflow rim (20). Similarly, the undulating or zigzag pattern that forms the outflow rim (23) of the anchoring structure is configured such that the support posts (22) are connected to the valleys (27) of the outflow rim (23). Locating the distal ends (24) of the support posts (22) at the valleys (27) of the outflow rim (23) will prevent the longitudinal extension of outflow rim (23) in the direction of the valve upon compression of the device, thereby eliminating any contact between valve and anchoring structure. Similarly, locating the proximal ends (25) of the support posts (22) at the peaks (29) of the inflow rim (20) prevents structural interference between the proximal ends (25) of the support posts (22), in particular the triangular shaped elements (31) designed to support the scalloped inflow annulus of the replacement valve, and the undulating pattern of the inflow rim (20), as well as longitudinal extension of the inflow rim (20) in the direction of the valve tissue. Thus, compression of the valve and anchoring structure does not lead to distortion of or injury to the valve.
  • FIG. 8 shows that the support posts (22) connect to the outflow rim (23) at a valley (27) of the undulating or zigzag pattern and that during compression, the support posts stabilize the anchoring structure by preventing any longitudinal extension at points of valve attachment, that is at the proximal (25) and distal (24) ends of the support posts. The commissural mounting tabs of the valve are attached to the anchoring structure by extending through the axial slots (40) of the support posts to the exterior of the anchoring structure, while the inflow annulus of the valve is connected to the inflow rim (20) of the anchoring structure via a fabric ring. This arrangement allows firm attachment of the distal or outflow end of valve to the anchoring structure and ensures the proper positioning of the valve, with the outflow end being supported such that the leaflets are allowed to open and close with the movement of fluid across the lumen of the valve. It should be noted that the particular shapes of the individual elements of the structures disclosed herein may be modified by a person of skill in the art to achieve the advantages described without departing from the scope of the present invention.
  • The number of support posts (22) in this preferred embodiment can range from two to four, depending on the number of commissural posts present in the valve sinus. Thus, in a preferred embodiment, the anchoring structure comprises three support posts (22) for a three-leaflet valve with a sinus that features three natural commissural posts. The support posts (22) of the anchoring structure are configured to coincide with the natural commissural posts of the sinus.
  • An advantage of this arrangement is the additional option for the surgeon of suturing the valve assembly into place, wherein the anchoring structure provides the surgeon with additional guidance as to the proper anatomical positioning of the valve inside the native valve sinuses. Since the anchoring structure is dimensioned to fit precisely into the valve sinus cavities, the surgeon's positioning task is simplified to a visual determination of the location of the commissural posts of the native sinuses and their alignment with the support posts (22) of the anchoring structure of the valve. Thus, the present preferred embodiment takes advantage of the natural features of the valve sinus for the rapid orientation and attachment of the valve assembly. The ability of the anchoring structure to emulate the architecture of the valve sinus thus significantly reduces the surgeon's time spent on suturing the valve into position, should he so desire.
  • The geometry of the preferred embodiment of a valve anchoring structure further naturally positions it across the entire longitudinal extension of the native valve sinus, lodging the anchoring structure firmly against the vessel walls. Proximally, the inflow rim (20) of the anchoring structure naturally fits into the native valve sinus at a position near the inflow narrowing (annulus) of the native valve sinus against which it is designed to rest, while distally, the outflow rim (23) of the anchoring structure fits into the sinus at a position near the outflow narrowing (annulus) of the sinus against which it is designed to rest.
  • Between the proximal and distal ends of the anchoring structure the only longitudinal mechanical elements of the anchoring structure are the support posts (22) which are confined to the native commissural posts between the sinuses, leaving the sinus cavities free to create the native fluid currents that support leaflet closure and valve operation in general. A further advantage of this preferred embodiment of the present invention is the ability of the anchoring structure to emulate the natural compartment formed by the sinus for anchoring the valve. Thus, the anchoring structure is able to extend completely across the sinuses without placing mechanical elements into the path of fluid flow and without obstructing flow to any vessel openings that may be present in the valve sinuses.
  • In a preferred implementation of the present embodiment, the anchoring structure exerts radial force against the vessel wall so as to produce a compression fit. This may be accomplished by oversizing the anchoring structure such that it permanently seeks to expand to its original size. Thus, both the inflow (20) and outflow (23) rims are designed to push radially against the sinus walls near the inflow and outflow annuli of the sinus. The undulating or zigzag pattern formed by the inflow (20) and outflow (23) rings further serves to provide tire-like traction against the sinus wall for anchoring. Thus, the combination of compression fit, traction and sewing cuff rings (37 and 38) of the anchoring structure provides a firm anchor for the replacement valve and an optimal configuration in the native valve sinus.
  • In preferred embodiments of the present invention, the anchoring structure comprises a material that is expandable from a compressed configuration illustrated in FIG. 8 into the configuration depicted in FIG. 7. The anchoring structure may be non-self expanding, i.e. capable of being expanded from a compressed state using mechanical means, such as a balloon inflated from within the radial center of the anchoring structure, or using the expansion and compression devices disclosed herein. The anchoring structure comprises vertical tab support posts (22) which are designed to prevent inelastic deformation when the anchoring structure is collapsed prior to implantation.
  • FIG. 9 shows a representative flat valve leaflet (36) before it is sewn together with a desired number of additional leaflets (36) to form a three-dimensional replacement valve. The flat pattern of the leaflet (36) can be used to dimension the anchoring structure shown in FIG. 10 such that the commissural tabs (35) of the valve (36) will coincide with the axial slots (21) at the distal ends (24) of the support posts (22) and the proximal edges (42) at which the leaflets will be stitched or otherwise attached to each other to form the inflow annulus of the valve can be attached to the proximal ends (25) of the support posts (22) of the anchoring structure via the triangular shaped elements (31).
  • FIGS. 9 and 10 also show how an anchoring structure and valve may be scaled to fit different sizes of valve sinuses while retaining the proportional dimensions of the valve sinus. For example, if the width (43) of the leaflet (36) shown in FIG. 9 is chosen for a certain valve size, then the distance (44) between support posts (22) of the anchoring structure shown in FIG. 10 will be determined accordingly. Likewise, the height (45) of the leaflet (36) in FIG. 9 will determine the length (46) of the support posts (22) of the anchoring structure in FIG. 10. In this manner, a person of skill in the art can dimension both the valve and anchoring structure to fit any size of valve sinus.
  • Another preferred embodiment of the present invention, illustrated in FIGS. 11 and 12, comprises a valve supported by a flared anchoring structure. The flared anchoring structure preferably comprises flared-out sections located at both the inflow (47) and outflow rims (48) to anchor it firmly against the narrowed inflow and outflow annuli of the valve sinuses. The flared distal end (48) of the anchoring structure is adapted to support the tab regions of the valve while the flared proximal end (47) supports the valve inflow annulus (33). The flared-out feature prevents contact between the valve tissue and the anchoring structure if the outflow rim (48) is positioned below the upper edges of the valve leaflets (36) in the open position, while also allowing the anchoring structure to secure itself in a sinus cavity of the vascular passageway. In this embodiment, the outflow rim (48) of the anchoring structure is comprised of diamond (49) and hexagon (50) shaped structures which facilitate collapsibility and dynamic compliance. The commissural tabs (35) of the valve (32) can be stitched directly to the hexagon shaped elements (50) of the outflow ring, rather than being secured via slots. The flared inflow rim (47) of the anchoring structure preferably comprises a single ring in the form of an undulating or zigzag pattern to which the valve's fabric ring (37) can be sewn. The inflow ring (47) of the anchoring structure is connected to the outflow rim (48) through vertical elements (51) that are positioned to coincide with the commissural posts of the native sinus region. Thus, the exemplary embodiment of FIGS. 11 and 12 comprises three vertical connecting elements (51) for a three-leaflet valve (32). However, it should be understood that the number of vertical connecting elements (51) is meant to be adapted to the number of native commissural posts present in the particular sinus region. The area between vertical connector elements (51) is thus left free of any structural elements for the accommodation of vessel openings that may be present in the particular valve sinus.
  • In another preferred embodiment, as illustrated in FIG. 13, a valve is supported by an anchoring structure comprising a plurality of posts (52) with a single ring (53) at the inflow rim. The ring (53) is configured in an undulating or zigzag pattern. In this exemplary embodiment the plurality of posts (52) number three for a three-leaflet valve sinus region. The three posts (52) extend in the distal direction from the single ring (53) located at the inflow end of the anchoring structure. The proximal end (33) of the valve is attached to the ring (53) portion of the anchoring structure so that the ring (53) provides support to the inflow annulus (33) of the valve. The inflow ring (53) comprises an undulating or zigzag pattern for tire-like traction against the vessel wall. The anchoring structure portion surrounding the proximal end (33) of the valve is preferably flared in an outward direction to improve anchoring forces against the vascular wall.
  • The three posts (52) extend from the proximal end (33) to the distal end (34) of the valve and provide cantilevered support to the tab regions (35) of the valve at the distal end (34). The three posts (52) are designed to be sufficiently flexible so that they may deflect inwardly in a controlled motion at back flow pressures to optimize the fatigue life of the anchoring structure. The posts (52) comprise a distal end (54) for the attachment of the valve commissural tabs (35). Below the distal end (54), the posts (52) comprise a diamond-shaped element (55) for enhanced structural stability and valve support. As with the previous embodiments of the present invention, the design according to the present embodiment creates open space between the proximal (33) and distal ends of the valve (34). This also ensures that there is no direct contact between the valve and the anchoring structure and that vessel openings located within the particular sinus remain unencumbered. Again, as in the preceding embodiments, the support posts (52) are configured to spatially coincide with the commissural posts of the valve sinuses for ease of positioning and anatomical optimization.
  • The anchoring structure embodiment illustrated in FIG. 14 comprises a valve supported by a multi-operational anchoring structure (56). The multi-operational anchoring structure (56) comprises a proximal end (57), a distal end (58), posts (59) extending from the proximal end (57) to the distal end (58), and a tab attachment window (60) attached to each post (59) at the distal end (58). The tab attachment windows (60) in the present embodiment have a triangular geometry that is designed to create an optimal interference fit between the anchoring structure and the commissural tabs The post (59) and tab attachment window (60) construction of the present embodiment allows inward deflection of the post at back flow pressure, thus providing cantilevered support to the valve and greater dynamic compliance with the sinus region. Both the proximal (57) and distal (58) ends of the anchoring structure are flared out to better secure the valve in the valvular sinus region. The proximal end or inflow rim (57) of the anchoring structure also preferably possesses barbs or hooks (61) at the proximal end (62) of the post (59) for better attachment to the vascular wall and/or the valve's inflow annulus. In this embodiment, the flared inflow rim (57) is depicted as featuring two undulating rings that are substantially parallel to one another, while the flared outflow rim features three undulating rings.
  • Yet another preferred embodiment of a valve anchoring device according to the present invention is illustrated in FIGS. 15-21. In this preferred embodiment, an elliptical segment (70) anchoring structure is used to support the valve (32) as shown in FIG. 15A. As shown in FIG. 15B, the elliptical segment anchoring structure (70) comprises a plurality of elliptical segments (71) that are joined together, either integrally, mechanically, or by adhesive means. Each elliptical segment (71) is flared outward at the proximal (72) and distal ends (73) of the anchoring structure and curved inward at the junctures (74) with the other segments (71) assuming the shape of a potato chip. When joined together side by side, the elliptical segments (71) form a tubular structure that is flared outward at both the inflow (72) and outflow (73) ends. The junctures (74) of the elliptical segments (71) are located at the center of a substantially straight area of the elliptical segments (71) that defines the longitudinal support post elements (75) of the elliptical segment anchoring structure (70) and also provides a gap location (75) near which the valve tabs (35) can be secured. The tab regions (35) extending from the seams of the valve can be attached to the anchoring structure using any suitable means, including, sewing, stapling, wedging or adhesive means. The tab regions (35) are preferably attached to the gaps (75) formed above the junctures (74) between the elliptical segments (71). The inflow (72) and outflow (73) rims of the anchoring structure are formed by the corresponding regions of the elliptical segments (71) that reside below and above the junctures (74). The inflow annulus of the valve can be secured at the inflow rim (72) via stitching to the inflow annulus fabric which also serves as a sealing gasket.
  • As shown in FIG. 16A, the vertical axes (76) of the elliptical segments (71) are dimensioned to exceed the axial length (77) of the valve (32), thereby eliminating valve leaflet (36) contact with the outflow rim (73) of the anchoring structure. FIG. 16B shows how both the valve (32) and anchoring structure (70) of the present embodiment can be compressed radially to facilitate implantation. The concave configurations of the elliptical segments (71) effectively form a radial spring that is capable of being radially collapsed under pressure for deployment and then expanded when positioned at the implant site. One advantageous feature of the instant design is that the region of juncture (74) between the elliptical segments (71) does not become extended upon compression of the anchoring structure. The valve (32) and anchoring structure (70) of the present embodiment can also be compression fit within a valve sinus cavity to exert radial force against the sinus walls.
  • As shown in FIG. 17, the anchoring structure (70) is preferably dimensioned to be lodged substantially within a valve sinus, with the regions of juncture (74) between the elliptical segments (71) being configured to reside at the location of the native commissural posts. The elliptical segment anchoring structure (70) is designed to expand at the proximal end (72) during peak flow and at the distal end (73) during peak backflow pressure, thereby maintaining pressure against the vascular wall. As a result, the valve and anchoring structure (70) of the present embodiment will remain secure in the valve sinus without sutures. A metal wire frame made from a metal that exhibits a high modulus of elasticity and that is biocompatible is preferred, such as Nitinol, as such materials exhibiting superior compressibility allow the anchoring structure to be self-expandable.
  • A further preferred embodiment of a valve anchoring structure according to the present invention is illustrated in FIGS. 18A and B. In the present embodiment, an elliptical segment anchoring structure (70) is presented in which the elliptical segments (71) are joined together by a specialized double crimp (78). FIG. 18B shows that the valve tabs (35) can be secured near the double crimp (78) that joins the elliptical segments (71). The tab regions (35) are preferably attached to the gaps (75) between the elliptical segments (71). The inflow annulus of the valve (33) can be secured at the inflow rim (72) via stitching to the inflow annulus fabric which also serves as a sealing gasket.
  • FIGS. 19A and B illustrate the double crimp (78) used to join the elliptical segments (71). As shown in FIGS. 19A and B, the double crimp (78) comprises two hollow tubes (79), one for each elliptical segment (71) to be inserted. The hollow tubes (79) of the double crimp (78) are designed to allow for better motion of the individual elliptical segments (71) and to minimize material stresses during expansion and compression of the anchoring structure. The double crimp (78) further comprises a central portion (80) joining the two hollow tubes (79). This central portion (80) comprises one or more holes (81) to facilitate the attachment of the valve commissural tabs to the anchoring structure and to reduce the mass of the double crimp (78). Thus, the double crimp (78) also serves as an attachment site for the valve and further acts as a stop against backflow pressure on the valve leaflets.
  • FIG. 20A shows the insertion of the elliptical segments (71) of the preferred anchoring structure embodiment (70) into the double crimp (78). As with the previous embodiments, the present embodiment is dimensioned to be lodged substantially within the valve sinuses, with the joined regions (74) of the elliptical segments in FIG. 20B configured to align with the commissural posts of the sinus and the flared inflow (72) and outflow ends (73) of the anchoring structure configured to rest against the sinus cavities.
  • FIGS. 21A through G show how the elliptical segment anchoring structure (70) may additionally be covered with cloth (82), particularly at the inflow end (72) to provide traction and a gasket-like seal. Thus, this preferred embodiment of the present invention is dimensioned to follow the sinus architecture and to lodge into the sinus cavities and against the inflow and outflow annuli of the sinuses for optimal securing and positioning of the replacement valve.
  • FIGS. 22A and B illustrate a further preferred embodiment the present invention. This figure shows an elliptical segment anchoring structure (90) made from one piece of tubing. As illustrated, the support posts (91) that form the slots (92) for the valve tabs include a series of small holes (93) on either side of the slot (92) to facilitate suture or mechanical attachment of the commissural tabs of the valve. Again, this anchoring structure (90) is dimensioned to fit substantially within the valve sinuses with the support posts (91) being configured to reside in the commissural posts between the individual sinus cavities. The present embodiment also exerts axial force particularly at the flared inflow (94) and outflow rims (95) against the sinus walls to anchor the valve.
  • Yet another embodiment of a valve and anchoring structure according to the present invention is illustrated in FIGS. 23A through D. In the present embodiment, a claw anchoring structure (100) is shown in FIG. 23A. This embodiment corresponds to an elliptical segment embodiment wherein the upper portions of each elliptical segment have been removed. The ends of the junctures (101) of the remaining elliptical segments are shaped into prongs or claws (102). Thus, the claw anchoring structure (100) comprises a flexible spring frame having a plurality of barbs (102), located distally just beyond where the valve leaflet tab regions meet the anchoring structure. The claw anchoring structure (100) preferably comprises at least one barb (102) for each valve leaflet tab included in the valve. The barbs (102) are designed to anchor the valve (32) and anchoring structure (100) to the vascular wall.
  • In another preferred embodiment of the invention, an anchoring structure is provided that lacks vertical support posts. As shown in FIG. 24, the representative anchoring structure configuration comprises an inflow ring (110) that is adapted to being secured to the inflow annulus of the valve (33) via stitching to the reinforced fabric sewing ring in a manner similar to the prior representative implementations. The undulating or sinusoidal pattern of the ring (110) facilitates radial collapse and expansion and exerts radial force against the vessel wall. The anchoring structure does not support the outflow annulus (34) of the valve. Rather, the valve's commissural tabs (35) are attached to the sinus walls via mechanical means, such as sutures, staples, or wire.
  • Another representative embodiment of an anchoring structure is shown in FIG. 25A. The present embodiment comprises a dual-ring anchoring structure (120). The dual ring (120) of the present embodiment may, as in the previous embodiment, be secured to the inflow annulus of the valve via stitching to the reinforced fabric sewing ring. The undulating or sinusoidal pattern of the individual rings (121) is configured such that the peaks (122) of one ring (121) coincide with the valleys (123) of the other ring and vice versa, thereby forming a sine-cosine pattern. This pattern facilitates radial collapse and expansion and exerts radial force against the vessel wall. As in the previous embodiment, the dual ring anchoring structure (120) does not support the outflow annulus of the valve. Rather, the valve's commissural tabs are attached to the native sinus walls via mechanical means, such as sutures, staples, or wire, or additionally by the adhesive means disclosed herein.
  • FIG. 25B shows another dual ring embodiment of the present invention. This anchoring structure is comprised of an upper (distal) dual ring (130) and a lower (proximal) dual ring (131). The lower dual ring (131) is connected to the proximal end of the valve at the inflow annulus while the upper dual ring (130) is connected to the distal end of the valve at the outflow annulus. The valve may be connected to the rings (130, 131) via sutures, clips or any other suitable means for attachment. The valve and the attached proximal (131) and distal (130) rings can be collapsed and inserted via a catheter. Once the valve has reached its desired location in the vascular passageway, the two rings (130, 131) are expanded to secure the valve in the vascular passageway. As in the previous embodiment, each dual ring (130, 131) comprises a wire frame with a circular cross-section and a sinusoidal pattern. The sinusoidal pattern may be of a sine-cosine shape with a varied frequency and amplitude. One or more longitudinal rods (132) may be used to connect the two dual rings (130, 131) and maintain longitudinal separation and radial orientation. The rods (132) may be removable so that once the valve is implanted in the vascular passageway they can be removed.
  • In another preferred embodiment, illustrated in FIG. 26, an upper single ring (140) with an undulating or zigzag pattern provides support to the tab regions (35) of the valve (32) at the distal end (34) of the valve whereas a lower single ring (141) configured in an undulating or sinusoidal pattern provides support to the inflow annulus (33) at the proximal end of the valve (32). The inflow ring (141) is stitched to the sewing fabric wrapped around the circumference of the inflow annulus of the valve, as described previously. The outflow ring (140) of the anchoring structure generally resides above the leaflets (36) to avoid leaflet contact. To improve traction, the inflow or outflow rings may comprise attachment barbs (142). The structural dissociation between the rings (140, 141) provides improved dynamic compliance while retaining the benefits of a two ring design.
  • Yet another embodiment of a valve and anchoring structure according to the present invention is illustrated in FIGS. 27A through C. In the valve anchoring structure according to the present embodiment shown in FIGS. 27A and C, the valve (32) is supported by a tubular anchoring structure (150). The tubular anchoring structure (150) is preferably made of metal or plastic. The tubular anchoring structure (150) is also preferably designed to be expandable. For example, the anchoring structure may be designed to be self-expandable, balloon-expandable, or mechanically-expandable. The tab regions (35) of the valve (32) are preferably attached to the distal end (151) of the tubular anchoring structure (150) using staples, sutures, wire fasteners, or any other suitable means. The inflow rim (152) of the tubular anchoring structure may comprise a plurality of suture bores (153) to facilitate attachment of the valve (32). The tubular anchoring structure (150) also comprises vertical support posts (154) with axial slots (155) for the insertion of the valve tabs (35). The vertical support posts (154) extend to the distal end (151) of the tubular anchoring structure (150). In a preferred implementation of the of the present embodiment, the means of attachment, or an alternative means, is used to also attach the tab regions (35) of the valve (32) to the vascular wall thereby securing the valve (32) and tubular anchoring structure (150) in the valve sinuses. Such fastening means can also be optionally used at the inflow annulus to provide additional anchoring.
  • Another embodiment of a valve and anchoring structure according to the present invention is illustrated in FIG. 28. In the present embodiment, a dual-ring anchoring structure (160) is shown, as seen in FIGS. 28C and D, with an inflow ring (161) and an outflow ring (162) connected by a vertical element (163) comprised of two posts (164). The anchoring structure (160) is designed to be circumferentially collapsible as can be seen in FIGS. 28A and B. As shown in FIGS. 28C and D, the anchoring structure (160) is collapsed by sliding the two posts (164) that are adjacent to each other in the expanded state (FIG. 28D) past each other to decrease the circumference of the upper outflow (162) and lower inflow (161) rings (FIG. 28C). Thus, prior to implantation the anchoring structure (160) is collapsed and, once the valve is properly positioned in the valve sinuses, the anchoring structure freely self-expands to its original dimensions. The self-expanding behavior of the present embodiment is due to Nitinol's relatively high modulus of elasticity, which imparts superior spring-like properties to the anchoring structure. Alternatively, if the anchoring structure is constructed of a non-self expanding material, it may be mechanically collapsed and expanded using the devices disclosed herein.
  • Another embodiment of a valve and anchoring structure according to the present invention is illustrated in FIGS. 29A and B. In the present embodiment, a dual-ring anchoring structure (170) is shown, with an inflow ring (171) and an outflow ring (172) connected by a vertical element (173) comprised of two posts (174). The inflow rim may further comprise tissue mounting posts (175). The anchoring structure (170) is designed to be circumferentially collapsible. FIG. 29A shows how the posts (174) are separated in the expanded state and FIG. 29B shows how the posts (174) form a single vertical element (173) in the collapsed state. Thus, prior to implantation the anchoring structure is collapsed and upon the positioning of the valve assembly in the valve sinuses, the anchoring structure (170) freely self-expands to its original dimensions. As in the previous embodiment, the self-expanding behavior of the present embodiment is a function of Nitinol's high modulus of elasticity. Alternatively, if the anchoring structure is constructed of a non-self expanding material, it may be mechanically collapsed and expanded using the devices disclosed herein.
  • A further embodiment of a valve and anchoring structure according to the present invention is illustrated in FIGS. 30A and B. The present embodiment comprises a spring-aided anchoring structure (180). The spring aided anchoring structure (180) preferably comprises three members (181) that are radially collapsible for implantation into the valve sinuses. The members (181) comprise peaks (182) that serve as valve attachment points and valleys (183) that serve to lodge the anchoring structure at the valve sinus inflow annulus. Following implantation, the anchoring structure (180) is expanded to its original dimensions by coil springs (184) that provide an outward radial force on each member. In a preferred embodiment, shown in FIG. 30B, the spring aided anchoring structure (180) comprises at least one anchoring section (185) for selectively securing the anchoring structure (180) in the valve sinus at the inflow annulus. Although the present embodiment illustrates three members (181) and three coil springs (184), it should be appreciated that two or more members (181) with a corresponding number of coil springs (184) may be used.
  • The anchoring structures of the present invention may be constructed from superelastic memory metal alloys, such as Nitinol, described in U.S. Pat. No. 6,451,025, incorporated herein by reference. Nitinol belongs to a family of intermetallic materials which contain a nearly equal mixture of nickel and titanium. Other elements can be added to adjust or modify the material properties. Nitinol exhibits both shape memory and superelastic properties. The shape memory effect of Nitinol allows for the restoration of the original shape of a plastically deformed structure by heating it. This is a result of the crystalline phase change known as thermoelastic martensitic transformation. Thus, below the transformation temperature, Nitinol is martensitic, i.e. easily deformable. Heating the material converts the material to its high strength, austenitic condition. Accordingly, prior to implantation, the valve assembly is chilled in sterile ice water. Upon cooling, the Nitinol anchoring structure enters its martensite phase. Once in this phase, the structure is malleable and can maintain a plastically deformed crushed configuration. When the crushed anchoring structure comprising the valve is delivered into the valve sinus, the increase in temperature results in a phase change from martensite to austenite. Through the phase change, the anchoring structure returns to its memorized shape, and thus expands back to its original size.
  • The anchoring structures can also be designed to use the superelasticity properties of Nitinol. With the superelastic design, the chilling procedure would not be necessary. The anchoring structure would be crushed at room temperature. The phase change to martensite would be accomplished by means of the stress generated during the crushing process. The anchoring structure would be held in the crushed configuration using force. Force is removed once the anchoring structure is delivered to the valve sinus, resulting in a phase transformation of the Nitinol from martensite to austenite. Through the phase change, the anchoring structure returns to its memorized shape and stresses and strains generated during the crushing process are removed. Alternatively, the anchoring structures of the present invention may be composed of a non-self expanding suitable material, such as biocompatible metals, including titanium, and plastics. Whether the valve assembly is designed to be self-expandable or non-self expandable, it may be compressed (and expanded, if non-self expandable) for implantation using the expansion and contraction devices disclosed herein.
  • Expansion and Contraction Devices
  • A preferred embodiment of an expansion and contraction device for implanting the valve assemblies of the present invention is illustrated in FIGS. 31-33. As seen in FIGS. 31A and B, the device of the present embodiment comprises a group of bendable hollow tubes or wires (200), a grip handle (201), and a circular element (202) that holds the wires (200) together at their proximal ends (203). Each wire (200) comprises a proximal end (203), a distal end (204) and a hollow shaft (205) running from the proximal end (203) to the distal end (204). The wires (200) are attached to the grip handle (201) at their proximal ends (203) via the circular element (202) such that the wires form a circular pattern.
  • As shown in FIGS. 32A and B, the expansion and contraction device further comprises a cylinder (206) having a proximal end (207) and a distal end (208). The cylinder (206) has holes (209) drilled along its distal perimeter (208). The holes (209) in the cylinder (206) are preferably drilled at an outward angle so that by forcing the wires (200) through the angled holes (209), the distal ends (204) of the wires (200) are driven radially outward. As the wires (200) are pushed further through the outwardly angled cylinder holes (209), the further the wires (200) spread radially, thereby expanding the anchoring structure that is positioned over the wires (200). Accordingly, the angle of the cylinder holes (209) controls the relationship between the longitudinal movement of the wires (200) and their radial dilation.
  • As shown in FIG. 33, a representative anchoring structure (210) of the present invention is attached to the distal ends (204) of the hollow wires (200). The cylinder (206) having a proximal end (207) and a distal end (208) has holes (209) drilled along its distal perimeter (208). The holes (209) in the cylinder (206) are drilled at an outward angle so that by forcing the wires (200) through the angled holes (209), the distal ends (204) of the wires (200) are driven radially outward. As this figure shows, when the wires (200) are pushed further through the outwardly angled cylinder holes (209), they are forced to spread radially, thereby expanding the anchoring structure (210) that is positioned over the wires (200) at their distal ends (204). In a preferred embodiment, a long suture is routed from the proximal end to the distal end of the wire down its hollow shaft, looped around a segment of the anchoring structure at the distal end of the wire and then routed back to the proximal end of the wire, where it is secured. Attached to the distal ends (204) of the hollow wires, the anchoring structure (210) contracts and expands radially in response to the longitudinal motion of the wires (200). Pulling the grip handle (201) proximally contracts the anchoring structure (210) into a collapsed state for implantation whereas pushing the grip handle (201) distally expands the anchoring structure (210). When the anchoring structure (210) is positioned in a desirable location in the vessel and expanded to the desired dimensions, the sutures are severed and removed from the proximal end (203) of the wires (200) in order to disconnect the anchoring structure (210) from the device. The device of the present embodiment is removed, thereby leaving the valve assembly securely situated in the valve sinus.
  • Another expansion and contraction device is illustrated in FIGS. 34 and 35. As shown in FIG. 34, the device of the present embodiment comprises a tube (220), multiple wall panels (221), springs (222) corresponding to the multiple wall panels (221), a spindle (223) and a plurality of connecting wires (224). The tube (220) comprises a hollow shaft (225) having a radial center (226), a proximal end (227), a distal end (228) as shown in FIG. 35, an interior wall (229) and an exterior wall (230), wherein a hole (231) corresponding to each wall panel (221) extends through the interior (229) and exterior wall (230) of the tube (220). In a preferred embodiment, the perimeter of the exterior wall (230) is surrounded by adjacent wall panels (221), only buffered by the springs (222) corresponding to the wall panels (221). The spindle (223) is attached to the interior wall (229) of the tube (220), preferably facing the tube's (220) radial center (226). A connecting wire (224) is attached to each wall panel (221) and routed through the spring (222) and the corresponding hole (231) in the tube wall (229, 230) to meet the other connecting wires (224), preferably at the radial center (226) of the tube (220).
  • As shown in FIG. 35, upon meeting at the radial center (226) of the tube (220), the wires (224) having been wrapped around the spindle (223), now run parallel to the tube's (220) longitudinal axis. By pulling the wires (224) proximally, the attached panels (221) compress the springs (222) against the tube's (220) exterior wall (230). In this compressed state, a collapsed valve assembly of the present invention can be placed over the panels (221). Once the device of the present embodiment, loaded with the valve assembly, is positioned at the desired location in the valve sinus, the tension in the wires (224) is relieved to force the wall panels (221) outward, thereby expanding the anchoring structure and valve. The length of the uncompressed spring (222) determines the diameter to which the anchoring structure can be expanded. The anchoring structure can optionally be secured to the wall panels (221), by staples, sutures, wire fasteners, or any other suitable means, so that the valve assembly may be selectively expanded and collapsed by preferably varying the tension on the connecting wires.
  • In FIGS. 36A and B, another preferred embodiment of an expansion and contraction device of the present invention is presented. In this embodiment, the anchoring structure (240) is composed of a shape memory metal or the like having a relatively high modulus of elasticity, and possessing an outward spring-like force when in a compressed state. Therefore, spring loaded wall panels are not necessary in the present embodiment. Instead, the wires (241) pass through sutures (242) that are threaded through holes (243) in the tube (244) wall and wrap around portions of the anchoring structure. Thus, the wires (241) keep the anchoring structure (240) compressed by pulling the sutures (242) around the anchoring structure (240) against the tube (244). Alternatively, the tube structure can be omitted with only the wires (241) and sutures (242) keeping the anchoring structure (240) in a compressed state. This would ensure that the valve within the anchoring structure is not contacted by any mechanical elements, such as a tube (244). Alternatively, the tube could be made from a cloth- or tissue-like material. Once the anchoring structure (240) is positioned in the desired location in the valve sinus, the wires (241) can be retracted, allowing the anchoring structure (240) to self-expand such that the tube (244) can be withdrawn, leaving the anchoring structure (240) securely lodged at the desired location of implantation. The sutures (242), which will remain wrapped about the anchoring structure (240), can be made of biodegradable material and thus will be resorbed by the body within a matter of days.
  • The contraction and expansion device illustrated in FIGS. 37 and 38 represents another preferred embodiment of the present invention. As illustrated in FIG. 37, each wall panel (250) is connected to a pin (251) which runs through the corresponding hole (252) in the tube (253) wall. The pin (251), protruding radially inward from the tube's interior, is preferably spring-loaded (254) toward the radial center of the tube (253). In a zero energy state, the wall panels (250) rest against the exterior wall of the tube (253) and the collapsed anchoring structure rests against the wall panels (250). Instead of wires, the present embodiment comprises a longitudinal shaft (255) running through the radial center of the tube. The shaft is comprised of a proximal end (256) and a distal end (257). The distal end (257) is connected to a central plate (258) having spiral shaped edges (259) as shown in FIGS. 37B and C. The central plate (258) is located in the tube (253), parallel to the tube's cross-section and is aligned with the spring-loaded (254) pins (251). The plate's spiral-shaped edges (259) preferably cause the distance from the plate's perimeter to the tube's radial center to vary along the plate's (258) perimeter. When the shaft (255) is rotated, the edge of the plate (259) pushes against each pin (251), thereby driving the corresponding panels (250) outward and expanding the anchoring structure, as FIG. 37C shows.
  • FIGS. 38A and B show how rotation of the shaft (255) pushes the wall panels (250) radially out, thereby expanding the anchoring structure (260). In a preferred embodiment, the anchoring structure (260) is sutured to the wall panels (250) to allow expansion and contraction of the anchoring structure by alternating rotation of the shaft. The sutures are preferably removable from the shaft's (255) proximal end to free the valve assembly from the device following implantation in the valve sinus.
  • In still another embodiment, as illustrated in FIG. 39, an expansion and contraction device similar to the previous embodiment is presented. Instead of a device comprising a central plate with spiral-shaped edges of varying dimensions, the present preferred embodiment utilizes a circular disk (270) with pre-cut spiral-shaped grooves (271) corresponding to the spring-loaded pins (272). Preferably, the grooves (271) provide a track of varying depth for the pins (272) such that the pins (272) are forced radially outward upon rotation of the disk (270), thereby expanding the anchoring structure.
  • Adhesive Means for Securing Replacement Valves
  • In addition to the disclosed features and mechanisms for securing the valve assembly comprising a valve and anchoring structure into position, the present invention provides the use of biocompatible adhesives. A number of adhesives may be used to seal the valve assembly to the surrounding tissue in the valve sinus. The following are examples of available adhesives and methods of use:
  • U.S. Pat. No. 5,549,904, the entire contents of which are incorporated herein by reference, discloses a formulated biological adhesive composition comprising tissue transglutaminase and a pharmaceutically acceptable carrier, the tissue transglutaminase in an effective amount to promote adhesion upon treatment of tissue in the presence of a divalent metal ion, such as calcium or strontium. In operation, the two components are mixed to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
  • U.S. Pat. No. 5,407,671, the entire contents of which are incorporated herein by reference, discloses a one-component tissue adhesive containing, in aqueous solution, fibrinogen, F XIII, a thrombin inhibitor, prothrombin factors, calcium ions and, where appropriate, a plasmin inhibitor. This adhesive can be reconstituted from a freeze-dried form with water. It can contain all active substances in pasteurized form and is then free of the risk of transmission of hepatitis and HTLV III. In operations, the one-component tissue adhesive is reconstituted from a freeze-dried form with water to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
  • U.S. Pat. No. 5,739,288, the entire contents of which are incorporated herein by reference, discloses a method for utilizing a fibrin sealant which comprises: (a) contacting a desired site with a composition comprising fibrin monomer or noncrosslinked fibrin; and (b) converting the fibrin monomer or noncrosslinked fibrin to a fibrin polymer concurrently with the contacting step, thereby forming a fibrin clot. In operation, the fibrin monomer or noncrosslinked fibrin is converted to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
  • U.S. Pat. No. 5,744,545, the entire contents of which are incorporated herein by reference, discloses a method for effecting the nonsurgical attachment of a first surface to a second surface, comprising the steps of: (a) providing collagen and a multifunctionally activated synthetic hydrophilic polymer; (b) mixing the collagen and synthetic polymer to initiate crosslinking between the collagen and the synthetic polymer; (c) applying the mixture of collagen and synthetic polymer to a first surface before substantial crosslinking has occurred between the collagen and the synthetic polymer; and (d) contacting the first surface with the second surface to effect adhesion between the two surfaces. Each surface can be a native tissue or implant surface. In operation, collagen and a multifunctionally activated synthetic hydrophilic polymer are mixed to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
  • U.S. Pat. No. 6,113,948, the entire contents of which are incorporated herein by reference, discloses soluble microparticles comprising fibrinogen or thrombin, in free-flowing form. These microparticles can be mixed to give a dry powder, to be used as a fibrin sealant that is activated only at a tissue site upon dissolving the soluble microparticles. In operation, soluble microparticles comprising fibrinogen or thrombin are contacted with water to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
  • U.S. Pat. Nos. 6,565,549, 5,387,450, 5,156,911 and 5,648,167, the entire contents of which are incorporated herein by reference, disclose a thermally activatable adhesive. A “thermally activatable” adhesive is an adhesive which exhibits an increase in “tack” or adhesion after being warmed to a temperature at or above the activation temperature of the adhesive. Preferably, the activation temperature of the thermally activatable adhesive is between about 28° C. and 60° C. More preferably, the activation temperature is between about 30° C. and 40° C. One exemplary thermally activatable adhesive is described as Example 1 in U.S. Pat. No. 5,648,167, which is incorporated by reference herein. It consists of a mixture of stearyl methacrylate (65.8 g), 2-ethylhexyl acrylate (28.2 g) and acrylic acid (6 g) monomers and a solution of catalyst BCEPC (0.2 g) in ethyl acetate (100 g) is slowly added by means of dropper funnels to ethyl acetate (50 g) heated under reflux (80 degrees C.) in a resin flask over a period of approximately 6 hours. Further ethyl acetate (50 g) is added to the mixture during the polymerization to maintain the mixture in a viscous but ungelled state. In operation, thermally activatable adhesive is heated to activate the sealable fixation means for securely fixing the valve assembly to tissue at a desired valve location.
  • FIG. 40 shows a preferred embodiment, wherein an outer circumferential reservoir (401) is located at an outermost radius of a valve anchoring structure (400) when the anchoring structure (400) is in an expanded state, wherein the reservoir is filled with a sealable fixation means for securely fixing the valve assembly (400) at a desired location within a body cavity. FIG. 40 further illustrates one embodiment of the reservoir (401) comprising a sealable fixation means, wherein the sealable fixation means may comprise a one-component biological adhesive. The sealable fixation means may be activated by exposing the biological adhesive to blood or heat.
  • FIG. 41 illustrates another preferred embodiment wherein the sealable fixation means may comprise a two-component biological adhesive. The sealable fixation means may be activated by mixing the two components. Thus, for example, if one reservoir (402) contains microparticles that are activated by contact with water, the second reservoir (403) would contain the water for the activation of the microparticles. This figure also shows that the reservoirs may be arranged concentrically as shown in FIG. 41B or adjacent to each other as shown in FIG. 41A.
  • FIG. 42 illustrates an exemplary reservoir (401) which may be attached to the valve anchoring structure by its inner wall (404) by sutures, glue, staples or some other appropriate method. FIG. 42 further illustrates a thin spot (405) on the outer wall (406) of the reservoir (401). The thin spots (405) are areas on the reservoir (401) that are adapted to rupture when placed under certain levels of pressure. The pressure is exerted on the thin spots (405) as the reservoir (401) is expanded along with the valve anchoring structure. The thin spots (405) are unable to withstand the pressure and therefore rupture releasing the contents of the reservoir (401) or reservoirs. In a preferred embodiment, the reservoir (401) is made of an elastic material that expands along with the expansion of the valve anchoring structure.
  • FIG. 43 illustrates a cross sectional view of the reservoir (401). The reservoir (401) may contain a lumen (407) which extends along at least a portion of the circumference of the reservoir. The reservoir (401) has one or more thin spots (405) along its outermost circumference, wherein the thin spots (405) are sized and configured to rupture when the reservoir (401) is expanded to an appropriate diameter. When the anchoring structure comprising the valve is fully expanded, the pressure exerted upon the expanded thin spots (405) causes them to rupture. In still another preferred embodiment, the reservoir (401) is made of a biodegradable material adapted for erosion or rupture to release the content of the reservoir (401) and activate the sealable fixation means in a desired timeframe after implantation. In a further preferred embodiment, a circumferentially outermost portion is pressure sensitive to rupture, wherein the contents of the reservoir (401) are released when the reservoir (401) is compressed against the sinus cavities during expansion and implantation of the valve assembly.
  • FIG. 44 shows a cross-sectional view of another preferred embodiment, illustrating thin spots (405) on a reservoir having two concentric component compartments, an inner compartment (408) and an outer compartment (409). Component A in an inner compartment (408) and component B in an outer compartment (409) are to be mixed to form adhesive for sealing the valve assembly against the valve sinuses. The inner compartment (408) has a plurality of thin spots (405) along its outermost circumference, wherein the thin spots (405) are sized and configured to rupture when the reservoir (401) is expanded to an appropriate diameter. The outer compartment (409) also has a plurality of thin spots (405) along its innermost circumference. The thin spots (405) of the inner compartment (408) and the thin spots (405) of the outer compartment (409) may be located adjacent to each other. In one preferred embodiment, the space between the adjacent pair of thin spots (405) on the inner (408) and outer (409) compartment may comprise a piercing element that is activated to rupture the thin spot or the pair of adjacent spots when the reservoir is expanded to an appropriate diameter or a predetermined diameter. Other embodiments of reservoir configuration, for example, two parallel compartments circumferentially or longitudinally, and suitable activation mechanism for the sealable fixation means are also within the scope of the present invention.
  • The present invention further comprises methods and devices for the sizing of native valves that require replacement.
  • Methods and Apparatus for Valve Sizing
  • Intravascular ultrasound (IVUS) uses high-frequency sound waves that are sent with a device called a transducer. The transducer is attached to the end of a catheter, which is threaded through a vein, artery, or other vessel lumen. The sound waves bounce off of the walls of the vessel and return to the transducer as echoes. The echoes can be converted into distances by computer. A preferred minimally invasive valve replacement sizer is shown in FIGS. 45A and B. For purposes of this application, the distal end or portion refers to the area closer to the body while the proximal end or portion refers to the area closer to the user of the valve replacement sizer. The device comprises a guidewire (500), an intravascular ultrasound (IVUS) catheter (501) having a transducer (502), and a balloon dilatation catheter (503) all positioned within the central lumen of a catheter. The transducer (502) is positioned in the IVUS sizing window (504) of the balloon catheter. The guide wire (500) advances and guides the catheter (501) to the appropriate location for valve sizing. FIG. 45A shows the catheter in deflated form, whereas in FIG. 45B the balloon dilatation catheter (503) has inflated the balloon (505).
  • In a preferred embodiment, shown in FIG. 46, the catheter (510) contains multiple lumens (511) in order to house a guidewire (512), an IVUS catheter (513), and a balloon dilatation catheter (514). FIG. 46 illustrates a cross sectional view. One of the separate lumens (511) contains the guidewire (512), another contains the IVUS catheter (513), and another contains the balloon dilatation catheter (514). The balloon dilatation catheter (514) has a balloon (515) attached circumferentially surrounding the balloon dilatation catheter (514) as well as a portion of the catheter (510).
  • FIG. 47 shows a balloon dilatation catheter (516) comprising a balloon (517) that circumferentially surrounds a portion of the catheter (518) proximal to its distal portion (519). More specifically, the balloon (517) comprises an outer wall (520) that circumferentially surrounds a portion of the catheter (518) near its distal portion (519). The balloon (517) also has a distal end (521) and a proximal end (522). In a preferred embodiment, within the area encompassed by the balloon, a transducer (523) is located on the IVUS catheter (524). Directly over the transducer (523) a sizing window (525) is placed on the IVUS catheter (524) to enable signals to be transmitted and received by the transducer (523) without interference. In a preferred embodiment, the sizing window (525) is simply an empty space. However, the sizing window (525) could be made from any substance which does not interfere with the signals emitted and received by the transducer (523).
  • Preferably, the balloon (517) is round but other shapes are possible and contemplated for use with the valve sizing apparatus. In particular, FIG. 48 shows a cross section of an inflated balloon (530) with curves forming leaflets (531) to enable fluid (532) to pass through the vessel while the balloon (530) is in its inflated state and the outer edges (533) of the leaflets (531) are in contact with the vessel wall (534) to measure the diameter. The balloon may further be made from compliant or non-compliant material.
  • FIG. 49 shows a preferred embodiment wherein the balloon (540) is inflated with saline (541). Preferably, the saline is pumped into the balloon (540) through the balloon dilatation catheter. Alternatively, the balloon (540) may be inflated with a gas or any other suitable substance. The balloon (540) is inflated to a chosen pressure by the person using the valve replacement sizer. When the balloon (540) has been inflated, the outermost portion of the outer wall (542) will be in contact with the vessel wall (543) or other lumen at the location where the replacement valve is to be placed. When the balloon (540) is completely inflated, the farthest radial points of the balloon's outer wall (542) will be equidistant to the center of the catheter (544). This distance is labeled as R. The transducer (545) may or may not be at the centermost point of the inflated balloon (540). Any deviation from the centermost point by the transducer (545) may be accounted for when calculating the diameter of the vessel lumen. However, the signal emitted by the transducer (545) preferably intersects the balloon (540) at its greatest radius.
  • FIG. 50 shows a preferred embodiment, wherein a transducer (550) emits an ultrasonic signal (556) in a perpendicular direction to the IVUS catheter (551). The signal is then reflected off the outer wall (552) of the balloon (540) and received by the transducer (550). The transducer (550) then transmits the data to the auxiliary processor (553) to determine the radius and diameter of the vessel lumen. Alternatively, an infrared light may be emitted and received by the transducer (550) to determine the radius and diameter of the vessel lumen. The diameter is calculated by knowing the speed of the signal and the time it takes for the signal to be reflected off the balloon wall (552) back to the transducer (550). The known speed is multiplied by the time to determine the radius of the balloon (540). The radius may be adjusted if the transducer (550) was not located at the centermost point of the catheter.
  • The present invention further provides devices and methods to remove the native diseased valves prior to implantation of the replacement valve assembly. In one embodiment of the present invention, the valve removing means is provided by the replacement valve assembly. In another embodiment, the valve removing means is provided by a valve sizing device of the present invention.
  • Valve Assemblies with Native Valve Removing Capabiliy
  • The present invention further provides valve assemblies comprising native valve removing capabilities. Thus, in a preferred embodiment, a valve anchoring structure having cutting means located at the annulus base for cutting a native valve is provided. Accordingly, when passing the valve assembly comprising the valve and anchoring structure through the vessel with the anchoring structure in a collapsed state, the cutting means can be advanced against the native valve with the anchoring structure in a partially expanded state. In this manner, the anchoring structure comprising the cutting means cuts at least a portion of the native valve by deploying the cutting means, before the valve assembly is secured to the desired valve location with the anchoring structure in the expanded state.
  • It is one object of the present invention to provide a valve assembly of the preferred embodiment having a tissue valve and an anchoring structure, which permits implantation without surgery or with minimal surgical intervention and provides native valve removing means for removing a dysfunctional native valve, followed by valve replacement. The native valve removing means on the anchoring structure is selected from a group consisting of: a plurality of sharp edge elements, each sharp edge element having a sharp end enabling the element to cut through at least a portion of the native valve; a plurality of electrode elements, wherein radiofrequency energy is delivered to each electrode element enabling the electrode element to cut through at least a portion of the native valve, and a plurality of ultrasound transducer elements, wherein ultrasound energy is delivered to each transducer element enabling the transducer element to cut through at least a portion of the native valve.
  • Percutaneous implantation of a valve prosthesis is achieved according to the invention, which is characterized in that the valve anchoring structure is made from a radially collapsible and re-expandable cylindrical support means for folding and expanding together with the collapsible replacement valve for implantation in the body by means of catheterization or other minimally invasive procedure. Catheters and catheter balloon systems are well known to those of skill in the art, for example, U.S. Pat. No. 6,605,056 issued on Aug. 23, 2003.
  • Accordingly, in one preferred embodiment of the invention shown in FIG. 51, the anchoring structure (600) comprises at least one ultrasound transducer (601) at the distal end portion of the lower ring (602), wherein each ultrasound transducer is sized and configured with ultrasound energy as cutting means for cutting a native valve. Ultrasound energy is delivered through conductor means (603) to each transducer element (601) enabling the transducer element (601) to cut through at least a portion of the native valve. In one embodiment, the conductor (603) passes through a delivery means and is connected to an external ultrasound energy generator. The ablative ultrasound delivery means and methods are well known to one skilled in the art, for example, U.S. Pat. No. 6,241,692 issued on Jun. 5, 2001.
  • FIG. 52 shows another preferred embodiment of a native valve removal system comprising a valve assembly having radiofrequency cutting means. In this preferred embodiment, the anchoring structure comprises at least one radiofrequency electrode (610) at the distal end portion of the lower ring (602), wherein each radiofrequency electrode (610) is sized and configured with radiofrequency energy as cutting means for cutting a native valve. Radiofrequency energy is delivered through conductor means (611) to each electrode element (610) enabling the electrode element to cut through at least a portion of the native valve. In one embodiment, the conductor (611) passes through delivery means and is connected to an external radiofrequency energy generator. The ablative radiofrequency delivery means and methods are well known to one skilled in the art, for example, U.S. Pat. No. 6,033,402 issued on Mar. 7, 2000.
  • FIG. 53 shows another embodiment of an anchoring structure having sharp edge cutting means (620). In one preferred embodiment, the anchoring structure comprises a set of sharp edge cutting elements (621) at the distal end portion of the cutting means (620) of the lower ring (602) of the anchoring structure, wherein each cutting element (621) has a cutting tip (622), and wherein each cutting element (621) of the cutting means is sized and configured, optionally with radiofrequency energy, as cutting means for cutting a native valve. In one embodiment, sharp edge cutting means on the delivery apparatus is rotatable, enabling the cutting element (621) to cut through at least a portion of the native valve. Sharp edge cutting means, with optionally ablative radiofrequency delivery means and methods, are well known to one skilled in the art, for example, U.S. Pat. No. 5,980,515 issued on Nov. 9, 1999.
  • FIG. 54 shows a partially inflated balloon catheter. A balloon catheter (630) is introduced in the vessel. The balloon means (632) of the balloon catheter (630) is led out of the protection cap (633) at the catheter tip (634) and is partly inflated through a fluid channel (635), which is led to the surface of the patient. In one embodiment, the balloon (632) is partially expanded and the sharp end (636) of the cutting means of the valve anchoring structure (637) is advanced to cut and remove at least a portion of the native valve. In another embodiment, the valve anchoring structure (637) comprises an ultrasound or radiofrequency cutting means (638). In one embodiment, the support structure is expanded at about 30 to 95% of full expansion for cutting the native valve. More preferably, the support structure is expanded at about 50 to 90% of the full expansion. In another embodiment, the balloon catheter (630) comprises a central channel (639) with respect to a central axial line (640) to receive a guide wire (641) which is used in a way known for viewing the introduction of the catheter through fluoroscopy.
  • Some aspects of the present invention provide a method of endovascularly implanting a valve through a vessel, comprising the steps of providing a collapsibly expandable valve assembly that comprises an anchoring structure according to the present invention with an annulus base and a collapsible valve connected to the anchoring structure, the collapsible valve being configured to permit blood flow in a direction and prevent blood flow in an opposite direction, the anchoring structure having cutting means located at the annulus base for cutting a native valve, passing the valve assembly through the vessel with the anchoring structure in a collapsed state, advancing the cutting means against the native valve with the anchoring structure in a partially expanded state, cutting at least a portion of the native valve by deploying the cutting means, and securing the valve assembly to the desired valve location with the anchoring structure in the expanded shape.
  • In operations, a method of implanting a valve assembly according to the present invention is given below: a valve assembly made of an anchoring structure of the present invention and a collapsible valve, as described above, is placed on a deflated balloon means and is compressed thereon, either manually or by use of the expansion/compression devices of the instant invention; the balloon means and the valve assembly are drawn into an insertion cover; a guide wire is inserted into a vessel through the central opening of the balloon catheter under continuous fluoroscopy; the insertion cover conveys the guide wire to a point in the channel in the immediate vicinity of the desired position of the valve assembly; the balloon means is pushed out of the protection cap and the valve assembly is positioned in the desired position if necessary by use of further imaging means to ensure accurate positioning; the balloon means is inflated partially; the valve assembly is advanced with its cutting means cutting at least a portion of the native valve; the balloon means is further inflated to position the valve at a desired site, preferably against the truncated valvular annulus; the balloon means is deflated; and the balloon means with entrapped tissue and debris inside the filter means, the guide wire, and the protection cap are drawn out and the opening in the channel, if any, wherein the valve prosthesis is inserted can be closed.
  • The present invention also provides for devices and methods to prevent the release of debris during removal of the native diseased valves from traveling to distant sites where such debris may cause undesirable physiological effects.
  • Distal Protection Assembly
  • As described above, removal or manipulation of diseased valves may result in dislodgment of parts of the valve or deposits formed thereon which may be carried by the fluid to other parts of the body. Thus, the present invention provides for specialized filters that capture material and debris generated during valve replacement procedures. The distal protection devices of the present invention are also effective in trapping material that may be released during other percutaneous interventional procedures, such as balloon angioplasty or stenting procedures by providing a temporary valve and filter in the same device.
  • In one preferred embodiment, shown in FIGS. 55A and B, the present invention provides for a temporary valve (700), which may be deployed at a desired location in a collapsed state and then expanded and secured to the walls of the passageway. The temporary valve (700) comprises two concentric one-way valves, an outer valve (701) and an inner valve (702) disposed within the outer valve (701), that open in opposite directions as shown in FIG. 55B. The outer valve (701) opens in response to positive fluid flow pressure, thereby regulating blood flow in substantially one direction. The inner valve (702) opens in the opposite direction of the outer valve (701) to facilitate the insertion of catheter based equipment (703) as shown in FIG. 55C and functions as a seal through which such equipment may be passed. The pressure required to open the individual valves may be manipulated to facilitate positive fluid flow, while precluding or minimizing retrograde flow that might otherwise occur as a result of back flow pressure. Hence, it is contemplated that the inner valve (702) be configured or constructed to open with relatively more pressure than that required to open the outer valve.
  • The outer (701) and inner valves (702) of the temporary valve (700) may be coupled together by radial support members. In one embodiment, the radial support members couple the inner surface of the outer valve to the outer surface of the inner valve. The length of the radial support means depends upon the dimension of the blood vessel or body cavity within which the temporary valve is to be deployed.
  • The temporary valve may be constructed from material that is capable of self-expanding the temporary valve, once it is deployed from the collapsed state at the desired location. Once expanded, catheter based equipment required for the particular surgical procedure may be passed through and movably operated in relation to the temporary valve.
  • In another embodiment of the present invention, the temporary valve may be combined with a filter that extends distally from the temporary valve to capture debris material. In this embodiment, the temporary valve-filter device is preferably configured such that the open proximal end is secured to the temporary valve and the closed distal end comprises an opening or a third valve to facilitate the passage of the catheter equipment through the distal end of the bag and out of the temporary valve. Additional valves may also be positioned in the filter to coincide with one or more branching arteries.
  • In yet another preferred embodiment of the present invention, the temporary valve-filter device may include one or more traps within the filter bag to trap debris material within the bag to reduce the likelihood of debris material leaving the filter when the catheter equipment is being passed through the filter bag. The filter traps may be comprised of one or more valves disposed within the filter bag that are configured to open with retrograde pressure. Alternatively, the traps may be comprised of flaps that extend inwardly from the perimeter of the bag to create a cupping effect that traps particulate matter and directs it outwardly toward the perimeter of the filter bag. The filter traps may be constructed of material that is capable of facilitating and filtering antegrade fluid flow, while retaining the debris material within the filter bag.
  • The valve-filter assembly previously described may also incorporate multiple valves. In this arrangement, debris may be better and better entrapped, and thus reduces the chance of debris coming out of the valve-filter assembly. The present invention is particularly useful while performing an interventional procedure in vital arteries, such as the carotid arteries and the aorta, in which critical downstream blood vessels can become blocked with debris material.
  • One benefit of the current invention is that it provides fast, simple, and quick deployment. One may deploy both the filter and temporary valve simultaneously. The valve-filter assembly may also include a cannulation system at the downstream end of the filter to remove particles and debris. The valve-filter assembly may also include a grinder for cutting up or reducing the size of the debris. This debris, in turn, may be removed by a cannulation system or be allowed to remain in the filter.
  • The valve-filter assembly is well-suited for use in minimally invasive surgery where the valve-filter may be placed in the aorta between the aortic valve and the innominate branch or the braciocephalic branch. In such a configuration, the valve-filter may be put in place before the start of surgery and function as a valve. The valve-filter may further collect debris and particles during removal and clean up of the old valve. The valve-filter may also stay in place while the new valve is put in place and until the end of the procedure to function as protection and as a valve. A vascular filter system is well known to one skilled in the art, for example, U.S. Pat. No. 6,485,501 issued on Nov. 26, 2002.
  • In all of the embodiments described above, the invention may be part of a catheter. The invention may also be assembled onto a separate catheter. The valve-filter may also be part of a non-catheter device, placed directly into a blood vessel or other lumen. In both the catheter and non-catheter embodiments, the valve-filter may be introduced into the body by the ways described in the following non-inclusive list: femoral artery, femoral vein, carotid artery, jugular vein, mouth, nose, urethra, vagina, brachial artery, subclavian vein, open sternotomies, partial sternotomies, and other places in the arterial and venous system.
  • Furthermore, in all of the embodiments described above, the filter mesh of the valve-filter may be of any size and shape required to trap all of the material while still providing sufficient surface area for providing satisfactory flows during the use of the filter. The filter may be a sheet or bag of different mesh sizes. In a preferred embodiment, the mesh size is optimized taking the following factors into consideration: flow conditions, application site, size of filter bag, rate of clotting, etc.
  • Radiopaque markers and/or sonoreflective markers, may be located on the catheter and/or the valve-filter assembly. An embodiment of the valve-filter catheter is described having an aortic transillumination system for locating and monitoring the position and deployment state of the catheter and the valve-filter assembly without fluoroscopy.
  • Additionally, visualization techniques including transcranial Doppler ultrasonography, transesophageal echocardiograpy, transthoracic echocardiography, epicardiac echocardiography, and transcutaneous or intravascular ultrasoneography in conjunction with the procedure may be used to ensure effective filtration.
  • Alternatively, or additionally, the material of the filter screen in each embodiment of the filter catheter may be made of or coated with an adherent material or substance to capture or hold embolic debris which comes into contact with the filter screen within the valve-filter assembly. Suitable adherent materials include, but are not limited to, known biocompatible adhesives and bioadhesive materials or substances, which are hemocompatible and non-thrombogenic. Such material are known to those having ordinary skill in the art and are described in, among other references, U.S. Pat. Nos. 4,768,523, 5,055,046, 5,066,709, 5,197,973, 5,225,196, 5,374,431, 5,578,310, 5,645,062, 5,648,167, 5,651,982, and 5,665,477. In one particularly preferred embodiment, only the upstream side of the elements of the filter screen are coated with the adherent material to capture the embolic material which comes in contact with the upstream side of the filter screen after entering the filter assembly. Other bioactive substances, for example, heparin or thrombolytic agents, may be impregnated into or coated on the surface of the filter screen material or incorporated into an adhesive coating.
  • In a preferred method, blood is filtered during cardiac surgery, in particular during percutaneous valve surgery, to protect a patient from embolization. In this method, the valve-filter is positioned in the aorta between the aortic valve and the inominate branch, where it filters blood before it reaches the carotid arteries, brachiocephalic trunk, and left subclavian artery. The valve contains the embolic material and foreign matter dislodged during the surgery and also provides a temporary valve for use during valve surgery. Such a method may be utilized both on and off pump. Such a method may also be utilized for aortic, mitral, and pulmonary valve surgery and repair.
  • Although this invention has been exemplified for purposes of illustration and description by reference to certain specific embodiments, it will be apparent to those skilled in the art that various modifications and alterations of the illustrated examples are possible. Numerous modifications, alterations, alternate embodiments, and alternate materials may be contemplated by those skilled in the art and may be utilized in accomplishing the present invention. Any such changes which derive directly from the teachings herein, and which do not depart from the spirit and scope of the invention, are deemed to be covered by this invention.

Claims (9)

1. A valve assembly comprising:
a replacement valve; and
an anchoring structure comprising one or more sinusoidal inflow rings.
2. The valve assembly of claim 1, wherein said valve is positioned internally to said anchoring structure.
3. The valve assembly of claim 2, wherein said valve comprises an inflow annulus, an outflow annulus, and a plurality of leaflets.
4. The valve assembly of claim 3, wherein said inflow annulus is scalloped.
5. The valve assembly of claim 1, wherein said inflow rings are configured in an inverse sinusoidal pattern.
6. The valve assembly of claim 1, wherein said anchoring structure further comprises one or more sinusoidal outflow rings.
7. The valve assembly of claim 6, wherein said sinusoidal outflow rings are configured in an inverse sinusoidal pattern.
8. The valve assembly of claim 6, further comprising a plurality of longitudinal rods connecting the inflow and outflow rings.
9. The valve assembly of claim 6, wherein the inflow or outflow rings further comprise attachment barbs
US10/680,728 2003-10-06 2003-10-06 Minimally invasive valve replacement system Abandoned US20050075713A1 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
US10/680,733 US20050075584A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,071 US7101396B2 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,716 US20050075718A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,732 US20050075720A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,562 US20050075724A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,068 US7044966B2 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,567 US20050096738A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,075 US20050075728A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,560 US20050075717A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,728 US20050075713A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,719 US20050075712A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,069 US20050075729A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,717 US20050075719A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,070 US20050075730A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
CA2545874A CA2545874C (en) 2003-10-06 2004-10-06 Minimally invasive valve replacement system
EP14163073.1A EP2789314B1 (en) 2003-10-06 2004-10-06 Minimally invasive valve replacement system
EP20198702.1A EP3821852A3 (en) 2003-10-06 2004-10-06 Minimally invasive valve replacement system
PCT/US2004/033026 WO2005046528A1 (en) 2003-10-06 2004-10-06 Minimally invasive valve replacement system
EP04794398.0A EP1684671B1 (en) 2003-10-06 2004-10-06 Minimally invasive valve replacement system

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US10/680,728 US20050075713A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,732 US20050075720A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,562 US20050075724A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,068 US7044966B2 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,733 US20050075584A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,069 US20050075729A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,719 US20050075712A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,717 US20050075719A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,070 US20050075730A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,560 US20050075717A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,075 US20050075728A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,567 US20050096738A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,716 US20050075718A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,071 US7101396B2 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system

Publications (1)

Publication Number Publication Date
US20050075713A1 true US20050075713A1 (en) 2005-04-07

Family

ID=46599162

Family Applications (14)

Application Number Title Priority Date Filing Date
US10/680,716 Abandoned US20050075718A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,567 Abandoned US20050096738A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,070 Abandoned US20050075730A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,560 Abandoned US20050075717A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,562 Abandoned US20050075724A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,733 Abandoned US20050075584A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,068 Expired - Lifetime US7044966B2 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,075 Abandoned US20050075728A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,717 Abandoned US20050075719A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,071 Expired - Lifetime US7101396B2 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,069 Abandoned US20050075729A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,732 Abandoned US20050075720A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,719 Abandoned US20050075712A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,728 Abandoned US20050075713A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system

Family Applications Before (13)

Application Number Title Priority Date Filing Date
US10/680,716 Abandoned US20050075718A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,567 Abandoned US20050096738A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,070 Abandoned US20050075730A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,560 Abandoned US20050075717A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,562 Abandoned US20050075724A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,733 Abandoned US20050075584A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,068 Expired - Lifetime US7044966B2 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,075 Abandoned US20050075728A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,717 Abandoned US20050075719A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,071 Expired - Lifetime US7101396B2 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,069 Abandoned US20050075729A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,732 Abandoned US20050075720A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system
US10/680,719 Abandoned US20050075712A1 (en) 2003-10-06 2003-10-06 Minimally invasive valve replacement system

Country Status (2)

Country Link
US (14) US20050075718A1 (en)
EP (1) EP2789314B1 (en)

Cited By (131)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040215333A1 (en) * 2002-04-16 2004-10-28 Carlos Duran Sigmoid valve and method for its percutaneous implantation
US20050197695A1 (en) * 2004-03-03 2005-09-08 Sorin Biomedica Cardio S.R.L. Minimally-invasive cardiac-valve prosthesis
US20050228494A1 (en) * 2004-03-29 2005-10-13 Salvador Marquez Controlled separation heart valve frame
US20060111773A1 (en) * 2004-11-19 2006-05-25 Biomedical Research Associates, Inc. Prosthetic venous valves
US20060122692A1 (en) * 2004-05-10 2006-06-08 Ran Gilad Stent valve and method of using same
US20060122693A1 (en) * 2004-05-10 2006-06-08 Youssef Biadillah Stent valve and method of manufacturing same
US20060122686A1 (en) * 2004-05-10 2006-06-08 Ran Gilad Stent and method of manufacturing same
US20060287717A1 (en) * 2005-05-24 2006-12-21 Rowe Stanton J Methods for rapid deployment of prosthetic heart valves
US20070021826A1 (en) * 2003-04-24 2007-01-25 Cook Incorporated Intralumenally implantable frames
US20070038291A1 (en) * 2003-04-24 2007-02-15 Cook Incorporated Intralumenally-implantable frames
US20070100435A1 (en) * 2003-04-24 2007-05-03 Cook Incorporated Artificial prostheses with preferred geometries
US20070254273A1 (en) * 2006-05-01 2007-11-01 Hugues Lafrance Simulated heart valve root for training and testing
US20080147182A1 (en) * 2006-12-19 2008-06-19 Sorin Biomedica Cardio S.R.L. Instrument and method for in situ deployment of cardiac valve prostheses
US20080249619A1 (en) * 2005-02-10 2008-10-09 Sorin Biomedica Cardio S.R.L. Cardiac-valve prosthesis
US20090030506A1 (en) * 2007-07-24 2009-01-29 Biotronik Vi Patent Ag Endoprosthesis and method for manufacturing same
US20090099653A1 (en) * 2007-10-12 2009-04-16 Sorin Biomedica Cardio S.R.L. Expandable valve prosthesis with sealing mechanism
US20090292350A1 (en) * 2008-01-24 2009-11-26 Medtronic, Inc. Stents for Prosthetic Heart Valves
US7670368B2 (en) 2005-02-07 2010-03-02 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US20100063363A1 (en) * 2005-02-10 2010-03-11 Hamman Baron L System, device, and method for providing access in a cardiovascular environment
US7682385B2 (en) 2002-04-03 2010-03-23 Boston Scientific Corporation Artificial valve
US7722666B2 (en) 2005-04-15 2010-05-25 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US7776053B2 (en) 2000-10-26 2010-08-17 Boston Scientific Scimed, Inc. Implantable valve system
US7780722B2 (en) 2005-02-07 2010-08-24 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7780627B2 (en) 2002-12-30 2010-08-24 Boston Scientific Scimed, Inc. Valve treatment catheter and methods
US7799038B2 (en) 2006-01-20 2010-09-21 Boston Scientific Scimed, Inc. Translumenal apparatus, system, and method
US20100249920A1 (en) * 2007-01-08 2010-09-30 Millipede Llc Reconfiguring heart features
US20100249908A1 (en) * 2009-03-31 2010-09-30 Edwards Lifesciences Corporation Prosthetic heart valve system with positioning markers
US7819915B2 (en) 2000-07-27 2010-10-26 Edwards Lifesciences Corporation Heart valve holders and handling clips therefor
US20100292782A1 (en) * 2009-05-13 2010-11-18 Sorin Biomedica Cardio S.R.L. Device for the in situ delivery of heart valves
US20100292783A1 (en) * 2009-05-13 2010-11-18 Sorin Biomedica Cardio S.R.L. Device for surgical interventions
US20100292784A1 (en) * 2009-05-13 2010-11-18 Sorin Biomedica Cardio S.r. I. Device for the in situ delivery of heart valves
US7854755B2 (en) 2005-02-01 2010-12-21 Boston Scientific Scimed, Inc. Vascular catheter, system, and method
US7854761B2 (en) 2003-12-19 2010-12-21 Boston Scientific Scimed, Inc. Methods for venous valve replacement with a catheter
US7878966B2 (en) 2005-02-04 2011-02-01 Boston Scientific Scimed, Inc. Ventricular assist and support device
US7892276B2 (en) 2007-12-21 2011-02-22 Boston Scientific Scimed, Inc. Valve with delayed leaflet deployment
US20110054598A1 (en) * 2005-07-13 2011-03-03 Edwards Lifesciences Corporation Contoured Sewing Ring for a Prosthetic Mitral Heart Valve
US20110098602A1 (en) * 2009-10-27 2011-04-28 Edwards Lifesciences Corporation Apparatus and Method for Measuring Body Orifice
US7951197B2 (en) 2005-04-08 2011-05-31 Medtronic, Inc. Two-piece prosthetic valves with snap-in connection and methods for use
US7951189B2 (en) 2005-09-21 2011-05-31 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US7959674B2 (en) 2002-07-16 2011-06-14 Medtronic, Inc. Suture locking assembly and method of use
US7967853B2 (en) 2007-02-05 2011-06-28 Boston Scientific Scimed, Inc. Percutaneous valve, system and method
US7967857B2 (en) 2006-01-27 2011-06-28 Medtronic, Inc. Gasket with spring collar for prosthetic heart valves and methods for making and using them
US7972377B2 (en) 2001-12-27 2011-07-05 Medtronic, Inc. Bioprosthetic heart valve
US7981153B2 (en) 2002-12-20 2011-07-19 Medtronic, Inc. Biologically implantable prosthesis methods of using
US8002824B2 (en) 2004-09-02 2011-08-23 Boston Scientific Scimed, Inc. Cardiac valve, system, and method
US8012198B2 (en) 2005-06-10 2011-09-06 Boston Scientific Scimed, Inc. Venous valve, system, and method
US8021421B2 (en) 2003-08-22 2011-09-20 Medtronic, Inc. Prosthesis heart valve fixturing device
US8038708B2 (en) 2001-02-05 2011-10-18 Cook Medical Technologies Llc Implantable device with remodelable material and covering material
US8057539B2 (en) 2006-12-19 2011-11-15 Sorin Biomedica Cardio S.R.L. System for in situ positioning of cardiac valve prostheses without occluding blood flow
US8114154B2 (en) 2007-09-07 2012-02-14 Sorin Biomedica Cardio S.R.L. Fluid-filled delivery system for in situ deployment of cardiac valve prostheses
US8128681B2 (en) 2003-12-19 2012-03-06 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US8133270B2 (en) 2007-01-08 2012-03-13 California Institute Of Technology In-situ formation of a valve
US8211169B2 (en) 2005-05-27 2012-07-03 Medtronic, Inc. Gasket with collar for prosthetic heart valves and methods for using them
US8221492B2 (en) 2003-04-24 2012-07-17 Cook Medical Technologies Artificial valve prosthesis with improved flow dynamics
US8308798B2 (en) 2008-12-19 2012-11-13 Edwards Lifesciences Corporation Quick-connect prosthetic heart valve and methods
US8348998B2 (en) 2009-06-26 2013-01-08 Edwards Lifesciences Corporation Unitary quick connect prosthetic heart valve and deployment system and methods
US20130046380A1 (en) * 2010-01-22 2013-02-21 4Tech Inc. Tricuspid valve repair using tension
CN103237523A (en) * 2010-09-01 2013-08-07 M阀门技术有限公司 Cardiac valve support structure
US8512397B2 (en) 2009-04-27 2013-08-20 Sorin Group Italia S.R.L. Prosthetic vascular conduit
US8603161B2 (en) 2003-10-08 2013-12-10 Medtronic, Inc. Attachment device and methods of using the same
US8641757B2 (en) 2010-09-10 2014-02-04 Edwards Lifesciences Corporation Systems for rapidly deploying surgical heart valves
US8685084B2 (en) 2011-12-29 2014-04-01 Sorin Group Italia S.R.L. Prosthetic vascular conduit and assembly method
US8808369B2 (en) 2009-10-05 2014-08-19 Mayo Foundation For Medical Education And Research Minimally invasive aortic valve replacement
US8808367B2 (en) 2007-09-07 2014-08-19 Sorin Group Italia S.R.L. Prosthetic valve delivery system including retrograde/antegrade approach
US8821569B2 (en) 2006-04-29 2014-09-02 Medtronic, Inc. Multiple component prosthetic heart valve assemblies and methods for delivering them
US8828079B2 (en) 2007-07-26 2014-09-09 Boston Scientific Scimed, Inc. Circulatory valve, system and method
US8834563B2 (en) 2008-12-23 2014-09-16 Sorin Group Italia S.R.L. Expandable prosthetic valve having anchoring appendages
US8840661B2 (en) 2008-05-16 2014-09-23 Sorin Group Italia S.R.L. Atraumatic prosthetic heart valve prosthesis
US8845720B2 (en) 2010-09-27 2014-09-30 Edwards Lifesciences Corporation Prosthetic heart valve frame with flexible commissures
US20150073543A1 (en) * 2010-03-26 2015-03-12 Thubrikar Aortic Valve, Inc. Valve component, frame component and prosthetic valve device including the same for implantation in a body lumen
US8986374B2 (en) 2010-05-10 2015-03-24 Edwards Lifesciences Corporation Prosthetic heart valve
US9078747B2 (en) 2011-12-21 2015-07-14 Edwards Lifesciences Corporation Anchoring device for replacing or repairing a heart valve
US9125741B2 (en) 2010-09-10 2015-09-08 Edwards Lifesciences Corporation Systems and methods for ensuring safe and rapid deployment of prosthetic heart valves
US9155617B2 (en) 2004-01-23 2015-10-13 Edwards Lifesciences Corporation Prosthetic mitral valve
US9161836B2 (en) 2011-02-14 2015-10-20 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
EP2568925A4 (en) * 2010-05-12 2015-10-21 Edwards Lifesciences Corp Low gradient prosthetic heart valve
US9180005B1 (en) 2014-07-17 2015-11-10 Millipede, Inc. Adjustable endolumenal mitral valve ring
US9192471B2 (en) 2007-01-08 2015-11-24 Millipede, Inc. Device for translumenal reshaping of a mitral valve annulus
US9248017B2 (en) 2010-05-21 2016-02-02 Sorin Group Italia S.R.L. Support device for valve prostheses and corresponding kit
US9289289B2 (en) 2011-02-14 2016-03-22 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US9314334B2 (en) 2008-11-25 2016-04-19 Edwards Lifesciences Corporation Conformal expansion of prosthetic devices to anatomical shapes
US9333100B2 (en) 2008-01-24 2016-05-10 Medtronic, Inc. Stents for prosthetic heart valves
US9370418B2 (en) 2010-09-10 2016-06-21 Edwards Lifesciences Corporation Rapidly deployable surgical heart valves
US9370419B2 (en) 2005-02-23 2016-06-21 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US9439762B2 (en) 2000-06-01 2016-09-13 Edwards Lifesciences Corporation Methods of implant of a heart valve with a convertible sewing ring
US9468527B2 (en) 2013-06-12 2016-10-18 Edwards Lifesciences Corporation Cardiac implant with integrated suture fasteners
US9504566B2 (en) 2014-06-20 2016-11-29 Edwards Lifesciences Corporation Surgical heart valves identifiable post-implant
US9549816B2 (en) 2014-04-03 2017-01-24 Edwards Lifesciences Corporation Method for manufacturing high durability heart valve
US9585752B2 (en) 2014-04-30 2017-03-07 Edwards Lifesciences Corporation Holder and deployment system for surgical heart valves
US9622859B2 (en) 2005-02-01 2017-04-18 Boston Scientific Scimed, Inc. Filter system and method
US9668859B2 (en) 2011-08-05 2017-06-06 California Institute Of Technology Percutaneous heart valve delivery systems
US9744037B2 (en) 2013-03-15 2017-08-29 California Institute Of Technology Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves
US9795480B2 (en) 2010-08-24 2017-10-24 Millipede, Inc. Reconfiguring tissue features of a heart annulus
US9848983B2 (en) 2015-02-13 2017-12-26 Millipede, Inc. Valve replacement using rotational anchors
US9907681B2 (en) 2013-03-14 2018-03-06 4Tech Inc. Stent with tether interface
US9919137B2 (en) 2013-08-28 2018-03-20 Edwards Lifesciences Corporation Integrated balloon catheter inflation system
US9956384B2 (en) 2014-01-24 2018-05-01 Cook Medical Technologies Llc Articulating balloon catheter and method for using the same
US10058323B2 (en) 2010-01-22 2018-08-28 4 Tech Inc. Tricuspid valve repair using tension
US10058425B2 (en) 2013-03-15 2018-08-28 Edwards Lifesciences Corporation Methods of assembling a valved aortic conduit
US10058313B2 (en) 2011-05-24 2018-08-28 Sorin Group Italia S.R.L. Transapical valve replacement
US10080653B2 (en) 2015-09-10 2018-09-25 Edwards Lifesciences Corporation Limited expansion heart valve
US10105224B2 (en) 2010-09-01 2018-10-23 Mvalve Technologies Ltd. Cardiac valve support structure
USD846122S1 (en) 2016-12-16 2019-04-16 Edwards Lifesciences Corporation Heart valve sizer
US10335275B2 (en) 2015-09-29 2019-07-02 Millipede, Inc. Methods for delivery of heart valve devices using intravascular ultrasound imaging
US10433963B2 (en) 2010-01-22 2019-10-08 4Tech Inc. Tissue anchor and delivery tool
US10441415B2 (en) 2013-09-20 2019-10-15 Edwards Lifesciences Corporation Heart valves with increased effective orifice area
US10449050B2 (en) 2013-01-09 2019-10-22 4 Tech Inc. Soft tissue depth-finding tool
US10456245B2 (en) 2016-05-16 2019-10-29 Edwards Lifesciences Corporation System and method for applying material to a stent
US10456246B2 (en) 2015-07-02 2019-10-29 Edwards Lifesciences Corporation Integrated hybrid heart valves
US10463485B2 (en) 2017-04-06 2019-11-05 Edwards Lifesciences Corporation Prosthetic valve holders with automatic deploying mechanisms
USD867594S1 (en) 2015-06-19 2019-11-19 Edwards Lifesciences Corporation Prosthetic heart valve
US10543080B2 (en) 2011-05-20 2020-01-28 Edwards Lifesciences Corporation Methods of making encapsulated heart valves
US10543088B2 (en) 2012-09-14 2020-01-28 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
US10548731B2 (en) 2017-02-10 2020-02-04 Boston Scientific Scimed, Inc. Implantable device and delivery system for reshaping a heart valve annulus
US10555813B2 (en) 2015-11-17 2020-02-11 Boston Scientific Scimed, Inc. Implantable device and delivery system for reshaping a heart valve annulus
US10667904B2 (en) 2016-03-08 2020-06-02 Edwards Lifesciences Corporation Valve implant with integrated sensor and transmitter
US10695170B2 (en) 2015-07-02 2020-06-30 Edwards Lifesciences Corporation Hybrid heart valves adapted for post-implant expansion
US10722316B2 (en) 2013-11-06 2020-07-28 Edwards Lifesciences Corporation Bioprosthetic heart valves having adaptive seals to minimize paravalvular leakage
US10799353B2 (en) 2017-04-28 2020-10-13 Edwards Lifesciences Corporation Prosthetic heart valve with collapsible holder
US10849755B2 (en) 2012-09-14 2020-12-01 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
USD908874S1 (en) 2018-07-11 2021-01-26 Edwards Lifesciences Corporation Collapsible heart valve sizer
US10912546B2 (en) 2005-04-22 2021-02-09 Laurent Schaller Catheter-based tissue remodeling devices and methods
US10940167B2 (en) 2012-02-10 2021-03-09 Cvdevices, Llc Methods and uses of biological tissues for various stent and other medical applications
US11007058B2 (en) 2013-03-15 2021-05-18 Edwards Lifesciences Corporation Valved aortic conduits
US11135057B2 (en) 2017-06-21 2021-10-05 Edwards Lifesciences Corporation Dual-wireform limited expansion heart valves
US11337805B2 (en) 2018-01-23 2022-05-24 Edwards Lifesciences Corporation Prosthetic valve holders, systems, and methods
US11406495B2 (en) 2013-02-11 2022-08-09 Cook Medical Technologies Llc Expandable support frame and medical device
US11504231B2 (en) 2018-05-23 2022-11-22 Corcym S.R.L. Cardiac valve prosthesis
US11554012B2 (en) 2019-12-16 2023-01-17 Edwards Lifesciences Corporation Valve holder assembly with suture looping protection
US11648118B2 (en) * 2017-07-06 2023-05-16 Raghuveer Basude Tissue grasping devices and related methods
US11690709B2 (en) 2015-09-02 2023-07-04 Edwards Lifesciences Corporation Methods for securing a transcatheter valve to a bioprosthetic cardiac structure

Families Citing this family (581)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6006134A (en) 1998-04-30 1999-12-21 Medtronic, Inc. Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers
US6530952B2 (en) 1997-12-29 2003-03-11 The Cleveland Clinic Foundation Bioprosthetic cardiovascular valve system
US8579966B2 (en) 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US8016877B2 (en) 1999-11-17 2011-09-13 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US7018406B2 (en) 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
US8241274B2 (en) 2000-01-19 2012-08-14 Medtronic, Inc. Method for guiding a medical device
US7749245B2 (en) 2000-01-27 2010-07-06 Medtronic, Inc. Cardiac valve procedure methods and devices
US6692513B2 (en) 2000-06-30 2004-02-17 Viacor, Inc. Intravascular filter with debris entrapment mechanism
EP1408997A2 (en) * 2000-06-16 2004-04-21 McGILL UNIVERSITY Kefir extract as an anti-cancer agent
EP1309289A2 (en) 2000-08-18 2003-05-14 Atritech, Inc. Expandable implant devices for filtering blood flow from atrial appendages
US7544206B2 (en) 2001-06-29 2009-06-09 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US8771302B2 (en) 2001-06-29 2014-07-08 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US8623077B2 (en) 2001-06-29 2014-01-07 Medtronic, Inc. Apparatus for replacing a cardiac valve
FR2826863B1 (en) 2001-07-04 2003-09-26 Jacques Seguin ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT
FR2828091B1 (en) 2001-07-31 2003-11-21 Seguin Jacques ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT
US7097659B2 (en) 2001-09-07 2006-08-29 Medtronic, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US20060292206A1 (en) 2001-11-26 2006-12-28 Kim Steven W Devices and methods for treatment of vascular aneurysms
US8721713B2 (en) 2002-04-23 2014-05-13 Medtronic, Inc. System for implanting a replacement valve
US7481821B2 (en) 2002-11-12 2009-01-27 Thomas J. Fogarty Embolization device and a method of using the same
US7766973B2 (en) * 2005-01-19 2010-08-03 Gi Dynamics, Inc. Eversion resistant sleeves
US20040260382A1 (en) * 2003-02-12 2004-12-23 Fogarty Thomas J. Intravascular implants and methods of using the same
CH696185A5 (en) * 2003-03-21 2007-02-15 Afksendiyos Kalangos Intraparietal reinforcement for aortic valve and reinforced valve has rod inserted in biological tissue or organic prosthesis with strut fixed to one end
AU2004253375B2 (en) * 2003-07-08 2011-07-14 Ventor Technologies Ltd. Implantable prosthetic devices particularly for transarterial delivery in the treatment of aortic stenosis, and methods of implanting such devices
US7201772B2 (en) * 2003-07-08 2007-04-10 Ventor Technologies, Ltd. Fluid flow prosthetic device
US20050015110A1 (en) 2003-07-18 2005-01-20 Fogarty Thomas J. Embolization device and a method of using the same
ATE442107T1 (en) * 2003-07-21 2009-09-15 Univ Pennsylvania PERCUTANE HEART VALVE
FR2858543B1 (en) 2003-08-08 2006-02-03 Assist Publ Hopitaux De Paris AORTIC AND ANCILLARY RING FOR ITS INSTALLATION
US7842084B2 (en) * 2005-06-21 2010-11-30 3F Therapeutics, Inc. Method and systems for sizing, folding, holding, and delivering a heart valve prosthesis
US20050075718A1 (en) 2003-10-06 2005-04-07 Nguyen Tuoc Tan Minimally invasive valve replacement system
US10219899B2 (en) * 2004-04-23 2019-03-05 Medtronic 3F Therapeutics, Inc. Cardiac valve replacement systems
US20060259137A1 (en) 2003-10-06 2006-11-16 Jason Artof Minimally invasive valve replacement system
US7604650B2 (en) * 2003-10-06 2009-10-20 3F Therapeutics, Inc. Method and assembly for distal embolic protection
US9579194B2 (en) 2003-10-06 2017-02-28 Medtronic ATS Medical, Inc. Anchoring structure with concave landing zone
US8915967B2 (en) * 2003-12-19 2014-12-23 Patrick Leahy Anti reflux system
US11278398B2 (en) 2003-12-23 2022-03-22 Boston Scientific Scimed, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US8287584B2 (en) 2005-11-14 2012-10-16 Sadra Medical, Inc. Medical implant deployment tool
US7824443B2 (en) 2003-12-23 2010-11-02 Sadra Medical, Inc. Medical implant delivery and deployment tool
US8579962B2 (en) 2003-12-23 2013-11-12 Sadra Medical, Inc. Methods and apparatus for performing valvuloplasty
US7824442B2 (en) * 2003-12-23 2010-11-02 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US20050137687A1 (en) 2003-12-23 2005-06-23 Sadra Medical Heart valve anchor and method
US20050137686A1 (en) * 2003-12-23 2005-06-23 Sadra Medical, A Delaware Corporation Externally expandable heart valve anchor and method
US7381219B2 (en) 2003-12-23 2008-06-03 Sadra Medical, Inc. Low profile heart valve and delivery system
US20120041550A1 (en) 2003-12-23 2012-02-16 Sadra Medical, Inc. Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements
US7959666B2 (en) 2003-12-23 2011-06-14 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US7329279B2 (en) 2003-12-23 2008-02-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US8840663B2 (en) 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve method
US8828078B2 (en) 2003-12-23 2014-09-09 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US9005273B2 (en) 2003-12-23 2015-04-14 Sadra Medical, Inc. Assessing the location and performance of replacement heart valves
US7445631B2 (en) 2003-12-23 2008-11-04 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US20050137694A1 (en) * 2003-12-23 2005-06-23 Haug Ulrich R. Methods and apparatus for endovascularly replacing a patient's heart valve
US8182528B2 (en) 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
US8603160B2 (en) 2003-12-23 2013-12-10 Sadra Medical, Inc. Method of using a retrievable heart valve anchor with a sheath
US9526609B2 (en) 2003-12-23 2016-12-27 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US7748389B2 (en) 2003-12-23 2010-07-06 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
CN101947146B (en) 2003-12-23 2014-08-06 萨德拉医学公司 Relocatable heart valve
US7780725B2 (en) 2004-06-16 2010-08-24 Sadra Medical, Inc. Everting heart valve
US8328868B2 (en) 2004-11-05 2012-12-11 Sadra Medical, Inc. Medical devices and delivery systems for delivering medical devices
US8343213B2 (en) 2003-12-23 2013-01-01 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
CN102488572A (en) 2004-02-27 2012-06-13 奥尔特克斯公司 Prosthetic heart valve delivery systems and methods
US20070073387A1 (en) * 2004-02-27 2007-03-29 Forster David C Prosthetic Heart Valves, Support Structures And Systems And Methods For Implanting The Same
WO2005087140A1 (en) 2004-03-11 2005-09-22 Percutaneous Cardiovascular Solutions Pty Limited Percutaneous heart valve prosthesis
US8349001B2 (en) 2004-04-07 2013-01-08 Medtronic, Inc. Pharmacological delivery implement for use with cardiac repair devices
EP1737390A1 (en) * 2004-04-08 2007-01-03 Cook Incorporated Implantable medical device with optimized shape
CN101052359A (en) 2004-04-23 2007-10-10 3F医疗有限公司 Implantable prosthetic valve
US7276078B2 (en) * 2004-06-30 2007-10-02 Edwards Lifesciences Pvt Paravalvular leak detection, sealing, and prevention
FR2874813B1 (en) * 2004-09-07 2007-06-22 Perouse Soc Par Actions Simpli VALVULAR PROSTHESIS
US20060052867A1 (en) 2004-09-07 2006-03-09 Medtronic, Inc Replacement prosthetic heart valve, system and method of implant
CA2580053C (en) 2004-09-14 2014-07-08 Edwards Lifesciences Ag. Device and method for treatment of heart valve regurgitation
US7331010B2 (en) * 2004-10-29 2008-02-12 International Business Machines Corporation System, method and storage medium for providing fault detection and correction in a memory subsystem
US8562672B2 (en) 2004-11-19 2013-10-22 Medtronic, Inc. Apparatus for treatment of cardiac valves and method of its manufacture
US20060161248A1 (en) * 2004-12-01 2006-07-20 Case Brian C Medical device with leak path
US7758640B2 (en) * 2004-12-16 2010-07-20 Valvexchange Inc. Cardiovascular valve assembly
DE102005003632A1 (en) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
US7331991B2 (en) * 2005-02-25 2008-02-19 California Institute Of Technology Implantable small percutaneous valve and methods of delivery
AU2005328535B2 (en) * 2005-03-01 2011-09-22 Leman Cardiovascular Sa Intraparietal reinforcing device for biological cardiac prosthesis and reinforced biological heart valve prosthesis
WO2006097931A2 (en) 2005-03-17 2006-09-21 Valtech Cardio, Ltd. Mitral valve treatment techniques
SE531468C2 (en) * 2005-04-21 2009-04-14 Edwards Lifesciences Ag An apparatus for controlling blood flow
US7962208B2 (en) 2005-04-25 2011-06-14 Cardiac Pacemakers, Inc. Method and apparatus for pacing during revascularization
US7914569B2 (en) 2005-05-13 2011-03-29 Medtronics Corevalve Llc Heart valve prosthesis and methods of manufacture and use
US9089423B2 (en) 2010-05-10 2015-07-28 Hlt, Inc. Stentless support structure
US8974523B2 (en) 2005-05-27 2015-03-10 Hlt, Inc. Stentless support structure
US7955372B2 (en) * 2005-06-01 2011-06-07 Board Of Trustees Of The Leland Stanford Junior University Endoluminal delivery system
US7780723B2 (en) * 2005-06-13 2010-08-24 Edwards Lifesciences Corporation Heart valve delivery system
US8951285B2 (en) 2005-07-05 2015-02-10 Mitralign, Inc. Tissue anchor, anchoring system and methods of using the same
WO2007016097A2 (en) * 2005-07-27 2007-02-08 Georgia Tech Research Corporation Implantable prosthetic vascular valve
US8790396B2 (en) * 2005-07-27 2014-07-29 Medtronic 3F Therapeutics, Inc. Methods and systems for cardiac valve delivery
US7455689B2 (en) * 2005-08-25 2008-11-25 Edwards Lifesciences Corporation Four-leaflet stented mitral heart valve
US7712606B2 (en) 2005-09-13 2010-05-11 Sadra Medical, Inc. Two-part package for medical implant
US20070078510A1 (en) 2005-09-26 2007-04-05 Ryan Timothy R Prosthetic cardiac and venous valves
US8167932B2 (en) 2005-10-18 2012-05-01 Edwards Lifesciences Corporation Heart valve delivery system with valve catheter
GB0521585D0 (en) * 2005-10-22 2005-11-30 Depuy Int Ltd A spinal support rod
GB0521582D0 (en) * 2005-10-22 2005-11-30 Depuy Int Ltd An implant for supporting a spinal column
EP3167847B1 (en) 2005-11-10 2020-10-14 Edwards Lifesciences CardiAQ LLC Heart valve prosthesis
US8764820B2 (en) 2005-11-16 2014-07-01 Edwards Lifesciences Corporation Transapical heart valve delivery system and method
WO2007100408A2 (en) * 2005-12-15 2007-09-07 Georgia Tech Research Corporation Papillary muscle position control devices, systems & methods
JP2009519784A (en) * 2005-12-15 2009-05-21 ジョージア テック リサーチ コーポレイション System and method for controlling heart valve dimensions
US8568473B2 (en) * 2005-12-15 2013-10-29 Georgia Tech Research Corporation Systems and methods for enabling heart valve replacement
US20070142907A1 (en) * 2005-12-16 2007-06-21 Micardia Corporation Adjustable prosthetic valve implant
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US9078781B2 (en) 2006-01-11 2015-07-14 Medtronic, Inc. Sterile cover for compressible stents used in percutaneous device delivery systems
GB0600662D0 (en) * 2006-01-13 2006-02-22 Depuy Int Ltd Spinal support rod kit
US8348952B2 (en) * 2006-01-26 2013-01-08 Depuy International Ltd. System and method for cooling a spinal correction device comprising a shape memory material for corrective spinal surgery
CN101415379B (en) 2006-02-14 2012-06-20 萨德拉医学公司 Systems for delivering a medical implant
WO2008029296A2 (en) * 2006-02-16 2008-03-13 Endocor Pte Ltd. Minimally invasive heart valve replacement
US20080275550A1 (en) * 2006-02-24 2008-11-06 Arash Kheradvar Implantable small percutaneous valve and methods of delivery
US7780724B2 (en) * 2006-02-24 2010-08-24 California Institute Of Technology Monolithic in situ forming valve system
US8147541B2 (en) 2006-02-27 2012-04-03 Aortx, Inc. Methods and devices for delivery of prosthetic heart valves and other prosthetics
US8403981B2 (en) * 2006-02-27 2013-03-26 CardiacMC, Inc. Methods and devices for delivery of prosthetic heart valves and other prosthetics
EP2004095B1 (en) 2006-03-28 2019-06-12 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
US7740655B2 (en) 2006-04-06 2010-06-22 Medtronic Vascular, Inc. Reinforced surgical conduit for implantation of a stented valve therein
US7591848B2 (en) * 2006-04-06 2009-09-22 Medtronic Vascular, Inc. Riveted stent valve for percutaneous use
US20070244544A1 (en) * 2006-04-14 2007-10-18 Medtronic Vascular, Inc. Seal for Enhanced Stented Valve Fixation
US8551161B2 (en) 2006-04-25 2013-10-08 Medtronic Vascular, Inc. Cardiac valve annulus restraining device
JP5016667B2 (en) 2006-04-29 2012-09-05 メドトロニック,インコーポレイテッド Multi-membered prosthetic heart valve assembly, apparatus using the same, and method of using the same
US8932348B2 (en) 2006-05-18 2015-01-13 Edwards Lifesciences Corporation Device and method for improving heart valve function
US8585594B2 (en) 2006-05-24 2013-11-19 Phoenix Biomedical, Inc. Methods of assessing inner surfaces of body lumens or organs
CN102283721B (en) 2006-06-01 2015-08-26 爱德华兹生命科学公司 For improving the prosthetic insert of heart valve function
JP2009540954A (en) * 2006-06-20 2009-11-26 エーオーテックス, インコーポレイテッド Prosthetic valve implantation site preparation technology
JP2009540955A (en) 2006-06-20 2009-11-26 エーオーテックス, インコーポレイテッド Artificial heart valves, support structures, and systems and methods for implanting them
EP2035723A4 (en) 2006-06-20 2011-11-30 Aortx Inc Torque shaft and torque drive
AU2007260951A1 (en) * 2006-06-21 2007-12-27 Aortx, Inc. Prosthetic valve implantation systems
US20080004696A1 (en) * 2006-06-29 2008-01-03 Valvexchange Inc. Cardiovascular valve assembly with resizable docking station
US20080126131A1 (en) * 2006-07-17 2008-05-29 Walgreen Co. Predictive Modeling And Risk Stratification Of A Medication Therapy Regimen
US20090306768A1 (en) 2006-07-28 2009-12-10 Cardiaq Valve Technologies, Inc. Percutaneous valve prosthesis and system and method for implanting same
US9585743B2 (en) 2006-07-31 2017-03-07 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
WO2008016578A2 (en) 2006-07-31 2008-02-07 Cartledge Richard G Sealable endovascular implants and methods for their use
US9408607B2 (en) 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
GB0617219D0 (en) 2006-08-31 2006-10-11 Barts & London Nhs Trust Blood vessel prosthesis and delivery apparatus
ES2385296T3 (en) 2006-09-08 2012-07-20 Edwards Lifesciences Corporation Integrated heart valve delivery system
US11304800B2 (en) 2006-09-19 2022-04-19 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US8834564B2 (en) 2006-09-19 2014-09-16 Medtronic, Inc. Sinus-engaging valve fixation member
US8052750B2 (en) 2006-09-19 2011-11-08 Medtronic Ventor Technologies Ltd Valve prosthesis fixation techniques using sandwiching
WO2008046092A2 (en) * 2006-10-13 2008-04-17 Creighton University Implantable valve prosthesis
DK2083901T3 (en) 2006-10-16 2018-02-26 Medtronic Ventor Tech Ltd TRANSAPICAL DELIVERY SYSTEM WITH VENTRICULO-ARTERIAL OVERFLOW BYPASS
EP2083902B1 (en) * 2006-10-18 2017-08-30 Inspiremd Ltd. Filter assemblies
US9974653B2 (en) 2006-12-05 2018-05-22 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US11259924B2 (en) 2006-12-05 2022-03-01 Valtech Cardio Ltd. Implantation of repair devices in the heart
JP5593545B2 (en) 2006-12-06 2014-09-24 メドトロニック シーブイ ルクセンブルク エス.アー.エール.エル. System and method for transapical delivery of a self-expanding valve secured to an annulus
US20100168844A1 (en) * 2007-01-26 2010-07-01 3F Therapeutics, Inc. Methods and systems for reducing paravalvular leakage in heart valves
EP2129332B1 (en) 2007-02-16 2019-01-23 Medtronic, Inc. Replacement prosthetic heart valves
US8070802B2 (en) * 2007-02-23 2011-12-06 The Trustees Of The University Of Pennsylvania Mitral valve system
US7753949B2 (en) * 2007-02-23 2010-07-13 The Trustees Of The University Of Pennsylvania Valve prosthesis systems and methods
US11660190B2 (en) 2007-03-13 2023-05-30 Edwards Lifesciences Corporation Tissue anchors, systems and methods, and devices
US7896915B2 (en) * 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
FR2915087B1 (en) 2007-04-20 2021-11-26 Corevalve Inc IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT.
US20080294248A1 (en) * 2007-05-25 2008-11-27 Medical Entrepreneurs Ii, Inc. Prosthetic Heart Valve
US7815677B2 (en) * 2007-07-09 2010-10-19 Leman Cardiovascular Sa Reinforcement device for a biological valve and reinforced biological valve
US8663318B2 (en) * 2007-07-23 2014-03-04 Hocor Cardiovascular Technologies Llc Method and apparatus for percutaneous aortic valve replacement
US8663319B2 (en) 2007-07-23 2014-03-04 Hocor Cardiovascular Technologies Llc Methods and apparatus for percutaneous aortic valve replacement
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US8747458B2 (en) 2007-08-20 2014-06-10 Medtronic Ventor Technologies Ltd. Stent loading tool and method for use thereof
EP3045147B8 (en) 2007-08-21 2017-05-31 Symetis SA A replacement valve
WO2009042196A2 (en) 2007-09-26 2009-04-02 St. Jude Medical, Inc. Collapsible prosthetic heart valves
US9532868B2 (en) 2007-09-28 2017-01-03 St. Jude Medical, Inc. Collapsible-expandable prosthetic heart valves with structures for clamping native tissue
WO2009045334A1 (en) 2007-09-28 2009-04-09 St. Jude Medical, Inc. Collapsible/expandable prosthetic heart valves with native calcified leaflet retention features
US10856970B2 (en) 2007-10-10 2020-12-08 Medtronic Ventor Technologies Ltd. Prosthetic heart valve for transfemoral delivery
WO2009052207A2 (en) 2007-10-17 2009-04-23 Hancock Jaffe Laboratories Biological valve for venous valve insufficiency
US20090105813A1 (en) * 2007-10-17 2009-04-23 Sean Chambers Implantable valve device
GB0720762D0 (en) 2007-10-24 2007-12-05 Depuy Spine Sorl Assembly for orthopaedic surgery
JP5603776B2 (en) 2007-10-25 2014-10-08 サイメティス エスアー Stent, valved stent and method, and delivery system thereof
US7846199B2 (en) * 2007-11-19 2010-12-07 Cook Incorporated Remodelable prosthetic valve
WO2009067432A1 (en) 2007-11-19 2009-05-28 Cook Incorporated Valve frame
PT3494930T (en) * 2007-12-14 2020-02-06 Edwards Lifesciences Corp Leaflet attachment frame for a prosthetic valve
GB2476451A (en) 2009-11-19 2011-06-29 Cook William Europ Stent Graft
US8574284B2 (en) 2007-12-26 2013-11-05 Cook Medical Technologies Llc Low profile non-symmetrical bare alignment stents with graft
US9226813B2 (en) 2007-12-26 2016-01-05 Cook Medical Technologies Llc Low profile non-symmetrical stent
US8728145B2 (en) * 2008-12-11 2014-05-20 Cook Medical Technologies Llc Low profile non-symmetrical stents and stent-grafts
US9180030B2 (en) 2007-12-26 2015-11-10 Cook Medical Technologies Llc Low profile non-symmetrical stent
US9089422B2 (en) 2008-01-24 2015-07-28 Medtronic, Inc. Markers for prosthetic heart valves
EP4378420A3 (en) * 2008-01-24 2024-08-14 Medtronic, Inc. Stents for prosthetic heart valves
CA2714062A1 (en) * 2008-01-24 2009-07-30 Medtronic, Inc. Stents for prosthetic heart valves
US9393115B2 (en) 2008-01-24 2016-07-19 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US9149358B2 (en) * 2008-01-24 2015-10-06 Medtronic, Inc. Delivery systems for prosthetic heart valves
WO2009104041A1 (en) * 2008-02-21 2009-08-27 Valerian Voinov Implantable prosthetic valve stent
GB0803302D0 (en) * 2008-02-22 2008-04-02 Barts & London Nhs Trust Blood vessel prosthesis and delivery apparatus
US9168130B2 (en) 2008-02-26 2015-10-27 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
ES2903231T3 (en) 2008-02-26 2022-03-31 Jenavalve Tech Inc Stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
WO2009108355A1 (en) 2008-02-28 2009-09-03 Medtronic, Inc. Prosthetic heart valve systems
DE102008012113A1 (en) 2008-03-02 2009-09-03 Transcatheter Technologies Gmbh Implant e.g. heart-valve-carrying stent, for e.g. arresting blood vessel, has fiber by which section of implant is reducible according to increasing of implant at extended diameter by unfolding or expansion of diameter with expansion unit
US8382829B1 (en) 2008-03-10 2013-02-26 Mitralign, Inc. Method to reduce mitral regurgitation by cinching the commissure of the mitral valve
US8696689B2 (en) * 2008-03-18 2014-04-15 Medtronic Ventor Technologies Ltd. Medical suturing device and method for use thereof
US8313525B2 (en) 2008-03-18 2012-11-20 Medtronic Ventor Technologies, Ltd. Valve suturing and implantation procedures
US8430927B2 (en) 2008-04-08 2013-04-30 Medtronic, Inc. Multiple orifice implantable heart valve and methods of implantation
US8312825B2 (en) 2008-04-23 2012-11-20 Medtronic, Inc. Methods and apparatuses for assembly of a pericardial prosthetic heart valve
US8696743B2 (en) 2008-04-23 2014-04-15 Medtronic, Inc. Tissue attachment devices and methods for prosthetic heart valves
US20090276040A1 (en) 2008-05-01 2009-11-05 Edwards Lifesciences Corporation Device and method for replacing mitral valve
US8197413B2 (en) * 2008-06-06 2012-06-12 Boston Scientific Scimed, Inc. Transducers, devices and systems containing the transducers, and methods of manufacture
LT3501455T (en) * 2008-06-06 2020-01-27 Edwards Lifesciences Corporation Low profile transcatheter heart valve
EP4176845A1 (en) 2008-07-15 2023-05-10 St. Jude Medical, LLC Collapsible and re-expandable prosthetic heart valve cuff designs
ES2421333T3 (en) * 2008-07-17 2013-08-30 Nvt Ag Cardiac valve prosthesis system
US8652202B2 (en) 2008-08-22 2014-02-18 Edwards Lifesciences Corporation Prosthetic heart valve and delivery apparatus
WO2010030859A1 (en) * 2008-09-12 2010-03-18 Valvexchange Inc. Valve assembly with exchangeable valve member and a tool set for exchanging the valve member
US8998981B2 (en) 2008-09-15 2015-04-07 Medtronic, Inc. Prosthetic heart valve having identifiers for aiding in radiographic positioning
US8721714B2 (en) 2008-09-17 2014-05-13 Medtronic Corevalve Llc Delivery system for deployment of medical devices
CA2749026C (en) 2008-09-29 2018-01-09 Impala, Inc. Heart valve
US8337541B2 (en) * 2008-10-01 2012-12-25 Cardiaq Valve Technologies, Inc. Delivery system for vascular implant
US8790387B2 (en) 2008-10-10 2014-07-29 Edwards Lifesciences Corporation Expandable sheath for introducing an endovascular delivery device into a body
US8137398B2 (en) 2008-10-13 2012-03-20 Medtronic Ventor Technologies Ltd Prosthetic valve having tapered tip when compressed for delivery
WO2010045477A2 (en) 2008-10-16 2010-04-22 Obalon Therapeutics, Inc. Intragastric volume-occupying device and method for fabricating same
US8986361B2 (en) 2008-10-17 2015-03-24 Medtronic Corevalve, Inc. Delivery system for deployment of medical devices
CN102438546B (en) 2008-11-21 2015-07-15 经皮心血管解决方案公司 Heart valve prosthesis
US8926696B2 (en) 2008-12-22 2015-01-06 Valtech Cardio, Ltd. Adjustable annuloplasty devices and adjustment mechanisms therefor
US8241351B2 (en) 2008-12-22 2012-08-14 Valtech Cardio, Ltd. Adjustable partial annuloplasty ring and mechanism therefor
US8911494B2 (en) 2009-05-04 2014-12-16 Valtech Cardio, Ltd. Deployment techniques for annuloplasty ring
US8715342B2 (en) 2009-05-07 2014-05-06 Valtech Cardio, Ltd. Annuloplasty ring with intra-ring anchoring
US10517719B2 (en) 2008-12-22 2019-12-31 Valtech Cardio, Ltd. Implantation of repair devices in the heart
US9681950B2 (en) * 2009-01-12 2017-06-20 Valve Medical Ltd. System and method for placing a percutaneous valve device
US8353956B2 (en) 2009-02-17 2013-01-15 Valtech Cardio, Ltd. Actively-engageable movement-restriction mechanism for use with an annuloplasty structure
GB0905444D0 (en) 2009-03-30 2009-05-13 Ucl Business Plc Heart valve prosthesis
EP2413843B1 (en) 2009-03-30 2020-04-22 Suzhou Jiecheng Medical Technology Co. Ltd. Sutureless valve prostheses and devices for delivery
US8414644B2 (en) 2009-04-15 2013-04-09 Cardiaq Valve Technologies, Inc. Vascular implant and delivery system
US9968452B2 (en) 2009-05-04 2018-05-15 Valtech Cardio, Ltd. Annuloplasty ring delivery cathethers
WO2013069019A2 (en) 2011-11-08 2013-05-16 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
JP5603934B2 (en) * 2009-06-05 2014-10-08 メドトロニック エイティーエス メディカル インコーポレイテッド Flexible commissure structure for attaching a bioprosthetic valve
US8439970B2 (en) 2009-07-14 2013-05-14 Edwards Lifesciences Corporation Transapical delivery system for heart valves
US20110077733A1 (en) * 2009-09-25 2011-03-31 Edwards Lifesciences Corporation Leaflet contacting apparatus and method
US20110313515A1 (en) 2010-06-21 2011-12-22 Arshad Quadri Replacement heart valve
US8652203B2 (en) 2010-09-23 2014-02-18 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
US9730790B2 (en) 2009-09-29 2017-08-15 Edwards Lifesciences Cardiaq Llc Replacement valve and method
US9180007B2 (en) 2009-10-29 2015-11-10 Valtech Cardio, Ltd. Apparatus and method for guide-wire based advancement of an adjustable implant
US10098737B2 (en) 2009-10-29 2018-10-16 Valtech Cardio, Ltd. Tissue anchor for annuloplasty device
EP4406514A3 (en) * 2009-11-02 2024-11-06 Boston Scientific Medical Device Limited Aortic bioprosthesis and systems for delivery thereof
CA2779616A1 (en) * 2009-11-03 2011-05-12 Large Bore Closure, L.L.C. Closure device
US9757263B2 (en) 2009-11-18 2017-09-12 Cook Medical Technologies Llc Stent graft and introducer assembly
US8500775B2 (en) * 2009-12-02 2013-08-06 Surefire Medical, Inc. Protection device and method against embolization agent reflux
US9539081B2 (en) 2009-12-02 2017-01-10 Surefire Medical, Inc. Method of operating a microvalve protection device
EP2506777B1 (en) 2009-12-02 2020-11-25 Valtech Cardio, Ltd. Combination of spool assembly coupled to a helical anchor and delivery tool for implantation thereof
US8696698B2 (en) 2009-12-02 2014-04-15 Surefire Medical, Inc. Microvalve protection device and method of use for protection against embolization agent reflux
US8870950B2 (en) 2009-12-08 2014-10-28 Mitral Tech Ltd. Rotation-based anchoring of an implant
US9358109B2 (en) * 2010-01-13 2016-06-07 Vinay Badhwar Transcorporeal delivery system and method
DE102010008362A1 (en) 2010-02-17 2011-08-18 Transcatheter Technologies GmbH, 93053 Medical implant which is expandable from a non-expanded state
US9226826B2 (en) 2010-02-24 2016-01-05 Medtronic, Inc. Transcatheter valve structure and methods for valve delivery
US9522062B2 (en) 2010-02-24 2016-12-20 Medtronic Ventor Technologies, Ltd. Mitral prosthesis and methods for implantation
US8795354B2 (en) 2010-03-05 2014-08-05 Edwards Lifesciences Corporation Low-profile heart valve and delivery system
US20110224785A1 (en) 2010-03-10 2011-09-15 Hacohen Gil Prosthetic mitral valve with tissue anchors
US8652204B2 (en) 2010-04-01 2014-02-18 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
US9545306B2 (en) 2010-04-21 2017-01-17 Medtronic, Inc. Prosthetic valve with sealing members and methods of use thereof
US8623075B2 (en) 2010-04-21 2014-01-07 Medtronic, Inc. Transcatheter prosthetic heart valve delivery system and method with controlled expansion of prosthetic heart valve
US8876892B2 (en) 2010-04-21 2014-11-04 Medtronic, Inc. Prosthetic heart valve delivery system with spacing
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
BR112012029896A2 (en) 2010-05-25 2017-06-20 Jenavalve Tech Inc prosthetic heart valve for stent graft and stent graft
WO2012004679A2 (en) 2010-07-09 2012-01-12 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US11653910B2 (en) 2010-07-21 2023-05-23 Cardiovalve Ltd. Helical anchor implantation
US8992604B2 (en) 2010-07-21 2015-03-31 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US9132009B2 (en) 2010-07-21 2015-09-15 Mitraltech Ltd. Guide wires with commissural anchors to advance a prosthetic valve
US9763657B2 (en) 2010-07-21 2017-09-19 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
WO2012012761A2 (en) * 2010-07-23 2012-01-26 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves
US8696737B2 (en) 2010-08-11 2014-04-15 Hlt, Inc. Reinforced commissural support structure
EP2611388B1 (en) 2010-09-01 2022-04-27 Medtronic Vascular Galway Prosthetic valve support structure
CN103108611B (en) 2010-09-10 2016-08-31 西美蒂斯股份公司 Valve replacement device
EP4042974B1 (en) 2010-10-05 2024-10-23 Edwards Lifesciences Corporation Prosthetic heart valve
US9770319B2 (en) 2010-12-01 2017-09-26 Surefire Medical, Inc. Closed tip dynamic microvalve protection device
US9579197B2 (en) * 2010-12-15 2017-02-28 Medtronic Vascular, Inc. Systems and methods for positioning a heart valve using visual markers
DE102010061371A1 (en) * 2010-12-20 2012-06-21 Transcatheter Technologies Gmbh Individual shaft fiber device and kit for folding or deploying a medical implant and method
US9421098B2 (en) 2010-12-23 2016-08-23 Twelve, Inc. System for mitral valve repair and replacement
BR112013018254B1 (en) 2011-01-21 2020-07-07 Obalon Therapeutics, Inc. system for inflating intragastric balloon
US9155619B2 (en) 2011-02-25 2015-10-13 Edwards Lifesciences Corporation Prosthetic heart valve delivery apparatus
EP2688516B1 (en) 2011-03-21 2022-08-17 Cephea Valve Technologies, Inc. Disk-based valve apparatus
US9381082B2 (en) 2011-04-22 2016-07-05 Edwards Lifesciences Corporation Devices, systems and methods for accurate positioning of a prosthetic valve
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US8840659B2 (en) * 2011-04-28 2014-09-23 Cook Medical Technologies Llc Stent and stent-graft designs
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
EP2520251A1 (en) 2011-05-05 2012-11-07 Symetis SA Method and Apparatus for Compressing Stent-Valves
US8840664B2 (en) * 2011-06-15 2014-09-23 Edwards Lifesciences Corporation Heart valve prosthesis anchoring device and methods
CN107647939A (en) 2011-06-21 2018-02-02 托尔福公司 Artificial heart valve film device and related system
US9918840B2 (en) 2011-06-23 2018-03-20 Valtech Cardio, Ltd. Closed band for percutaneous annuloplasty
US10792152B2 (en) 2011-06-23 2020-10-06 Valtech Cardio, Ltd. Closed band for percutaneous annuloplasty
EP2731550B1 (en) 2011-07-12 2016-02-24 Boston Scientific Scimed, Inc. Coupling system for a replacement valve
US8795357B2 (en) 2011-07-15 2014-08-05 Edwards Lifesciences Corporation Perivalvular sealing for transcatheter heart valve
EP3424468A1 (en) 2011-07-21 2019-01-09 4Tech Inc. Apparatus for tricuspid valve repair using tension
US9119716B2 (en) 2011-07-27 2015-09-01 Edwards Lifesciences Corporation Delivery systems for prosthetic heart valve
WO2013021374A2 (en) 2011-08-05 2013-02-14 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
EP2739214B1 (en) 2011-08-05 2018-10-10 Cardiovalve Ltd Percutaneous mitral valve replacement and sealing
US20140324164A1 (en) 2011-08-05 2014-10-30 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US8852272B2 (en) 2011-08-05 2014-10-07 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US9089668B2 (en) 2011-09-28 2015-07-28 Surefire Medical, Inc. Flow directional infusion device
US9655722B2 (en) 2011-10-19 2017-05-23 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
EA201400481A1 (en) 2011-10-19 2014-10-30 Твелв, Инк. ARTIFICIAL HEART VALVE DEVICES, ARTIFICIAL MITRAL VALVES AND RELATED SYSTEMS AND METHODS
US9763780B2 (en) 2011-10-19 2017-09-19 Twelve, Inc. Devices, systems and methods for heart valve replacement
US11202704B2 (en) 2011-10-19 2021-12-21 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9039757B2 (en) 2011-10-19 2015-05-26 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
EP4252714A3 (en) 2011-10-19 2023-12-20 Twelve, Inc. Device for heart valve replacement
CA2852369A1 (en) 2011-10-21 2013-04-25 Jenavalve Technology Inc. Catheter system for introducing an expandable heart valve stent into the body of a patient, insertion system with a catheter system and medical device for treatment of a heart valve defect
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US8858623B2 (en) 2011-11-04 2014-10-14 Valtech Cardio, Ltd. Implant having multiple rotational assemblies
US9131926B2 (en) 2011-11-10 2015-09-15 Boston Scientific Scimed, Inc. Direct connect flush system
US8940014B2 (en) 2011-11-15 2015-01-27 Boston Scientific Scimed, Inc. Bond between components of a medical device
US8951243B2 (en) 2011-12-03 2015-02-10 Boston Scientific Scimed, Inc. Medical device handle
EP2787926B1 (en) 2011-12-09 2022-07-06 Edwards Lifesciences Corporation Prosthetic heart valve improved commissure supports
EP2886084B1 (en) 2011-12-12 2018-02-14 David Alon Heart valve repair device
US8652145B2 (en) 2011-12-14 2014-02-18 Edwards Lifesciences Corporation System and method for crimping a prosthetic valve
US9510945B2 (en) 2011-12-20 2016-12-06 Boston Scientific Scimed Inc. Medical device handle
US9277993B2 (en) 2011-12-20 2016-03-08 Boston Scientific Scimed, Inc. Medical device delivery systems
US10172708B2 (en) 2012-01-25 2019-01-08 Boston Scientific Scimed, Inc. Valve assembly with a bioabsorbable gasket and a replaceable valve implant
EP3424469A1 (en) 2012-02-22 2019-01-09 Syntheon TAVR, LLC Actively controllable stent, stent graft and heart valve
US9089341B2 (en) 2012-02-28 2015-07-28 Surefire Medical, Inc. Renal nerve neuromodulation device
US20130304197A1 (en) * 2012-02-28 2013-11-14 Mvalve Technologies Ltd. Cardiac valve modification device
WO2013128432A1 (en) 2012-02-28 2013-09-06 Mvalve Technologies Ltd. Cardiac valve support structure
US9579198B2 (en) 2012-03-01 2017-02-28 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US20130274873A1 (en) 2012-03-22 2013-10-17 Symetis Sa Transcatheter Stent-Valves and Methods, Systems and Devices for Addressing Para-Valve Leakage
US11207176B2 (en) 2012-03-22 2021-12-28 Boston Scientific Scimed, Inc. Transcatheter stent-valves and methods, systems and devices for addressing para-valve leakage
US9427315B2 (en) 2012-04-19 2016-08-30 Caisson Interventional, LLC Valve replacement systems and methods
US9011515B2 (en) 2012-04-19 2015-04-21 Caisson Interventional, LLC Heart valve assembly systems and methods
CN104487022B (en) * 2012-05-09 2017-03-29 波士顿科学国际有限公司 The valve of the reduction profile with locking member
CA2873838C (en) * 2012-05-15 2018-11-27 Valve Medical Ltd. System and method for assembling a folded percutaneous valve
CN104470471B (en) 2012-05-16 2017-05-31 耶拿阀门科技有限责任公司 Catheter delivery system for introducing an expandable heart valve prosthesis and medical device for treating a heart valve defect
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US8961594B2 (en) 2012-05-31 2015-02-24 4Tech Inc. Heart valve repair system
US9883941B2 (en) 2012-06-19 2018-02-06 Boston Scientific Scimed, Inc. Replacement heart valve
US20140005776A1 (en) 2012-06-29 2014-01-02 St. Jude Medical, Cardiology Division, Inc. Leaflet attachment for function in various shapes and sizes
US20140018902A1 (en) * 2012-07-12 2014-01-16 Makor Issues And Rights Ltd. Tailor-made stent graft and procedure for minimally invasive aneurysm repair with novel tailor-made balloon, novel guidewire, and novel capsulated bioglue
US9232995B2 (en) 2013-01-08 2016-01-12 Medtronic, Inc. Valve prosthesis and method for delivery
US10206775B2 (en) 2012-08-13 2019-02-19 Medtronic, Inc. Heart valve prosthesis
US9387080B2 (en) 2012-09-27 2016-07-12 Elwha Llc Artificial joint components including synovial fluid deflecting structures
US8845739B2 (en) 2012-09-27 2014-09-30 Elwha Llc Artificial joint components including mechanized synovial fluid deflecting structures
US8845741B2 (en) 2012-09-27 2014-09-30 Seavete LLC Artificial joint components including integral magnetic fields configured to deflect wear debris particles
US8828081B2 (en) 2012-09-27 2014-09-09 Elwha Llc Artificial joint components including synovial fluid deflecting structures
CA2885354A1 (en) 2012-09-29 2014-04-03 Mitralign, Inc. Plication lock delivery system and method of use thereof
EP3730066A1 (en) 2012-10-23 2020-10-28 Valtech Cardio, Ltd. Percutaneous tissue anchor techniques
EP3517052A1 (en) 2012-10-23 2019-07-31 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
US8628571B1 (en) 2012-11-13 2014-01-14 Mitraltech Ltd. Percutaneously-deliverable mechanical valve
US20140155993A1 (en) * 2012-12-04 2014-06-05 The Cleveland Clinic Foundation Device for mitigating or preventing paravalvular leaks
WO2014087402A1 (en) 2012-12-06 2014-06-12 Valtech Cardio, Ltd. Techniques for guide-wire based advancement of a tool
US9066801B2 (en) 2013-01-08 2015-06-30 Medtronic, Inc. Valve prosthesis and method for delivery
US20140200662A1 (en) * 2013-01-16 2014-07-17 Mvalve Technologies Ltd. Anchoring elements for intracardiac devices
US20150351906A1 (en) 2013-01-24 2015-12-10 Mitraltech Ltd. Ventricularly-anchored prosthetic valves
US9724084B2 (en) 2013-02-26 2017-08-08 Mitralign, Inc. Devices and methods for percutaneous tricuspid valve repair
US10583002B2 (en) 2013-03-11 2020-03-10 Neovasc Tiara Inc. Prosthetic valve with anti-pivoting mechanism
CN105163687B (en) 2013-03-14 2019-08-13 心肺医疗股份有限公司 Embolus protection device and application method
US9730791B2 (en) 2013-03-14 2017-08-15 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US9681951B2 (en) 2013-03-14 2017-06-20 Edwards Lifesciences Cardiaq Llc Prosthesis with outer skirt and anchors
US11259923B2 (en) 2013-03-14 2022-03-01 Jc Medical, Inc. Methods and devices for delivery of a prosthetic valve
US11406497B2 (en) 2013-03-14 2022-08-09 Jc Medical, Inc. Heart valve prosthesis
US20140277427A1 (en) 2013-03-14 2014-09-18 Cardiaq Valve Technologies, Inc. Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
AU2014261117B2 (en) * 2013-03-14 2017-03-30 Valve Medical Ltd. Temporary valve and valve-filter
US10449333B2 (en) 2013-03-14 2019-10-22 Valtech Cardio, Ltd. Guidewire feeder
US10149757B2 (en) 2013-03-15 2018-12-11 Edwards Lifesciences Corporation System and method for transaortic delivery of a prosthetic heart valve
CN105283214B (en) 2013-03-15 2018-10-16 北京泰德制药股份有限公司 Translate conduit, system and its application method
CN105208973B (en) 2013-03-15 2018-04-03 Hlt股份有限公司 Low profile prosthetic valve structures
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US10219724B2 (en) 2013-05-02 2019-03-05 VS Medtech, Inc. Systems and methods for measuring and characterizing interior surfaces of luminal structures
WO2014179763A1 (en) 2013-05-03 2014-11-06 Medtronic Inc. Valve delivery tool
CN105246431B (en) 2013-05-20 2018-04-06 托尔福公司 Implantable cardiac valve device, mitral valve repair device and related system and method
MX361339B (en) 2013-05-20 2018-12-04 Edwards Lifesciences Corp Prosthetic heart valve delivery apparatus.
US11076952B2 (en) * 2013-06-14 2021-08-03 The Regents Of The University Of California Collapsible atrioventricular valve prosthesis
US10524904B2 (en) * 2013-07-11 2020-01-07 Medtronic, Inc. Valve positioning device
US8870948B1 (en) 2013-07-17 2014-10-28 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
WO2015013666A1 (en) 2013-07-26 2015-01-29 Cardiaq Valve Technologies, Inc. Systems and methods for sealing openings in an anatomical wall
SG10202103500PA (en) 2013-08-12 2021-05-28 Mitral Valve Tech Sarl Apparatus and methods for implanting a replacement heart valve
EP4098226A1 (en) 2013-08-30 2022-12-07 JenaValve Technology, Inc. Endoprosthesis comprising a radially collapsible frame and a prosthetic valve
US10070857B2 (en) 2013-08-31 2018-09-11 Mitralign, Inc. Devices and methods for locating and implanting tissue anchors at mitral valve commissure
US10117742B2 (en) 2013-09-12 2018-11-06 St. Jude Medical, Cardiology Division, Inc. Stent designs for prosthetic heart valves
US10299793B2 (en) 2013-10-23 2019-05-28 Valtech Cardio, Ltd. Anchor magazine
US9050188B2 (en) 2013-10-23 2015-06-09 Caisson Interventional, LLC Methods and systems for heart valve therapy
US9662202B2 (en) 2013-10-24 2017-05-30 Medtronic, Inc. Heart valve prosthesis
US10052095B2 (en) 2013-10-30 2018-08-21 4Tech Inc. Multiple anchoring-point tension system
US10039643B2 (en) 2013-10-30 2018-08-07 4Tech Inc. Multiple anchoring-point tension system
US10022114B2 (en) 2013-10-30 2018-07-17 4Tech Inc. Percutaneous tether locking
US9913715B2 (en) 2013-11-06 2018-03-13 St. Jude Medical, Cardiology Division, Inc. Paravalvular leak sealing mechanism
CN106456320B (en) 2013-11-11 2020-01-21 爱德华兹生命科学卡迪尔克有限责任公司 System and method for manufacturing stent frames
EP3071149B1 (en) 2013-11-19 2022-06-01 St. Jude Medical, Cardiology Division, Inc. Sealing structures for paravalvular leak protection
US10098734B2 (en) 2013-12-05 2018-10-16 Edwards Lifesciences Corporation Prosthetic heart valve and delivery apparatus
US9610162B2 (en) 2013-12-26 2017-04-04 Valtech Cardio, Ltd. Implantation of flexible implant
US20150209141A1 (en) * 2014-01-24 2015-07-30 St. Jude Medical, Cardiology Division, Inc. Stationary intra-annular halo designs for paravalvular leak (pvl) reduction-passive channel filling cuff designs
US9820852B2 (en) 2014-01-24 2017-11-21 St. Jude Medical, Cardiology Division, Inc. Stationary intra-annular halo designs for paravalvular leak (PVL) reduction—active channel filling cuff designs
CA2910087C (en) 2014-02-18 2022-06-07 Edwards Lifesciences Corporation Flexible commissure frame
US10004599B2 (en) 2014-02-21 2018-06-26 Edwards Lifesciences Cardiaq Llc Prosthesis, delivery device and methods of use
USD755384S1 (en) 2014-03-05 2016-05-03 Edwards Lifesciences Cardiaq Llc Stent
US9968740B2 (en) 2014-03-25 2018-05-15 Surefire Medical, Inc. Closed tip dynamic microvalve protection device
US9889031B1 (en) 2014-03-25 2018-02-13 Surefire Medical, Inc. Method of gastric artery embolization
EP3125826B1 (en) 2014-03-31 2020-10-07 St. Jude Medical, Cardiology Division, Inc. Paravalvular sealing via extended cuff mechanisms
US10154904B2 (en) 2014-04-28 2018-12-18 Edwards Lifesciences Corporation Intravascular introducer devices
WO2015171743A2 (en) 2014-05-07 2015-11-12 Baylor College Of Medicine Artificial, flexible valves and methods of fabricating and serially expanding the same
US10195025B2 (en) 2014-05-12 2019-02-05 Edwards Lifesciences Corporation Prosthetic heart valve
CA3161000A1 (en) 2014-05-19 2015-11-26 Edwards Lifesciences Cardiaq Llc Replacement mitral valve with annular flap
EP3134033B1 (en) 2014-05-29 2018-04-04 Edwards Lifesciences CardiAQ LLC Prosthesis and delivery device
US9532870B2 (en) 2014-06-06 2017-01-03 Edwards Lifesciences Corporation Prosthetic valve for replacing a mitral valve
US9974647B2 (en) 2014-06-12 2018-05-22 Caisson Interventional, LLC Two stage anchor and mitral valve assembly
EP3157607B1 (en) 2014-06-19 2019-08-07 4Tech Inc. Cardiac tissue cinching
EP3166512B1 (en) 2014-07-08 2020-08-19 Avinger, Inc. High speed chronic total occlusion crossing devices
EP4066786A1 (en) 2014-07-30 2022-10-05 Cardiovalve Ltd. Articulatable prosthetic valve
US10016272B2 (en) 2014-09-12 2018-07-10 Mitral Valve Technologies Sarl Mitral repair and replacement devices and methods
US20160095701A1 (en) * 2014-10-07 2016-04-07 St. Jude Medical, Cardiology Division, Inc. Bi-Leaflet Mitral Valve Design
EP4331503A3 (en) 2014-10-14 2024-06-05 Edwards Lifesciences Innovation (Israel) Ltd. Leaflet-restraining techniques
US9750607B2 (en) 2014-10-23 2017-09-05 Caisson Interventional, LLC Systems and methods for heart valve therapy
US9750605B2 (en) 2014-10-23 2017-09-05 Caisson Interventional, LLC Systems and methods for heart valve therapy
US9901445B2 (en) 2014-11-21 2018-02-27 Boston Scientific Scimed, Inc. Valve locking mechanism
CN106999178B (en) 2014-12-02 2019-12-24 4科技有限公司 Eccentric tissue anchor
EP3229736B1 (en) 2014-12-09 2024-01-10 Cephea Valve Technologies, Inc. Replacement cardiac valves and method of manufacture
EP3037064B1 (en) 2014-12-23 2018-03-14 Venus MedTech (HangZhou), Inc. Minimally invasive mitral valve replacement with brim
US10449043B2 (en) 2015-01-16 2019-10-22 Boston Scientific Scimed, Inc. Displacement based lock and release mechanism
US9861477B2 (en) 2015-01-26 2018-01-09 Boston Scientific Scimed Inc. Prosthetic heart valve square leaflet-leaflet stitch
US9788942B2 (en) 2015-02-03 2017-10-17 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
WO2016126524A1 (en) 2015-02-03 2016-08-11 Boston Scientific Scimed, Inc. Prosthetic heart valve having tubular seal
US9974651B2 (en) 2015-02-05 2018-05-22 Mitral Tech Ltd. Prosthetic valve with axially-sliding frames
ES2978714T3 (en) 2015-02-05 2024-09-18 Cardiovalve Ltd Prosthetic valve with axial sliding frames
US20160256269A1 (en) 2015-03-05 2016-09-08 Mitralign, Inc. Devices for treating paravalvular leakage and methods use thereof
US10285809B2 (en) 2015-03-06 2019-05-14 Boston Scientific Scimed Inc. TAVI anchoring assist device
US10426617B2 (en) 2015-03-06 2019-10-01 Boston Scientific Scimed, Inc. Low profile valve locking mechanism and commissure assembly
US10080652B2 (en) 2015-03-13 2018-09-25 Boston Scientific Scimed, Inc. Prosthetic heart valve having an improved tubular seal
JP6785786B2 (en) 2015-03-19 2020-11-18 ケーソン・インターヴェンショナル・エルエルシー Systems and methods for heart valve treatment
CN107405198B (en) 2015-03-20 2021-04-20 耶拿阀门科技股份有限公司 Heart valve prosthesis delivery system and method of delivering a heart valve prosthesis with an introducer sheath
US20160287839A1 (en) 2015-03-31 2016-10-06 Surefire Medical, Inc. Apparatus and Method for Infusing an Immunotherapy Agent to a Solid Tumor for Treatment
US10327896B2 (en) 2015-04-10 2019-06-25 Edwards Lifesciences Corporation Expandable sheath with elastomeric cross sectional portions
US10792471B2 (en) 2015-04-10 2020-10-06 Edwards Lifesciences Corporation Expandable sheath
US10441416B2 (en) 2015-04-21 2019-10-15 Edwards Lifesciences Corporation Percutaneous mitral valve replacement device
KR101588310B1 (en) * 2015-04-22 2016-01-25 (주)태웅메디칼 Artificial heart valves using the pericardial and manufacturing method
CR20170480A (en) 2015-04-30 2018-02-21 Valtech Cardio Ltd Annuloplasty technologies
US10376363B2 (en) 2015-04-30 2019-08-13 Edwards Lifesciences Cardiaq Llc Replacement mitral valve, delivery system for replacement mitral valve and methods of use
EP4403138A3 (en) 2015-05-01 2024-10-09 JenaValve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
WO2016183526A1 (en) 2015-05-14 2016-11-17 Cephea Valve Technologies, Inc. Replacement mitral valves
US10849746B2 (en) 2015-05-14 2020-12-01 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
US10016273B2 (en) 2015-06-05 2018-07-10 Medtronic, Inc. Filtered sealing components for a transcatheter valve prosthesis
US10226335B2 (en) 2015-06-22 2019-03-12 Edwards Lifesciences Cardiaq Llc Actively controllable heart valve implant and method of controlling same
US10092400B2 (en) 2015-06-23 2018-10-09 Edwards Lifesciences Cardiaq Llc Systems and methods for anchoring and sealing a prosthetic heart valve
US10195392B2 (en) 2015-07-02 2019-02-05 Boston Scientific Scimed, Inc. Clip-on catheter
US10335277B2 (en) 2015-07-02 2019-07-02 Boston Scientific Scimed Inc. Adjustable nosecone
US9974650B2 (en) 2015-07-14 2018-05-22 Edwards Lifesciences Corporation Prosthetic heart valve
US10136991B2 (en) 2015-08-12 2018-11-27 Boston Scientific Scimed Inc. Replacement heart valve implant
US10179041B2 (en) 2015-08-12 2019-01-15 Boston Scientific Scimed Icn. Pinless release mechanism
WO2017035002A1 (en) 2015-08-21 2017-03-02 Twelve Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
US10575951B2 (en) 2015-08-26 2020-03-03 Edwards Lifesciences Cardiaq Llc Delivery device and methods of use for transapical delivery of replacement mitral valve
US10117744B2 (en) 2015-08-26 2018-11-06 Edwards Lifesciences Cardiaq Llc Replacement heart valves and methods of delivery
US10350066B2 (en) 2015-08-28 2019-07-16 Edwards Lifesciences Cardiaq Llc Steerable delivery system for replacement mitral valve and methods of use
US10350047B2 (en) 2015-09-02 2019-07-16 Edwards Lifesciences Corporation Method and system for packaging and preparing a prosthetic heart valve and associated delivery system
US10779940B2 (en) 2015-09-03 2020-09-22 Boston Scientific Scimed, Inc. Medical device handle
US10314703B2 (en) 2015-09-21 2019-06-11 Edwards Lifesciences Corporation Cylindrical implant and balloon
CN109172045B (en) 2015-11-06 2021-04-06 麦克尔有限公司 Mitral valve prosthesis
US10321996B2 (en) 2015-11-11 2019-06-18 Edwards Lifesciences Corporation Prosthetic valve delivery apparatus having clutch mechanism
US11033387B2 (en) 2015-11-23 2021-06-15 Edwards Lifesciences Corporation Methods for controlled heart valve delivery
US10265169B2 (en) 2015-11-23 2019-04-23 Edwards Lifesciences Corporation Apparatus for controlled heart valve delivery
US10357351B2 (en) 2015-12-04 2019-07-23 Edwards Lifesciences Corporation Storage assembly for prosthetic valve
US9931204B2 (en) 2015-12-10 2018-04-03 Medtronic, Inc. Transcatheter heart valve replacement systems, heart valve prostheses, and methods for percutaneous heart valve replacement
WO2017100927A1 (en) 2015-12-15 2017-06-22 Neovasc Tiara Inc. Transseptal delivery system
US10537453B2 (en) 2015-12-16 2020-01-21 Obalon Therapeutics, Inc. Intragastric device with expandable portions
US10751182B2 (en) 2015-12-30 2020-08-25 Edwards Lifesciences Corporation System and method for reshaping right heart
US10828160B2 (en) 2015-12-30 2020-11-10 Edwards Lifesciences Corporation System and method for reducing tricuspid regurgitation
AU2016380345B2 (en) 2015-12-30 2021-10-28 Caisson Interventional, LLC Systems and methods for heart valve therapy
CA3007670A1 (en) 2016-01-29 2017-08-03 Neovasc Tiara Inc. Prosthetic valve for avoiding obstruction of outflow
US10342660B2 (en) 2016-02-02 2019-07-09 Boston Scientific Inc. Tensioned sheathing aids
US10363130B2 (en) 2016-02-05 2019-07-30 Edwards Lifesciences Corporation Devices and systems for docking a heart valve
US10179043B2 (en) 2016-02-12 2019-01-15 Edwards Lifesciences Corporation Prosthetic heart valve having multi-level sealing member
US10531866B2 (en) 2016-02-16 2020-01-14 Cardiovalve Ltd. Techniques for providing a replacement valve and transseptal communication
WO2017160823A1 (en) 2016-03-14 2017-09-21 Medtronic Vascular Inc. Stented prosthetic heart valve having a wrap and delivery devices
US10398549B2 (en) 2016-03-15 2019-09-03 Abbott Cardiovascular Systems Inc. System and method for transcatheter heart valve platform
CA3216740A1 (en) 2016-03-24 2017-09-28 Edwards Lifesciences Corporation Delivery system for prosthetic heart valve
USD815744S1 (en) 2016-04-28 2018-04-17 Edwards Lifesciences Cardiaq Llc Valve frame for a delivery system
EP3448316B1 (en) 2016-04-29 2023-03-29 Medtronic Vascular Inc. Prosthetic heart valve devices with tethered anchors
US10583005B2 (en) 2016-05-13 2020-03-10 Boston Scientific Scimed, Inc. Medical device handle
US10245136B2 (en) 2016-05-13 2019-04-02 Boston Scientific Scimed Inc. Containment vessel with implant sheathing guide
JP7081749B2 (en) 2016-05-13 2022-06-07 イエナバルブ テクノロジー インク Heart valve prosthesis delivery system
US10201416B2 (en) 2016-05-16 2019-02-12 Boston Scientific Scimed, Inc. Replacement heart valve implant with invertible leaflets
US10702274B2 (en) 2016-05-26 2020-07-07 Edwards Lifesciences Corporation Method and system for closing left atrial appendage
US11331187B2 (en) 2016-06-17 2022-05-17 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
GB201611910D0 (en) 2016-07-08 2016-08-24 Valtech Cardio Ltd Adjustable annuloplasty device with alternating peaks and troughs
US10350062B2 (en) 2016-07-21 2019-07-16 Edwards Lifesciences Corporation Replacement heart valve prosthesis
US11096781B2 (en) 2016-08-01 2021-08-24 Edwards Lifesciences Corporation Prosthetic heart valve
GB201613219D0 (en) 2016-08-01 2016-09-14 Mitraltech Ltd Minimally-invasive delivery systems
USD800908S1 (en) 2016-08-10 2017-10-24 Mitraltech Ltd. Prosthetic valve element
WO2018029680A1 (en) 2016-08-10 2018-02-15 Mitraltech Ltd. Prosthetic valve with concentric frames
US10828152B2 (en) 2016-08-11 2020-11-10 4C Medical Technologies, Inc. Heart chamber prosthetic valve implant with base, spring and dome sections with single chamber anchoring for preservation, supplementation and/or replacement of native valve function
US10646340B2 (en) 2016-08-19 2020-05-12 Edwards Lifesciences Corporation Steerable delivery system for replacement mitral valve
CA3034006A1 (en) 2016-08-26 2018-03-01 Edwards Lifesciences Corporation Multi-portion replacement heart valve prosthesis
US11400263B1 (en) 2016-09-19 2022-08-02 Trisalus Life Sciences, Inc. System and method for selective pressure-controlled therapeutic delivery
US10780250B1 (en) 2016-09-19 2020-09-22 Surefire Medical, Inc. System and method for selective pressure-controlled therapeutic delivery
US10575944B2 (en) 2016-09-22 2020-03-03 Edwards Lifesciences Corporation Prosthetic heart valve with reduced stitching
WO2018081252A1 (en) * 2016-10-26 2018-05-03 Medtronic Vascular Inc. Stented prosthetic heart valve having a paravalvular sealing wrap
US10758348B2 (en) 2016-11-02 2020-09-01 Edwards Lifesciences Corporation Supra and sub-annular mitral valve delivery system
US10973631B2 (en) 2016-11-17 2021-04-13 Edwards Lifesciences Corporation Crimping accessory device for a prosthetic valve
US10463484B2 (en) 2016-11-17 2019-11-05 Edwards Lifesciences Corporation Prosthetic heart valve having leaflet inflow below frame
AU2017361296B2 (en) 2016-11-21 2022-09-29 Neovasc Tiara Inc. Methods and systems for rapid retraction of a transcatheter heart valve delivery system
US10603165B2 (en) 2016-12-06 2020-03-31 Edwards Lifesciences Corporation Mechanically expanding heart valve and delivery apparatus therefor
US10813749B2 (en) 2016-12-20 2020-10-27 Edwards Lifesciences Corporation Docking device made with 3D woven fabric
US10653523B2 (en) 2017-01-19 2020-05-19 4C Medical Technologies, Inc. Systems, methods and devices for delivery systems, methods and devices for implanting prosthetic heart valves
US10433993B2 (en) 2017-01-20 2019-10-08 Medtronic Vascular, Inc. Valve prosthesis having a radially-expandable sleeve integrated thereon for delivery and prevention of paravalvular leakage
US11013600B2 (en) 2017-01-23 2021-05-25 Edwards Lifesciences Corporation Covered prosthetic heart valve
US11654023B2 (en) 2017-01-23 2023-05-23 Edwards Lifesciences Corporation Covered prosthetic heart valve
EP4209196A1 (en) 2017-01-23 2023-07-12 Cephea Valve Technologies, Inc. Replacement mitral valves
US11185406B2 (en) 2017-01-23 2021-11-30 Edwards Lifesciences Corporation Covered prosthetic heart valve
JP7046078B2 (en) 2017-01-23 2022-04-01 セフィア・バルブ・テクノロジーズ,インコーポレイテッド Replacement mitral valve
US10561495B2 (en) 2017-01-24 2020-02-18 4C Medical Technologies, Inc. Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve
WO2018138658A1 (en) 2017-01-27 2018-08-02 Jenavalve Technology, Inc. Heart valve mimicry
USD867595S1 (en) 2017-02-01 2019-11-19 Edwards Lifesciences Corporation Stent
US12029647B2 (en) 2017-03-07 2024-07-09 4C Medical Technologies, Inc. Systems, methods and devices for prosthetic heart valve with single valve leaflet
US10588636B2 (en) 2017-03-20 2020-03-17 Surefire Medical, Inc. Dynamic reconfigurable microvalve protection device
US10575950B2 (en) 2017-04-18 2020-03-03 Twelve, Inc. Hydraulic systems for delivering prosthetic heart valve devices and associated methods
US10433961B2 (en) 2017-04-18 2019-10-08 Twelve, Inc. Delivery systems with tethers for prosthetic heart valve devices and associated methods
US10702378B2 (en) 2017-04-18 2020-07-07 Twelve, Inc. Prosthetic heart valve device and associated systems and methods
US11045627B2 (en) 2017-04-18 2021-06-29 Edwards Lifesciences Corporation Catheter system with linear actuation control mechanism
US10959846B2 (en) 2017-05-10 2021-03-30 Edwards Lifesciences Corporation Mitral valve spacer device
US10792151B2 (en) 2017-05-11 2020-10-06 Twelve, Inc. Delivery systems for delivering prosthetic heart valve devices and associated methods
US10842619B2 (en) 2017-05-12 2020-11-24 Edwards Lifesciences Corporation Prosthetic heart valve docking assembly
US11135056B2 (en) 2017-05-15 2021-10-05 Edwards Lifesciences Corporation Devices and methods of commissure formation for prosthetic heart valve
EP3630013B1 (en) 2017-05-22 2024-04-24 Edwards Lifesciences Corporation Valve anchor
US12064341B2 (en) 2017-05-31 2024-08-20 Edwards Lifesciences Corporation Sealing member for prosthetic heart valve
US10646338B2 (en) 2017-06-02 2020-05-12 Twelve, Inc. Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods
US10869759B2 (en) 2017-06-05 2020-12-22 Edwards Lifesciences Corporation Mechanically expandable heart valve
US11026785B2 (en) 2017-06-05 2021-06-08 Edwards Lifesciences Corporation Mechanically expandable heart valve
US10709591B2 (en) 2017-06-06 2020-07-14 Twelve, Inc. Crimping device and method for loading stents and prosthetic heart valves
WO2018226915A1 (en) 2017-06-08 2018-12-13 Boston Scientific Scimed, Inc. Heart valve implant commissure support structure
US12036113B2 (en) 2017-06-14 2024-07-16 4C Medical Technologies, Inc. Delivery of heart chamber prosthetic valve implant
US10729541B2 (en) 2017-07-06 2020-08-04 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
CN114748212A (en) 2017-07-06 2022-07-15 爱德华兹生命科学公司 Steerable rail delivery system
US10786352B2 (en) 2017-07-06 2020-09-29 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10918473B2 (en) 2017-07-18 2021-02-16 Edwards Lifesciences Corporation Transcatheter heart valve storage container and crimping mechanism
US10898325B2 (en) 2017-08-01 2021-01-26 Boston Scientific Scimed, Inc. Medical implant locking mechanism
US10575948B2 (en) 2017-08-03 2020-03-03 Cardiovalve Ltd. Prosthetic heart valve
US11246704B2 (en) 2017-08-03 2022-02-15 Cardiovalve Ltd. Prosthetic heart valve
US12064347B2 (en) 2017-08-03 2024-08-20 Cardiovalve Ltd. Prosthetic heart valve
US10888421B2 (en) 2017-09-19 2021-01-12 Cardiovalve Ltd. Prosthetic heart valve with pouch
US10537426B2 (en) 2017-08-03 2020-01-21 Cardiovalve Ltd. Prosthetic heart valve
US11793633B2 (en) 2017-08-03 2023-10-24 Cardiovalve Ltd. Prosthetic heart valve
IL314778A (en) 2017-08-11 2024-10-01 Edwards Lifesciences Corp Sealing element for prosthetic heart valve
US11083575B2 (en) 2017-08-14 2021-08-10 Edwards Lifesciences Corporation Heart valve frame design with non-uniform struts
US10932903B2 (en) 2017-08-15 2021-03-02 Edwards Lifesciences Corporation Skirt assembly for implantable prosthetic valve
EP3668449A1 (en) 2017-08-16 2020-06-24 Boston Scientific Scimed, Inc. Replacement heart valve commissure assembly
US10898319B2 (en) 2017-08-17 2021-01-26 Edwards Lifesciences Corporation Sealing member for prosthetic heart valve
US10973628B2 (en) 2017-08-18 2021-04-13 Edwards Lifesciences Corporation Pericardial sealing member for prosthetic heart valve
US10722353B2 (en) 2017-08-21 2020-07-28 Edwards Lifesciences Corporation Sealing member for prosthetic heart valve
US10856984B2 (en) 2017-08-25 2020-12-08 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US10973629B2 (en) 2017-09-06 2021-04-13 Edwards Lifesciences Corporation Sealing member for prosthetic heart valve
US11147667B2 (en) 2017-09-08 2021-10-19 Edwards Lifesciences Corporation Sealing member for prosthetic heart valve
US11304804B2 (en) 2017-09-19 2022-04-19 Cardiovalve, Ltd. Prosthetic valve with connecting struts of variable size and tissue anchoring legs of variable size that extend from junctions
US10835221B2 (en) 2017-11-02 2020-11-17 Valtech Cardio, Ltd. Implant-cinching devices and systems
JP2021503341A (en) * 2017-11-16 2021-02-12 ザ チルドレンズ メディカル センター コーポレーション Geometrically compatible heart valve replacement device
US11135062B2 (en) 2017-11-20 2021-10-05 Valtech Cardio Ltd. Cinching of dilated heart muscle
GB201720803D0 (en) 2017-12-13 2018-01-24 Mitraltech Ltd Prosthetic Valve and delivery tool therefor
US11020226B2 (en) 2018-01-07 2021-06-01 Jc Medical, Inc. Prosthetic heart valve delivery system
CN210697903U (en) 2018-01-07 2020-06-09 苏州杰成医疗科技有限公司 Heart valve prosthesis
GB201800399D0 (en) 2018-01-10 2018-02-21 Mitraltech Ltd Temperature-control during crimping of an implant
WO2019144069A2 (en) 2018-01-19 2019-07-25 Boston Scientific Scimed, Inc. Inductance mode deployment sensors for transcatheter valve system
US11246625B2 (en) 2018-01-19 2022-02-15 Boston Scientific Scimed, Inc. Medical device delivery system with feedback loop
WO2019144121A1 (en) 2018-01-22 2019-07-25 Edwards Lifesciences Corporation Heart shape preserving anchor
WO2019145947A1 (en) 2018-01-24 2019-08-01 Valtech Cardio, Ltd. Contraction of an annuloplasty structure
WO2019147846A2 (en) 2018-01-25 2019-08-01 Edwards Lifesciences Corporation Delivery system for aided replacement valve recapture and repositioning post- deployment
EP4248904A3 (en) 2018-01-26 2023-11-29 Edwards Lifesciences Innovation (Israel) Ltd. Techniques for facilitating heart valve tethering and chord replacement
EP3749252A1 (en) 2018-02-07 2020-12-16 Boston Scientific Scimed, Inc. Medical device delivery system with alignment feature
EP3758651B1 (en) 2018-02-26 2022-12-07 Boston Scientific Scimed, Inc. Embedded radiopaque marker in adaptive seal
US11051934B2 (en) 2018-02-28 2021-07-06 Edwards Lifesciences Corporation Prosthetic mitral valve with improved anchors and seal
WO2019183372A1 (en) * 2018-03-21 2019-09-26 Cornell University Mitral valves with integrated cutting features
US11318011B2 (en) 2018-04-27 2022-05-03 Edwards Lifesciences Corporation Mechanically expandable heart valve with leaflet clamps
CN116269937A (en) * 2018-04-30 2023-06-23 爱德华兹生命科学公司 Push-on sheath style
GB2574576B (en) * 2018-05-01 2022-07-20 The David J Wheatley Discretionary Trust Heart valve
WO2019222367A1 (en) 2018-05-15 2019-11-21 Boston Scientific Scimed, Inc. Replacement heart valve commissure assembly
US11241310B2 (en) 2018-06-13 2022-02-08 Boston Scientific Scimed, Inc. Replacement heart valve delivery device
SG11202013066PA (en) 2018-07-12 2021-01-28 Valtech Cardio Ltd Annuloplasty systems and locking tools therefor
US11850398B2 (en) 2018-08-01 2023-12-26 Trisalus Life Sciences, Inc. Systems and methods for pressure-facilitated therapeutic agent delivery
US11857441B2 (en) 2018-09-04 2024-01-02 4C Medical Technologies, Inc. Stent loading device
US11338117B2 (en) 2018-10-08 2022-05-24 Trisalus Life Sciences, Inc. Implantable dual pathway therapeutic agent delivery port
EP3866731B1 (en) 2018-10-19 2024-08-28 Edwards Lifesciences Corporation Prosthetic heart valve having non-cylindrical frame
JP7260930B2 (en) 2018-11-08 2023-04-19 ニオバスク ティアラ インコーポレイテッド Ventricular deployment of a transcatheter mitral valve prosthesis
CN109350307B (en) * 2018-12-03 2023-08-29 宁波健世科技股份有限公司 Transcatheter prosthetic valve replacement system
WO2020123486A1 (en) 2018-12-10 2020-06-18 Boston Scientific Scimed, Inc. Medical device delivery system including a resistance member
JP2022517423A (en) 2019-01-17 2022-03-08 エドワーズ ライフサイエンシーズ コーポレイション Frame for artificial valve
US11304792B2 (en) * 2019-02-13 2022-04-19 Emboline, Inc. Catheter with integrated embolic protection device
AU2020233892A1 (en) 2019-03-08 2021-11-04 Neovasc Tiara Inc. Retrievable prosthesis delivery system
CN113873973B (en) 2019-03-26 2023-12-22 爱德华兹生命科学公司 prosthetic heart valve
JP7438236B2 (en) 2019-04-01 2024-02-26 ニオバスク ティアラ インコーポレイテッド Controllably deployable prosthetic valve
CA3136334A1 (en) 2019-04-10 2020-10-15 Neovasc Tiara Inc. Prosthetic valve with natural blood flow
US11439504B2 (en) 2019-05-10 2022-09-13 Boston Scientific Scimed, Inc. Replacement heart valve with improved cusp washout and reduced loading
WO2020236931A1 (en) 2019-05-20 2020-11-26 Neovasc Tiara Inc. Introducer with hemostasis mechanism
US11311376B2 (en) 2019-06-20 2022-04-26 Neovase Tiara Inc. Low profile prosthetic mitral valve
EP4051182B1 (en) 2019-10-29 2024-08-21 Edwards Lifesciences Innovation (Israel) Ltd. Annuloplasty and tissue anchor technologies
US11801131B2 (en) 2019-12-20 2023-10-31 Medtronic Vascular, Inc. Elliptical heart valve prostheses, delivery systems, and methods of use
CN115003255A (en) 2020-01-10 2022-09-02 爱德华兹生命科学公司 Method of assembling prosthetic heart valve leaflets
US11931253B2 (en) 2020-01-31 2024-03-19 4C Medical Technologies, Inc. Prosthetic heart valve delivery system: ball-slide attachment
US12053375B2 (en) 2020-03-05 2024-08-06 4C Medical Technologies, Inc. Prosthetic mitral valve with improved atrial and/or annular apposition and paravalvular leakage mitigation
US11992403B2 (en) 2020-03-06 2024-05-28 4C Medical Technologies, Inc. Devices, systems and methods for improving recapture of prosthetic heart valve device with stent frame having valve support with inwardly stent cells
US12023247B2 (en) 2020-05-20 2024-07-02 Edwards Lifesciences Corporation Reducing the diameter of a cardiac valve annulus with independent control over each of the anchors that are launched into the annulus
WO2021257774A1 (en) 2020-06-18 2021-12-23 Edwards Lifesciences Corporation Crimping methods
CN111772882B (en) * 2020-08-17 2021-07-13 四川大学 Pulmonary artery support and pulmonary valve replacement device convenient to control
WO2022103747A1 (en) 2020-11-10 2022-05-19 Edwards Lifesciences Corporation Prosthetic heart valves with hermetic layers or valvular structures to reduce thrombosis risk
CN114681126A (en) * 2020-12-28 2022-07-01 杭州德晋医疗科技有限公司 Multi-stent valve dilator and valve dilation system
WO2022159431A1 (en) * 2021-01-20 2022-07-28 Edwards Lifesciences Corporation Mechanically expandable bi-caval docking device
CN116981432A (en) 2021-01-20 2023-10-31 爱德华兹生命科学公司 Connection skirt for attaching leaflets to a frame of a prosthetic heart valve
EP4312883A1 (en) 2021-03-23 2024-02-07 Edwards Lifesciences Corporation Prosthetic heart valve having elongated sealing member
WO2023161766A1 (en) * 2022-02-25 2023-08-31 Medtronic, Inc. Prosthetic heart valve
WO2024030237A1 (en) 2022-08-03 2024-02-08 The Children's Medical Center Corporation Geometrically-accommodating heart valve replacement device
WO2024112523A1 (en) * 2022-11-21 2024-05-30 St. Jude Medical, Cardiology Division, Inc. Transcatheter prosthetic atrioventricular valve with stiffening structure

Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657744A (en) * 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US3714671A (en) * 1970-11-30 1973-02-06 Cutter Lab Tissue-type heart valve with a graft support ring or stent
US4680031A (en) * 1982-11-29 1987-07-14 Tascon Medical Technology Corporation Heart valve prosthesis
US5411552A (en) * 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5500014A (en) * 1989-05-31 1996-03-19 Baxter International Inc. Biological valvular prothesis
US5840081A (en) * 1990-05-18 1998-11-24 Andersen; Henning Rud System and method for implanting cardiac valves
US5855601A (en) * 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
US20010007956A1 (en) * 1996-12-31 2001-07-12 Brice Letac Valve prosthesis for implantation in body channels
US20010011017A1 (en) * 1995-09-29 2001-08-02 Rolf Biedermann Cordless telecommunication system with backup interoperability of cordless telecommunication applications, in particular of a gap-specific dect system
US20020052651A1 (en) * 2000-01-27 2002-05-02 Keith Myers Prosthetic heart valve
US6425916B1 (en) * 1999-02-10 2002-07-30 Michi E. Garrison Methods and devices for implanting cardiac valves
US6454799B1 (en) * 2000-04-06 2002-09-24 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
US6494909B2 (en) * 2000-12-01 2002-12-17 Prodesco, Inc. Endovascular valve
US6503272B2 (en) * 2001-03-21 2003-01-07 Cordis Corporation Stent-based venous valves
US20030040792A1 (en) * 2000-09-12 2003-02-27 Shlomo Gabbay Heart valve prosthesis and sutureless implantation of a heart valve prosthesis
US6530952B2 (en) * 1997-12-29 2003-03-11 The Cleveland Clinic Foundation Bioprosthetic cardiovascular valve system
US20030060875A1 (en) * 2000-01-17 2003-03-27 Wittens Cornelis Hendrikus Anna Implant valve for implantation in a blood vessel
US20030130729A1 (en) * 2002-01-04 2003-07-10 David Paniagua Percutaneously implantable replacement heart valve device and method of making same
US20030153974A1 (en) * 2001-10-11 2003-08-14 Benjamin Spenser Implantable prosthetic valve
US6658418B2 (en) * 1996-02-27 2003-12-02 Datamize Llc Authoring system for computer-based information delivery system
US6733525B2 (en) * 2001-03-23 2004-05-11 Edwards Lifesciences Corporation Rolled minimally-invasive heart valves and methods of use
US20040093060A1 (en) * 1999-11-17 2004-05-13 Jacques Seguin Prosthetic valve for transluminal delivery
US20040210306A1 (en) * 2003-04-17 2004-10-21 Quijano Rodolfo C. Device for reduction of pressure effects of cardiac tricuspid valve regurgitation
US20050043790A1 (en) * 2001-07-04 2005-02-24 Jacques Seguin Kit enabling a prosthetic valve to be placed in a body enabling a prosthetic valve to be put into place in a duct in the body

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US411552A (en) * 1889-09-24 The worcester fire
US682559A (en) * 1901-03-08 1901-09-10 Harry C Mack Bobbin.
US3571815A (en) * 1968-09-19 1971-03-23 John V Somyk Suture ring for heart valve
US4768523A (en) 1981-04-29 1988-09-06 Lifecore Biomedical, Inc. Hydrogel adhesive
US4626255A (en) * 1983-09-23 1986-12-02 Christian Weinhold Heart valve bioprothesis
US5225196A (en) 1983-11-14 1993-07-06 Columbia Laboratories, Inc. Bioadhesive compositions and methods of treatment therewith
DE3622642A1 (en) 1986-07-05 1988-01-14 Behringwerke Ag ONE-COMPONENT TISSUE ADHESIVE AND METHOD FOR THE PRODUCTION THEREOF
US4725274A (en) * 1986-10-24 1988-02-16 Baxter Travenol Laboratories, Inc. Prosthetic heart valve
US5936035A (en) 1988-11-21 1999-08-10 Cohesion Technologies, Inc. Biocompatible adhesive compositions
US4994077A (en) * 1989-04-21 1991-02-19 Dobben Richard L Artificial heart valve for implantation in a blood vessel
AU5549590A (en) 1989-05-11 1990-11-29 Landec Labs, Inc. Temperature-activated adhesive assemblies
US5156911A (en) 1989-05-11 1992-10-20 Landec Labs Inc. Skin-activated temperature-sensitive adhesive assemblies
US5648167A (en) 1990-03-29 1997-07-15 Smith & Nephew Plc Adhesive compositions
US5037434A (en) * 1990-04-11 1991-08-06 Carbomedics, Inc. Bioprosthetic heart valve with elastic commissures
US5147391A (en) * 1990-04-11 1992-09-15 Carbomedics, Inc. Bioprosthetic heart valve with semi-permeable commissure posts and deformable leaflets
US5066709A (en) 1990-09-20 1991-11-19 Gaf Chemicals Corporation Bioadhesive composition
US5055046A (en) 1990-09-20 1991-10-08 Isp Investments Inc. Bioadhesive composition
US5197973A (en) 1990-12-14 1993-03-30 Creative Biomolecules, Inc. Synthetic bioadhesive
US5370685A (en) * 1991-07-16 1994-12-06 Stanford Surgical Technologies, Inc. Endovascular aortic valve replacement
US5267554A (en) * 1991-11-15 1993-12-07 Wilk Peter J Spreadable laparoscopic retractor and associated method of use
US5163953A (en) * 1992-02-10 1992-11-17 Vince Dennis J Toroidal artificial heart valve stent
US5509900A (en) * 1992-03-02 1996-04-23 Kirkman; Thomas R. Apparatus and method for retaining a catheter in a blood vessel in a fixed position
JPH07508975A (en) 1992-04-23 1995-10-05 バーレックス ラボラトリーズ インコーポレイテッド Bioadhesive aqueous mineral oil emulsion ointment base, topical pharmaceutical compositions comprising it and its use in wound healing
CN1091315A (en) 1992-10-08 1994-08-31 E·R·斯奎布父子公司 Fibrin sealant compositions and using method thereof
GB2274995B (en) 1993-02-15 1996-10-09 John Mccune Anderson Biomedical electrode device
US6010531A (en) * 1993-02-22 2000-01-04 Heartport, Inc. Less-invasive devices and methods for cardiac valve surgery
US5549904A (en) 1993-06-03 1996-08-27 Orthogene, Inc. Biological adhesive composition and method of promoting adhesion between tissue surfaces
EP0667133B1 (en) * 1993-12-14 2001-03-07 Sante Camilli A percutaneous implantable valve for the use in blood vessels
WO1995022316A1 (en) 1994-02-17 1995-08-24 New York Blood Center, Inc. Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
US5474065A (en) 1994-04-04 1995-12-12 Graphic Controls Corporation Non-invasive fetal probe
US5752522A (en) * 1995-05-04 1998-05-19 Cardiovascular Concepts, Inc. Lesion diameter measurement catheter and method
US5716417A (en) * 1995-06-07 1998-02-10 St. Jude Medical, Inc. Integral supporting structure for bioprosthetic heart valve
US5769882A (en) * 1995-09-08 1998-06-23 Medtronic, Inc. Methods and apparatus for conformably sealing prostheses within body lumens
US6287315B1 (en) * 1995-10-30 2001-09-11 World Medical Manufacturing Corporation Apparatus for delivering an endoluminal prosthesis
US6533805B1 (en) 1996-04-01 2003-03-18 General Surgical Innovations, Inc. Prosthesis and method for deployment within a body lumen
EP0914096B1 (en) 1996-05-17 2003-08-13 Elan Drug Delivery Limited Microparticles and their use in wound therapy
NL1004827C2 (en) * 1996-12-18 1998-06-19 Surgical Innovations Vof Device for regulating blood circulation.
US5957949A (en) * 1997-05-01 1999-09-28 World Medical Manufacturing Corp. Percutaneous placement valve stent
US6245102B1 (en) * 1997-05-07 2001-06-12 Iowa-India Investments Company Ltd. Stent, stent graft and stent valve
US5925063A (en) * 1997-09-26 1999-07-20 Khosravi; Farhad Coiled sheet valve, filter or occlusive device and methods of use
US5980515A (en) 1997-12-19 1999-11-09 Irvine Biomedical, Inc. Devices and methods for lead extraction
US6159178A (en) 1998-01-23 2000-12-12 Heartport, Inc. Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested
US6102943A (en) * 1998-01-26 2000-08-15 Ave Connaught Endoluminal stents and their manufacture
US6074418A (en) * 1998-04-20 2000-06-13 St. Jude Medical, Inc. Driver tool for heart valve prosthesis fasteners
US7452371B2 (en) * 1999-06-02 2008-11-18 Cook Incorporated Implantable vascular device
US6254636B1 (en) * 1998-06-26 2001-07-03 St. Jude Medical, Inc. Single suture biological tissue aortic stentless valve
US6267781B1 (en) * 1998-08-31 2001-07-31 Quantum Therapeutics Corp. Medical device and methods for treating valvular annulus
US6033402A (en) 1998-09-28 2000-03-07 Irvine Biomedical, Inc. Ablation device for lead extraction and methods thereof
US6241692B1 (en) 1998-10-06 2001-06-05 Irvine Biomedical, Inc. Ultrasonic ablation device and methods for lead extraction
US6558418B2 (en) 1999-01-26 2003-05-06 Edwards Lifesciences Corporation Flexible heart valve
US6736845B2 (en) * 1999-01-26 2004-05-18 Edwards Lifesciences Corporation Holder for flexible heart valve
US6896690B1 (en) * 2000-01-27 2005-05-24 Viacor, Inc. Cardiac valve procedure methods and devices
AU764886B2 (en) 1999-01-27 2003-09-04 Viacor Incorporated Cardiac valve procedure methods and devices
US6638717B2 (en) 1999-05-19 2003-10-28 Aventis Pharmaceuticals, Inc. Microarray-based subtractive hybridzation
US6299637B1 (en) * 1999-08-20 2001-10-09 Samuel M. Shaolian Transluminally implantable venous valve
FR2800984B1 (en) * 1999-11-17 2001-12-14 Jacques Seguin DEVICE FOR REPLACING A HEART VALVE PERCUTANEOUSLY
FR2815844B1 (en) 2000-10-31 2003-01-17 Jacques Seguin TUBULAR SUPPORT FOR THE PERCUTANEOUS POSITIONING OF A REPLACEMENT HEART VALVE
US6458153B1 (en) * 1999-12-31 2002-10-01 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US7749245B2 (en) * 2000-01-27 2010-07-06 Medtronic, Inc. Cardiac valve procedure methods and devices
DE10010074B4 (en) 2000-02-28 2005-04-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Device for fastening and anchoring heart valve prostheses
US6566649B1 (en) 2000-05-26 2003-05-20 Precision Drilling Technology Services Group Inc. Standoff compensation for nuclear measurements
US6485501B1 (en) 2000-08-11 2002-11-26 Cordis Corporation Vascular filter system with guidewire and capture mechanism
US6893459B1 (en) * 2000-09-20 2005-05-17 Ample Medical, Inc. Heart valve annulus device and method of using same
WO2002026168A2 (en) * 2000-09-29 2002-04-04 Tricardia, Llc Venous valvuloplasty device
US6974476B2 (en) * 2003-05-05 2005-12-13 Rex Medical, L.P. Percutaneous aortic valve
US6752829B2 (en) * 2001-01-30 2004-06-22 Scimed Life Systems, Inc. Stent with channel(s) for containing and delivering a biologically active material and method for manufacturing the same
NL1017275C2 (en) * 2001-02-02 2002-08-05 Univ Eindhoven Tech Heart valve prosthesis has through passage with wall at least partly formed by flexible valve components with free outer ends and movable radially for opening and closing through passage
US7556646B2 (en) * 2001-09-13 2009-07-07 Edwards Lifesciences Corporation Methods and apparatuses for deploying minimally-invasive heart valves
US20040193253A1 (en) * 2001-04-30 2004-09-30 Thorpe Patricia E Replacement venous valve
US6605056B2 (en) 2001-07-11 2003-08-12 Scimed Life Systems, Inc. Conformable balloon
FR2828091B1 (en) * 2001-07-31 2003-11-21 Seguin Jacques ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT
US7097659B2 (en) * 2001-09-07 2006-08-29 Medtronic, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US7192441B2 (en) * 2001-10-16 2007-03-20 Scimed Life Systems, Inc. Aortic artery aneurysm endovascular prosthesis
US6755857B2 (en) * 2001-12-12 2004-06-29 Sulzer Carbomedics Inc. Polymer heart valve with perforated stent and sewing cuff
US6716241B2 (en) * 2002-03-05 2004-04-06 John G. Wilder Venous valve and graft combination
US20030199971A1 (en) * 2002-04-23 2003-10-23 Numed, Inc. Biological replacement valve assembly
US6733526B2 (en) * 2002-04-25 2004-05-11 Advanced Medical Optics, Inc. Method of improving adherence and centering of intra-corneal implants on corneal bed
WO2003092554A1 (en) * 2002-05-03 2003-11-13 The General Hospital Corporation Involuted endovascular valve and method of construction
AU2003225291A1 (en) * 2002-05-10 2003-11-11 Cordis Corporation Method of making a medical device having a thin wall tubular membrane over a structural frame
US7351256B2 (en) 2002-05-10 2008-04-01 Cordis Corporation Frame based unidirectional flow prosthetic implant
US20040059412A1 (en) * 2002-09-25 2004-03-25 Lytle Thomas William Heart valve holder
US6682462B1 (en) * 2003-02-21 2004-01-27 Sunny Lee Dual-purpose exerciser operable in pedaling and rowing modes
US7399315B2 (en) * 2003-03-18 2008-07-15 Edwards Lifescience Corporation Minimally-invasive heart valve with cusp positioners
EP1615595B1 (en) * 2003-04-24 2009-10-21 Cook Incorporated Artificial valve prosthesis with improved flow dynamics
DE602004018059D1 (en) * 2003-04-30 2009-01-15 Medtronic Vascular Inc Perivascular repair system for leaks
US20050075718A1 (en) 2003-10-06 2005-04-07 Nguyen Tuoc Tan Minimally invasive valve replacement system
CA2545874C (en) 2003-10-06 2012-02-21 3F Therapeutics, Inc. Minimally invasive valve replacement system
CN101052359A (en) 2004-04-23 2007-10-10 3F医疗有限公司 Implantable prosthetic valve
KR20230029317A (en) 2021-08-24 2023-03-03 엘지디스플레이 주식회사 Display device, data driving circuit and display driving method

Patent Citations (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657744A (en) * 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US3714671A (en) * 1970-11-30 1973-02-06 Cutter Lab Tissue-type heart valve with a graft support ring or stent
US4680031A (en) * 1982-11-29 1987-07-14 Tascon Medical Technology Corporation Heart valve prosthesis
US5500014A (en) * 1989-05-31 1996-03-19 Baxter International Inc. Biological valvular prothesis
US6582462B1 (en) * 1990-05-18 2003-06-24 Heartport, Inc. Valve prosthesis for implantation in the body and a catheter for implanting such valve prosthesis
US5411552A (en) * 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5840081A (en) * 1990-05-18 1998-11-24 Andersen; Henning Rud System and method for implanting cardiac valves
US6168614B1 (en) * 1990-05-18 2001-01-02 Heartport, Inc. Valve prosthesis for implantation in the body
US20010011017A1 (en) * 1995-09-29 2001-08-02 Rolf Biedermann Cordless telecommunication system with backup interoperability of cordless telecommunication applications, in particular of a gap-specific dect system
US6658418B2 (en) * 1996-02-27 2003-12-02 Datamize Llc Authoring system for computer-based information delivery system
US5855601A (en) * 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
US20010007956A1 (en) * 1996-12-31 2001-07-12 Brice Letac Valve prosthesis for implantation in body channels
US20030014104A1 (en) * 1996-12-31 2003-01-16 Alain Cribier Value prosthesis for implantation in body channels
US20030109924A1 (en) * 1996-12-31 2003-06-12 Alain Cribier Implanting a valve prosthesis in body channels
US6530952B2 (en) * 1997-12-29 2003-03-11 The Cleveland Clinic Foundation Bioprosthetic cardiovascular valve system
US6425916B1 (en) * 1999-02-10 2002-07-30 Michi E. Garrison Methods and devices for implanting cardiac valves
US20040093060A1 (en) * 1999-11-17 2004-05-13 Jacques Seguin Prosthetic valve for transluminal delivery
US20030060875A1 (en) * 2000-01-17 2003-03-27 Wittens Cornelis Hendrikus Anna Implant valve for implantation in a blood vessel
US6682559B2 (en) * 2000-01-27 2004-01-27 3F Therapeutics, Inc. Prosthetic heart valve
US20020052651A1 (en) * 2000-01-27 2002-05-02 Keith Myers Prosthetic heart valve
US6767362B2 (en) * 2000-04-06 2004-07-27 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
US6454799B1 (en) * 2000-04-06 2002-09-24 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
US20030040792A1 (en) * 2000-09-12 2003-02-27 Shlomo Gabbay Heart valve prosthesis and sutureless implantation of a heart valve prosthesis
US6494909B2 (en) * 2000-12-01 2002-12-17 Prodesco, Inc. Endovascular valve
US6503272B2 (en) * 2001-03-21 2003-01-07 Cordis Corporation Stent-based venous valves
US6733525B2 (en) * 2001-03-23 2004-05-11 Edwards Lifesciences Corporation Rolled minimally-invasive heart valves and methods of use
US20050043790A1 (en) * 2001-07-04 2005-02-24 Jacques Seguin Kit enabling a prosthetic valve to be placed in a body enabling a prosthetic valve to be put into place in a duct in the body
US6730118B2 (en) * 2001-10-11 2004-05-04 Percutaneous Valve Technologies, Inc. Implantable prosthetic valve
US20030153974A1 (en) * 2001-10-11 2003-08-14 Benjamin Spenser Implantable prosthetic valve
US20030130729A1 (en) * 2002-01-04 2003-07-10 David Paniagua Percutaneously implantable replacement heart valve device and method of making same
US20040210306A1 (en) * 2003-04-17 2004-10-21 Quijano Rodolfo C. Device for reduction of pressure effects of cardiac tricuspid valve regurgitation

Cited By (293)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10238486B2 (en) 2000-06-01 2019-03-26 Edwards Lifesciences Corporation Heart valve with integrated stent and sewing ring
US9439762B2 (en) 2000-06-01 2016-09-13 Edwards Lifesciences Corporation Methods of implant of a heart valve with a convertible sewing ring
US7819915B2 (en) 2000-07-27 2010-10-26 Edwards Lifesciences Corporation Heart valve holders and handling clips therefor
US7776053B2 (en) 2000-10-26 2010-08-17 Boston Scientific Scimed, Inc. Implantable valve system
US8038708B2 (en) 2001-02-05 2011-10-18 Cook Medical Technologies Llc Implantable device with remodelable material and covering material
US7972377B2 (en) 2001-12-27 2011-07-05 Medtronic, Inc. Bioprosthetic heart valve
US7682385B2 (en) 2002-04-03 2010-03-23 Boston Scientific Corporation Artificial valve
US20040215333A1 (en) * 2002-04-16 2004-10-28 Carlos Duran Sigmoid valve and method for its percutaneous implantation
US7125418B2 (en) * 2002-04-16 2006-10-24 The International Heart Institute Of Montana Foundation Sigmoid valve and method for its percutaneous implantation
US7806920B2 (en) * 2002-04-16 2010-10-05 The International Heart Institute Of Montana Foundation Sigmoid valve and method for its percutaneous implantation
US20070016290A1 (en) * 2002-04-16 2007-01-18 Carlos Duran Sigmoid valve and method for its percutaneous implantation
US7959674B2 (en) 2002-07-16 2011-06-14 Medtronic, Inc. Suture locking assembly and method of use
US8349003B2 (en) 2002-07-16 2013-01-08 Medtronic, Inc. Suture locking assembly and method of use
US9333078B2 (en) 2002-12-20 2016-05-10 Medtronic, Inc. Heart valve assemblies
US8025695B2 (en) 2002-12-20 2011-09-27 Medtronic, Inc. Biologically implantable heart valve system
US8460373B2 (en) 2002-12-20 2013-06-11 Medtronic, Inc. Method for implanting a heart valve within an annulus of a patient
US8623080B2 (en) 2002-12-20 2014-01-07 Medtronic, Inc. Biologically implantable prosthesis and methods of using the same
US7981153B2 (en) 2002-12-20 2011-07-19 Medtronic, Inc. Biologically implantable prosthesis methods of using
US10595991B2 (en) 2002-12-20 2020-03-24 Medtronic, Inc. Heart valve assemblies
US8551162B2 (en) 2002-12-20 2013-10-08 Medtronic, Inc. Biologically implantable prosthesis
US7780627B2 (en) 2002-12-30 2010-08-24 Boston Scientific Scimed, Inc. Valve treatment catheter and methods
US8221492B2 (en) 2003-04-24 2012-07-17 Cook Medical Technologies Artificial valve prosthesis with improved flow dynamics
US7658759B2 (en) * 2003-04-24 2010-02-09 Cook Incorporated Intralumenally implantable frames
US7625399B2 (en) * 2003-04-24 2009-12-01 Cook Incorporated Intralumenally-implantable frames
US20070021826A1 (en) * 2003-04-24 2007-01-25 Cook Incorporated Intralumenally implantable frames
US8771338B2 (en) 2003-04-24 2014-07-08 Cook Medical Technologies Llc Intralumenally-implantable frames
US9421096B2 (en) 2003-04-24 2016-08-23 Cook Medical Technologies Llc Artificial valve prosthesis with improved flow dynamics
US20100114296A1 (en) * 2003-04-24 2010-05-06 Cook Incorporated Intralumenally-implantable frames
US7717952B2 (en) * 2003-04-24 2010-05-18 Cook Incorporated Artificial prostheses with preferred geometries
US8470020B2 (en) 2003-04-24 2013-06-25 Cook Medical Technologies Llc Intralumenally-implantable frames
US20070038291A1 (en) * 2003-04-24 2007-02-15 Cook Incorporated Intralumenally-implantable frames
US9326871B2 (en) 2003-04-24 2016-05-03 Cook Medical Technologies Llc Intralumenally-implantable frames
US8157857B2 (en) * 2003-04-24 2012-04-17 Cook Medical Technologies Llc Intralumenally-implantable frames
US20070100435A1 (en) * 2003-04-24 2007-05-03 Cook Incorporated Artificial prostheses with preferred geometries
US8021421B2 (en) 2003-08-22 2011-09-20 Medtronic, Inc. Prosthesis heart valve fixturing device
US8747463B2 (en) 2003-08-22 2014-06-10 Medtronic, Inc. Methods of using a prosthesis fixturing device
US8603161B2 (en) 2003-10-08 2013-12-10 Medtronic, Inc. Attachment device and methods of using the same
US9301843B2 (en) 2003-12-19 2016-04-05 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US10869764B2 (en) 2003-12-19 2020-12-22 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US8721717B2 (en) 2003-12-19 2014-05-13 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US8128681B2 (en) 2003-12-19 2012-03-06 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7854761B2 (en) 2003-12-19 2010-12-21 Boston Scientific Scimed, Inc. Methods for venous valve replacement with a catheter
US9155617B2 (en) 2004-01-23 2015-10-13 Edwards Lifesciences Corporation Prosthetic mitral valve
US10085836B2 (en) 2004-01-23 2018-10-02 Edwards Lifesciences Corporation Prosthetic mitral valve
US9730794B2 (en) 2004-01-23 2017-08-15 Edwards Lifesciences Corporation Prosthetic mitral valve
US10342661B2 (en) 2004-01-23 2019-07-09 Edwards Lifesciences Corporation Prosthetic mitral valve
US9867695B2 (en) 2004-03-03 2018-01-16 Sorin Group Italia S.R.L. Minimally-invasive cardiac-valve prosthesis
US8109996B2 (en) 2004-03-03 2012-02-07 Sorin Biomedica Cardio, S.R.L. Minimally-invasive cardiac-valve prosthesis
US20050197695A1 (en) * 2004-03-03 2005-09-08 Sorin Biomedica Cardio S.R.L. Minimally-invasive cardiac-valve prosthesis
US8535373B2 (en) 2004-03-03 2013-09-17 Sorin Group Italia S.R.L. Minimally-invasive cardiac-valve prosthesis
US20050228494A1 (en) * 2004-03-29 2005-10-13 Salvador Marquez Controlled separation heart valve frame
US20060122692A1 (en) * 2004-05-10 2006-06-08 Ran Gilad Stent valve and method of using same
US20060122686A1 (en) * 2004-05-10 2006-06-08 Ran Gilad Stent and method of manufacturing same
US20060122693A1 (en) * 2004-05-10 2006-06-08 Youssef Biadillah Stent valve and method of manufacturing same
US8002824B2 (en) 2004-09-02 2011-08-23 Boston Scientific Scimed, Inc. Cardiac valve, system, and method
US9918834B2 (en) 2004-09-02 2018-03-20 Boston Scientific Scimed, Inc. Cardiac valve, system and method
US8932349B2 (en) 2004-09-02 2015-01-13 Boston Scientific Scimed, Inc. Cardiac valve, system, and method
US7744642B2 (en) * 2004-11-19 2010-06-29 Biomedical Research Associates, Inc. Prosthetic venous valves
US20060111773A1 (en) * 2004-11-19 2006-05-25 Biomedical Research Associates, Inc. Prosthetic venous valves
US7854755B2 (en) 2005-02-01 2010-12-21 Boston Scientific Scimed, Inc. Vascular catheter, system, and method
US9622859B2 (en) 2005-02-01 2017-04-18 Boston Scientific Scimed, Inc. Filter system and method
US7878966B2 (en) 2005-02-04 2011-02-01 Boston Scientific Scimed, Inc. Ventricular assist and support device
US7780722B2 (en) 2005-02-07 2010-08-24 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7670368B2 (en) 2005-02-07 2010-03-02 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US20100063363A1 (en) * 2005-02-10 2010-03-11 Hamman Baron L System, device, and method for providing access in a cardiovascular environment
US8920492B2 (en) 2005-02-10 2014-12-30 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US9895223B2 (en) 2005-02-10 2018-02-20 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US8540768B2 (en) 2005-02-10 2013-09-24 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US8574257B2 (en) 2005-02-10 2013-11-05 Edwards Lifesciences Corporation System, device, and method for providing access in a cardiovascular environment
US7857845B2 (en) 2005-02-10 2010-12-28 Sorin Biomedica Cardio S.R.L. Cardiac-valve prosthesis
US9486313B2 (en) 2005-02-10 2016-11-08 Sorin Group Italia S.R.L. Cardiac valve prosthesis
US20080249619A1 (en) * 2005-02-10 2008-10-09 Sorin Biomedica Cardio S.R.L. Cardiac-valve prosthesis
US8539662B2 (en) 2005-02-10 2013-09-24 Sorin Group Italia S.R.L. Cardiac-valve prosthesis
US9808341B2 (en) 2005-02-23 2017-11-07 Boston Scientific Scimed Inc. Valve apparatus, system and method
US9370419B2 (en) 2005-02-23 2016-06-21 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US7951197B2 (en) 2005-04-08 2011-05-31 Medtronic, Inc. Two-piece prosthetic valves with snap-in connection and methods for use
US8500802B2 (en) 2005-04-08 2013-08-06 Medtronic, Inc. Two-piece prosthetic valves with snap-in connection and methods for use
US8512399B2 (en) 2005-04-15 2013-08-20 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US9861473B2 (en) 2005-04-15 2018-01-09 Boston Scientific Scimed Inc. Valve apparatus, system and method
US7722666B2 (en) 2005-04-15 2010-05-25 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US10912546B2 (en) 2005-04-22 2021-02-09 Laurent Schaller Catheter-based tissue remodeling devices and methods
US10966696B2 (en) 2005-04-22 2021-04-06 Laurent Schaller Catheter-based tissue remodeling devices and methods
US20060287717A1 (en) * 2005-05-24 2006-12-21 Rowe Stanton J Methods for rapid deployment of prosthetic heart valves
US8911493B2 (en) 2005-05-24 2014-12-16 Edwards Lifesciences Corporation Rapid deployment prosthetic heart valves
US20060287719A1 (en) * 2005-05-24 2006-12-21 Rowe Stanton J Rapid deployment prosthetic heart valve
US11284998B2 (en) 2005-05-24 2022-03-29 Edwards Lifesciences Corporation Surgical methods of replacing prosthetic heart valves
US8500798B2 (en) 2005-05-24 2013-08-06 Edwards Lifesciences Corporation Rapid deployment prosthetic heart valve
US10456251B2 (en) 2005-05-24 2019-10-29 Edwards Lifesciences Corporation Surgical methods of replacing prosthetic heart valves
US7708775B2 (en) 2005-05-24 2010-05-04 Edwards Lifesciences Corporation Methods for rapid deployment of prosthetic heart valves
US9554903B2 (en) 2005-05-24 2017-01-31 Edwards Lifesciences Corporation Rapid deployment prosthetic heart valve
US10130468B2 (en) 2005-05-24 2018-11-20 Edwards Lifesciences Corporation Replacement prosthetic heart valves
US8211169B2 (en) 2005-05-27 2012-07-03 Medtronic, Inc. Gasket with collar for prosthetic heart valves and methods for using them
US11337812B2 (en) 2005-06-10 2022-05-24 Boston Scientific Scimed, Inc. Venous valve, system and method
US8012198B2 (en) 2005-06-10 2011-09-06 Boston Scientific Scimed, Inc. Venous valve, system, and method
US9028542B2 (en) 2005-06-10 2015-05-12 Boston Scientific Scimed, Inc. Venous valve, system, and method
US8506625B2 (en) 2005-07-13 2013-08-13 Edwards Lifesciences Corporation Contoured sewing ring for a prosthetic mitral heart valve
US20110054598A1 (en) * 2005-07-13 2011-03-03 Edwards Lifesciences Corporation Contoured Sewing Ring for a Prosthetic Mitral Heart Valve
US8672997B2 (en) 2005-09-21 2014-03-18 Boston Scientific Scimed, Inc. Valve with sinus
US10548734B2 (en) 2005-09-21 2020-02-04 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US7951189B2 (en) 2005-09-21 2011-05-31 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US8460365B2 (en) 2005-09-21 2013-06-11 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US9474609B2 (en) 2005-09-21 2016-10-25 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US7799038B2 (en) 2006-01-20 2010-09-21 Boston Scientific Scimed, Inc. Translumenal apparatus, system, and method
US7967857B2 (en) 2006-01-27 2011-06-28 Medtronic, Inc. Gasket with spring collar for prosthetic heart valves and methods for making and using them
US8821569B2 (en) 2006-04-29 2014-09-02 Medtronic, Inc. Multiple component prosthetic heart valve assemblies and methods for delivering them
US8021161B2 (en) 2006-05-01 2011-09-20 Edwards Lifesciences Corporation Simulated heart valve root for training and testing
US20070254273A1 (en) * 2006-05-01 2007-11-01 Hugues Lafrance Simulated heart valve root for training and testing
US8057539B2 (en) 2006-12-19 2011-11-15 Sorin Biomedica Cardio S.R.L. System for in situ positioning of cardiac valve prostheses without occluding blood flow
US9056008B2 (en) 2006-12-19 2015-06-16 Sorin Group Italia S.R.L. Instrument and method for in situ development of cardiac valve prostheses
US8470024B2 (en) 2006-12-19 2013-06-25 Sorin Group Italia S.R.L. Device for in situ positioning of cardiac valve prosthesis
US20080147182A1 (en) * 2006-12-19 2008-06-19 Sorin Biomedica Cardio S.R.L. Instrument and method for in situ deployment of cardiac valve prostheses
US20080262507A1 (en) * 2006-12-19 2008-10-23 Sorin Biomedica Cardio S.R.L. Instrument and method for in situ deployment of cardiac valve prostheses
US8070799B2 (en) 2006-12-19 2011-12-06 Sorin Biomedica Cardio S.R.L. Instrument and method for in situ deployment of cardiac valve prostheses
US7993392B2 (en) 2006-12-19 2011-08-09 Sorin Biomedica Cardio S.R.L. Instrument and method for in situ deployment of cardiac valve prostheses
US8348999B2 (en) 2007-01-08 2013-01-08 California Institute Of Technology In-situ formation of a valve
US20100249920A1 (en) * 2007-01-08 2010-09-30 Millipede Llc Reconfiguring heart features
US8133270B2 (en) 2007-01-08 2012-03-13 California Institute Of Technology In-situ formation of a valve
US9192471B2 (en) 2007-01-08 2015-11-24 Millipede, Inc. Device for translumenal reshaping of a mitral valve annulus
US8470023B2 (en) 2007-02-05 2013-06-25 Boston Scientific Scimed, Inc. Percutaneous valve, system, and method
US9421083B2 (en) 2007-02-05 2016-08-23 Boston Scientific Scimed Inc. Percutaneous valve, system and method
US10226344B2 (en) 2007-02-05 2019-03-12 Boston Scientific Scimed, Inc. Percutaneous valve, system and method
US11504239B2 (en) 2007-02-05 2022-11-22 Boston Scientific Scimed, Inc. Percutaneous valve, system and method
US7967853B2 (en) 2007-02-05 2011-06-28 Boston Scientific Scimed, Inc. Percutaneous valve, system and method
US20090030506A1 (en) * 2007-07-24 2009-01-29 Biotronik Vi Patent Ag Endoprosthesis and method for manufacturing same
US8828079B2 (en) 2007-07-26 2014-09-09 Boston Scientific Scimed, Inc. Circulatory valve, system and method
US8808367B2 (en) 2007-09-07 2014-08-19 Sorin Group Italia S.R.L. Prosthetic valve delivery system including retrograde/antegrade approach
US8114154B2 (en) 2007-09-07 2012-02-14 Sorin Biomedica Cardio S.R.L. Fluid-filled delivery system for in situ deployment of cardiac valve prostheses
US8475521B2 (en) 2007-09-07 2013-07-02 Sorin Group Italia S.R.L. Streamlined delivery system for in situ deployment of cardiac valve prostheses
US8486137B2 (en) 2007-09-07 2013-07-16 Sorin Group Italia S.R.L. Streamlined, apical delivery system for in situ deployment of cardiac valve prostheses
US9848981B2 (en) 2007-10-12 2017-12-26 Mayo Foundation For Medical Education And Research Expandable valve prosthesis with sealing mechanism
US20090099653A1 (en) * 2007-10-12 2009-04-16 Sorin Biomedica Cardio S.R.L. Expandable valve prosthesis with sealing mechanism
US10966823B2 (en) 2007-10-12 2021-04-06 Sorin Group Italia S.R.L. Expandable valve prosthesis with sealing mechanism
US7892276B2 (en) 2007-12-21 2011-02-22 Boston Scientific Scimed, Inc. Valve with delayed leaflet deployment
US8137394B2 (en) 2007-12-21 2012-03-20 Boston Scientific Scimed, Inc. Valve with delayed leaflet deployment
US8414641B2 (en) 2007-12-21 2013-04-09 Boston Scientific Scimed, Inc. Valve with delayed leaflet deployment
US9333100B2 (en) 2008-01-24 2016-05-10 Medtronic, Inc. Stents for prosthetic heart valves
US20090292350A1 (en) * 2008-01-24 2009-11-26 Medtronic, Inc. Stents for Prosthetic Heart Valves
US11607311B2 (en) * 2008-01-24 2023-03-21 Medtronic, Inc. Stents for prosthetic heart valves
US10758343B2 (en) * 2008-01-24 2020-09-01 Medtronic, Inc. Stent for prosthetic heart valves
US20160296327A1 (en) * 2008-01-24 2016-10-13 Medtronic, Inc. Stent for Prosthetic Heart Valves
US8628566B2 (en) * 2008-01-24 2014-01-14 Medtronic, Inc. Stents for prosthetic heart valves
US20210322161A1 (en) * 2008-01-24 2021-10-21 Medtronic, Inc. Stents for Prosthetic Heart Valves
US8840661B2 (en) 2008-05-16 2014-09-23 Sorin Group Italia S.R.L. Atraumatic prosthetic heart valve prosthesis
US9314334B2 (en) 2008-11-25 2016-04-19 Edwards Lifesciences Corporation Conformal expansion of prosthetic devices to anatomical shapes
US10667906B2 (en) 2008-11-25 2020-06-02 Edwards Lifesciences Corporation Methods of conformal expansion of prosthetic heart valves
US8308798B2 (en) 2008-12-19 2012-11-13 Edwards Lifesciences Corporation Quick-connect prosthetic heart valve and methods
US11504232B2 (en) 2008-12-19 2022-11-22 Edwards Lifesciences Corporation Rapid implant prosthetic heart valve system
US9005278B2 (en) 2008-12-19 2015-04-14 Edwards Lifesciences Corporation Quick-connect prosthetic heart valve
US10182909B2 (en) 2008-12-19 2019-01-22 Edwards Lifesciences Corporation Methods for quickly implanting a prosthetic heart valve
US10799346B2 (en) 2008-12-19 2020-10-13 Edwards Lifesciences Corporation Methods for quickly implanting a prosthetic heart valve
US9561100B2 (en) 2008-12-19 2017-02-07 Edwards Lifesciences Corporation Systems for quickly delivering a prosthetic heart valve
US12011350B2 (en) 2008-12-19 2024-06-18 Edwards Lifesciences Corporation Rapid implant prosthetic heart valve system
US10098733B2 (en) 2008-12-23 2018-10-16 Sorin Group Italia S.R.L. Expandable prosthetic valve having anchoring appendages
US8834563B2 (en) 2008-12-23 2014-09-16 Sorin Group Italia S.R.L. Expandable prosthetic valve having anchoring appendages
US20100249894A1 (en) * 2009-03-31 2010-09-30 Edwards Lifesciences Corporation Prosthetic heart valve system
US9931207B2 (en) 2009-03-31 2018-04-03 Edwards Lifesciences Corporation Methods of implanting a heart valve at an aortic annulus
US9248016B2 (en) 2009-03-31 2016-02-02 Edwards Lifesciences Corporation Prosthetic heart valve system
US10842623B2 (en) 2009-03-31 2020-11-24 Edwards Lifesciences Corporation Methods of implanting prosthetic heart valve using position markers
US9980818B2 (en) 2009-03-31 2018-05-29 Edwards Lifesciences Corporation Prosthetic heart valve system with positioning markers
US20100249908A1 (en) * 2009-03-31 2010-09-30 Edwards Lifesciences Corporation Prosthetic heart valve system with positioning markers
US8512397B2 (en) 2009-04-27 2013-08-20 Sorin Group Italia S.R.L. Prosthetic vascular conduit
US20100292782A1 (en) * 2009-05-13 2010-11-18 Sorin Biomedica Cardio S.R.L. Device for the in situ delivery of heart valves
US8353953B2 (en) 2009-05-13 2013-01-15 Sorin Biomedica Cardio, S.R.L. Device for the in situ delivery of heart valves
US20100292783A1 (en) * 2009-05-13 2010-11-18 Sorin Biomedica Cardio S.R.L. Device for surgical interventions
US9168105B2 (en) 2009-05-13 2015-10-27 Sorin Group Italia S.R.L. Device for surgical interventions
US20100292784A1 (en) * 2009-05-13 2010-11-18 Sorin Biomedica Cardio S.r. I. Device for the in situ delivery of heart valves
US8403982B2 (en) 2009-05-13 2013-03-26 Sorin Group Italia S.R.L. Device for the in situ delivery of heart valves
US8696742B2 (en) 2009-06-26 2014-04-15 Edwards Lifesciences Corporation Unitary quick-connect prosthetic heart valve deployment methods
US10555810B2 (en) 2009-06-26 2020-02-11 Edwards Lifesciences Corporation Prosthetic heart valve deployment systems
US9005277B2 (en) 2009-06-26 2015-04-14 Edwards Lifesciences Corporation Unitary quick-connect prosthetic heart valve deployment system
US8348998B2 (en) 2009-06-26 2013-01-08 Edwards Lifesciences Corporation Unitary quick connect prosthetic heart valve and deployment system and methods
US8808369B2 (en) 2009-10-05 2014-08-19 Mayo Foundation For Medical Education And Research Minimally invasive aortic valve replacement
US20110098602A1 (en) * 2009-10-27 2011-04-28 Edwards Lifesciences Corporation Apparatus and Method for Measuring Body Orifice
US10231646B2 (en) 2009-10-27 2019-03-19 Edwards Lifesciences Corporation Device for measuring an aortic valve annulus in an expanded condition
US11412954B2 (en) 2009-10-27 2022-08-16 Edwards Lifesciences Corporation Device for measuring an aortic valve annulus in an expanded condition
US8449625B2 (en) 2009-10-27 2013-05-28 Edwards Lifesciences Corporation Methods of measuring heart valve annuluses for valve replacement
US9603553B2 (en) 2009-10-27 2017-03-28 Edwards Lifesciences Corporation Methods of measuring heart valve annuluses for valve replacement
US10433963B2 (en) 2010-01-22 2019-10-08 4Tech Inc. Tissue anchor and delivery tool
US10058323B2 (en) 2010-01-22 2018-08-28 4 Tech Inc. Tricuspid valve repair using tension
US20130046380A1 (en) * 2010-01-22 2013-02-21 4Tech Inc. Tricuspid valve repair using tension
US20150073543A1 (en) * 2010-03-26 2015-03-12 Thubrikar Aortic Valve, Inc. Valve component, frame component and prosthetic valve device including the same for implantation in a body lumen
US9549814B2 (en) * 2010-03-26 2017-01-24 Thubrikar Aortic Valve, Inc. Valve component, frame component and prosthetic valve device including the same for implantation in a body lumen
US11571299B2 (en) 2010-05-10 2023-02-07 Edwards Lifesciences Corporation Methods for manufacturing resilient prosthetic surgical heart valves
US10702383B2 (en) 2010-05-10 2020-07-07 Edwards Lifesciences Corporation Methods of delivering and implanting resilient prosthetic surgical heart valves
US8986374B2 (en) 2010-05-10 2015-03-24 Edwards Lifesciences Corporation Prosthetic heart valve
EP2568925A4 (en) * 2010-05-12 2015-10-21 Edwards Lifesciences Corp Low gradient prosthetic heart valve
US10463480B2 (en) 2010-05-12 2019-11-05 Edwards Lifesciences Corporation Leaflet for low gradient prosthetic heart valve
US11266497B2 (en) 2010-05-12 2022-03-08 Edwards Lifesciences Corporation Low gradient prosthetic heart valves
US9554901B2 (en) 2010-05-12 2017-01-31 Edwards Lifesciences Corporation Low gradient prosthetic heart valve
US9248017B2 (en) 2010-05-21 2016-02-02 Sorin Group Italia S.R.L. Support device for valve prostheses and corresponding kit
US9795480B2 (en) 2010-08-24 2017-10-24 Millipede, Inc. Reconfiguring tissue features of a heart annulus
CN103237523A (en) * 2010-09-01 2013-08-07 M阀门技术有限公司 Cardiac valve support structure
US9301836B2 (en) 2010-09-01 2016-04-05 Mvalve Technologies Ltd. Cardiac valve support structure
US10105224B2 (en) 2010-09-01 2018-10-23 Mvalve Technologies Ltd. Cardiac valve support structure
US9504563B2 (en) 2010-09-10 2016-11-29 Edwards Lifesciences Corporation Rapidly deployable surgical heart valves
US10039641B2 (en) 2010-09-10 2018-08-07 Edwards Lifesciences Corporation Methods of rapidly deployable surgical heart valves
US10548728B2 (en) 2010-09-10 2020-02-04 Edwards Lifesciences Corporation Safety systems for expansion of prosthetic heart valves
US9125741B2 (en) 2010-09-10 2015-09-08 Edwards Lifesciences Corporation Systems and methods for ensuring safe and rapid deployment of prosthetic heart valves
US9968450B2 (en) 2010-09-10 2018-05-15 Edwards Lifesciences Corporation Methods for ensuring safe and rapid deployment of prosthetic heart valves
US9370418B2 (en) 2010-09-10 2016-06-21 Edwards Lifesciences Corporation Rapidly deployable surgical heart valves
US11471279B2 (en) 2010-09-10 2022-10-18 Edwards Lifesciences Corporation Systems for rapidly deployable surgical heart valves
US12053377B2 (en) 2010-09-10 2024-08-06 Edwards Lifesciences Corporation Methods for rapidly deployable surgical heart valves
US11775613B2 (en) 2010-09-10 2023-10-03 Edwards Lifesciences Corporation Methods of safely expanding prosthetic heart valves
US8641757B2 (en) 2010-09-10 2014-02-04 Edwards Lifesciences Corporation Systems for rapidly deploying surgical heart valves
US11197757B2 (en) 2010-09-10 2021-12-14 Edwards Lifesciences Corporation Methods of safely expanding prosthetic heart valves
US10722358B2 (en) 2010-09-10 2020-07-28 Edwards Lifesciences Corporation Systems for rapidly deployable surgical heart valves
US10736741B2 (en) 2010-09-27 2020-08-11 Edwards Lifesciences Corporation Methods of delivery of heart valves
US11207178B2 (en) 2010-09-27 2021-12-28 Edwards Lifesciences Corporation Collapsible-expandable heart valves
US8845720B2 (en) 2010-09-27 2014-09-30 Edwards Lifesciences Corporation Prosthetic heart valve frame with flexible commissures
US9861479B2 (en) 2010-09-27 2018-01-09 Edwards Lifesciences Corporation Methods of delivery of flexible heart valves
US9161836B2 (en) 2011-02-14 2015-10-20 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US9289289B2 (en) 2011-02-14 2016-03-22 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
US11517426B2 (en) 2011-05-20 2022-12-06 Edwards Lifesciences Corporation Encapsulated heart valves
US10543080B2 (en) 2011-05-20 2020-01-28 Edwards Lifesciences Corporation Methods of making encapsulated heart valves
US10058313B2 (en) 2011-05-24 2018-08-28 Sorin Group Italia S.R.L. Transapical valve replacement
US9668859B2 (en) 2011-08-05 2017-06-06 California Institute Of Technology Percutaneous heart valve delivery systems
US10238489B2 (en) 2011-12-21 2019-03-26 Edwards Lifesciences Corporation Anchoring device and method for replacing or repairing a heart valve
US10849752B2 (en) 2011-12-21 2020-12-01 Edwards Lifesciences Corporation Methods for anchoring a device at a native heart valve annulus
US9078747B2 (en) 2011-12-21 2015-07-14 Edwards Lifesciences Corporation Anchoring device for replacing or repairing a heart valve
US11452602B2 (en) 2011-12-21 2022-09-27 Edwards Lifesciences Corporation Anchoring device for replacing or repairing a native heart valve annulus
US9138314B2 (en) 2011-12-29 2015-09-22 Sorin Group Italia S.R.L. Prosthetic vascular conduit and assembly method
US8685084B2 (en) 2011-12-29 2014-04-01 Sorin Group Italia S.R.L. Prosthetic vascular conduit and assembly method
US10940167B2 (en) 2012-02-10 2021-03-09 Cvdevices, Llc Methods and uses of biological tissues for various stent and other medical applications
US10543088B2 (en) 2012-09-14 2020-01-28 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
US10849755B2 (en) 2012-09-14 2020-12-01 Boston Scientific Scimed, Inc. Mitral valve inversion prostheses
US10449050B2 (en) 2013-01-09 2019-10-22 4 Tech Inc. Soft tissue depth-finding tool
US11406495B2 (en) 2013-02-11 2022-08-09 Cook Medical Technologies Llc Expandable support frame and medical device
US9907681B2 (en) 2013-03-14 2018-03-06 4Tech Inc. Stent with tether interface
US10058425B2 (en) 2013-03-15 2018-08-28 Edwards Lifesciences Corporation Methods of assembling a valved aortic conduit
US9744037B2 (en) 2013-03-15 2017-08-29 California Institute Of Technology Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves
US11007058B2 (en) 2013-03-15 2021-05-18 Edwards Lifesciences Corporation Valved aortic conduits
US11648116B2 (en) 2013-03-15 2023-05-16 Edwards Lifesciences Corporation Methods of assembling valved aortic conduits
US11464633B2 (en) 2013-06-12 2022-10-11 Edwards Lifesciences Corporation Heart valve implants with side slits
US10314706B2 (en) 2013-06-12 2019-06-11 Edwards Lifesciences Corporation Methods of implanting a cardiac implant with integrated suture fasteners
US9468527B2 (en) 2013-06-12 2016-10-18 Edwards Lifesciences Corporation Cardiac implant with integrated suture fasteners
US9968451B2 (en) 2013-06-12 2018-05-15 Edwards Lifesciences Corporation Cardiac implant with integrated suture fasteners
US10702680B2 (en) 2013-08-28 2020-07-07 Edwards Lifesciences Corporation Method of operating an integrated balloon catheter inflation system
US9919137B2 (en) 2013-08-28 2018-03-20 Edwards Lifesciences Corporation Integrated balloon catheter inflation system
US11266499B2 (en) 2013-09-20 2022-03-08 Edwards Lifesciences Corporation Heart valves with increased effective orifice area
US10441415B2 (en) 2013-09-20 2019-10-15 Edwards Lifesciences Corporation Heart valves with increased effective orifice area
US10722316B2 (en) 2013-11-06 2020-07-28 Edwards Lifesciences Corporation Bioprosthetic heart valves having adaptive seals to minimize paravalvular leakage
US12089971B2 (en) 2013-11-06 2024-09-17 Edwards Lifesciences Corporation Bioprosthetic heart valves having adaptive seals to minimize perivalvular leakage
US9956384B2 (en) 2014-01-24 2018-05-01 Cook Medical Technologies Llc Articulating balloon catheter and method for using the same
US9549816B2 (en) 2014-04-03 2017-01-24 Edwards Lifesciences Corporation Method for manufacturing high durability heart valve
US11376122B2 (en) 2014-04-30 2022-07-05 Edwards Lifesciences Corporation Holder and deployment system for surgical heart valves
US9585752B2 (en) 2014-04-30 2017-03-07 Edwards Lifesciences Corporation Holder and deployment system for surgical heart valves
US11980544B2 (en) 2014-04-30 2024-05-14 Edwards Lifesciences Corporation Holder and deployment system for prosthetic heart valves
US10307249B2 (en) 2014-04-30 2019-06-04 Edwards Lifesciences Corporation Holder and deployment system for surgical heart valves
US9504566B2 (en) 2014-06-20 2016-11-29 Edwards Lifesciences Corporation Surgical heart valves identifiable post-implant
US11154394B2 (en) 2014-06-20 2021-10-26 Edwards Lifesciences Corporation Methods of identifying and replacing implanted heart valves
US10130469B2 (en) 2014-06-20 2018-11-20 Edwards Lifesciences Corporation Expandable surgical heart valve indicators
US12023235B2 (en) 2014-07-17 2024-07-02 Boston Scientific Scimed, Inc. Adjustable endolumenal implant for reshaping the mitral valve annulus
US9615926B2 (en) 2014-07-17 2017-04-11 Millipede, Inc. Adjustable endolumenal implant for reshaping the mitral valve annulus
US9622862B2 (en) 2014-07-17 2017-04-18 Millipede, Inc. Prosthetic mitral valve with adjustable support
US9180005B1 (en) 2014-07-17 2015-11-10 Millipede, Inc. Adjustable endolumenal mitral valve ring
US9913706B2 (en) 2014-07-17 2018-03-13 Millipede, Inc. Adjustable endolumenal implant for reshaping the mitral valve annulus
US10136985B2 (en) 2014-07-17 2018-11-27 Millipede, Inc. Method of reconfiguring a mitral valve annulus
US10695160B2 (en) 2014-07-17 2020-06-30 Boston Scientific Scimed, Inc. Adjustable endolumenal implant for reshaping the mitral valve annulus
US9848983B2 (en) 2015-02-13 2017-12-26 Millipede, Inc. Valve replacement using rotational anchors
US10258466B2 (en) 2015-02-13 2019-04-16 Millipede, Inc. Valve replacement using moveable restrains and angled struts
US11918462B2 (en) 2015-02-13 2024-03-05 Boston Scientific Scimed, Inc. Valve replacement using moveable restraints and angled struts
USD867594S1 (en) 2015-06-19 2019-11-19 Edwards Lifesciences Corporation Prosthetic heart valve
USD893031S1 (en) 2015-06-19 2020-08-11 Edwards Lifesciences Corporation Prosthetic heart valve
US11690714B2 (en) 2015-07-02 2023-07-04 Edwards Lifesciences Corporation Hybrid heart valves adapted for post-implant expansion
US10695170B2 (en) 2015-07-02 2020-06-30 Edwards Lifesciences Corporation Hybrid heart valves adapted for post-implant expansion
US11654020B2 (en) 2015-07-02 2023-05-23 Edwards Lifesciences Corporation Hybrid heart valves
US10456246B2 (en) 2015-07-02 2019-10-29 Edwards Lifesciences Corporation Integrated hybrid heart valves
US11690709B2 (en) 2015-09-02 2023-07-04 Edwards Lifesciences Corporation Methods for securing a transcatheter valve to a bioprosthetic cardiac structure
US10751174B2 (en) 2015-09-10 2020-08-25 Edwards Lifesciences Corporation Limited expansion heart valve
US11806232B2 (en) 2015-09-10 2023-11-07 Edwards Lifesciences Corporation Limited expansion valve-in-valve procedures
US10080653B2 (en) 2015-09-10 2018-09-25 Edwards Lifesciences Corporation Limited expansion heart valve
US10335275B2 (en) 2015-09-29 2019-07-02 Millipede, Inc. Methods for delivery of heart valve devices using intravascular ultrasound imaging
US10555813B2 (en) 2015-11-17 2020-02-11 Boston Scientific Scimed, Inc. Implantable device and delivery system for reshaping a heart valve annulus
US11471275B2 (en) 2016-03-08 2022-10-18 Edwards Lifesciences Corporation Valve implant with integrated sensor and transmitter
US10667904B2 (en) 2016-03-08 2020-06-02 Edwards Lifesciences Corporation Valve implant with integrated sensor and transmitter
US10456245B2 (en) 2016-05-16 2019-10-29 Edwards Lifesciences Corporation System and method for applying material to a stent
USD846122S1 (en) 2016-12-16 2019-04-16 Edwards Lifesciences Corporation Heart valve sizer
US10548731B2 (en) 2017-02-10 2020-02-04 Boston Scientific Scimed, Inc. Implantable device and delivery system for reshaping a heart valve annulus
US10463485B2 (en) 2017-04-06 2019-11-05 Edwards Lifesciences Corporation Prosthetic valve holders with automatic deploying mechanisms
US11376125B2 (en) 2017-04-06 2022-07-05 Edwards Lifesciences Corporation Prosthetic valve holders with automatic deploying mechanisms
US10799353B2 (en) 2017-04-28 2020-10-13 Edwards Lifesciences Corporation Prosthetic heart valve with collapsible holder
US11911273B2 (en) 2017-04-28 2024-02-27 Edwards Lifesciences Corporation Prosthetic heart valve with collapsible holder
US11135057B2 (en) 2017-06-21 2021-10-05 Edwards Lifesciences Corporation Dual-wireform limited expansion heart valves
US20230233325A1 (en) * 2017-07-06 2023-07-27 Raghuveer Basude Tissue grasping devices and related methods
US11648118B2 (en) * 2017-07-06 2023-05-16 Raghuveer Basude Tissue grasping devices and related methods
US11337805B2 (en) 2018-01-23 2022-05-24 Edwards Lifesciences Corporation Prosthetic valve holders, systems, and methods
US11969341B2 (en) 2018-05-23 2024-04-30 Corcym S.R.L. Cardiac valve prosthesis
US11504231B2 (en) 2018-05-23 2022-11-22 Corcym S.R.L. Cardiac valve prosthesis
USD995774S1 (en) 2018-07-11 2023-08-15 Edwards Lifesciences Corporation Collapsible heart valve sizer
USD908874S1 (en) 2018-07-11 2021-01-26 Edwards Lifesciences Corporation Collapsible heart valve sizer
USD952143S1 (en) 2018-07-11 2022-05-17 Edwards Lifesciences Corporation Collapsible heart valve sizer
US11554012B2 (en) 2019-12-16 2023-01-17 Edwards Lifesciences Corporation Valve holder assembly with suture looping protection
US11951006B2 (en) 2019-12-16 2024-04-09 Edwards Lifesciences Corporation Valve holder assembly with suture looping protection

Also Published As

Publication number Publication date
US20050075719A1 (en) 2005-04-07
US20050075730A1 (en) 2005-04-07
US20050075718A1 (en) 2005-04-07
US20050096738A1 (en) 2005-05-05
EP2789314A2 (en) 2014-10-15
US20050075724A1 (en) 2005-04-07
US20050075584A1 (en) 2005-04-07
US20050075720A1 (en) 2005-04-07
US20050075717A1 (en) 2005-04-07
US7101396B2 (en) 2006-09-05
EP2789314A3 (en) 2014-10-22
US7044966B2 (en) 2006-05-16
US20050075729A1 (en) 2005-04-07
EP2789314B1 (en) 2018-04-25
US20050075731A1 (en) 2005-04-07
US20050075728A1 (en) 2005-04-07
US20050075726A1 (en) 2005-04-07
US20050075712A1 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
US7101396B2 (en) Minimally invasive valve replacement system
EP1684671B1 (en) Minimally invasive valve replacement system
EP2040645B1 (en) Minimally invasive valve replacement system
JP6559730B2 (en) Cardiovascular prosthetic valve and system having the cardiovascular prosthetic valve
CN109199639B (en) Prosthetic heart valve devices, prosthetic mitral valves, and associated systems and methods
KR101146035B1 (en) Stent-valves for valve replacement and associated methods for surgery
JP2016519973A (en) Implantable heart valve device, mitral valve repair device, and related systems and methods
JP2009520535A (en) Valve replacement stent valves and related surgical methods and systems
WO2008092101A9 (en) Methods and systems for reducing paravalvular leakage in heart valves
US20230079043A1 (en) Tip assemblies, systems, and methods for fracturing a frame of a deployed prosthesis

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION